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Abstract  
In   this   PhD   thesis   I   summarize   my   research   into   the   genetics   and  
pathophysiology   of   progressive  myoclonus   epilepsy   (PME)   associated   with  
mutations   in  GOSR2.  This  disorder   is  characterized  by  early  disease  onset  
with   ataxia   around   3   years   of   age,   followed   by   development   of   cortical  
myoclonus,  generalized  epilepsy  and  a  rapid  deterioration  of  motor  function.  
Upon   beginning   my   PhD,   only   one   homozygous   GOSR2   mutation   –  
c.430G>T   (p.G144W)   –   had   been   shown   to   cause   PME.   Furthermore,  
because  GOSR2   encodes   a   Golgi   SNARE   protein   (termed   Membrin)   that  
mediates  ER-­to-­Golgi   trafficking   in  every  cell  of   the  human  body,   it  was  an  
unresolved   mystery   how   this   mutation   gives   rise   to   a   largely   selective  
neuronal  disorder.  
I   first   describe   my   discovery   of   the   novel   c.491-­493delAGA   (p.K164del)  
GOSR2  mutation  in  a  PME  patient  who  also  carried  the  previously  described  
c.430G>T  variant   in   the  compound  heterozygous  state.  Overall,   the  clinical  
phenotype   of   this   patient   was   remarkably   consistent   with   previous   cases,  
although  her  disease  course  appeared  milder.  My  finding  thus  expanded  the  
phenotypes   and   genotypes   linked   to   this   disorder,   thus   providing   an  
additional  tool  to  investigate  the  underlying  disease  mechanisms.  
In   the   subsequent   chapters   I   summarize   our   attempts   to   unravel   why   the  
nervous   system   is   selectively   affected   in   GOSR2-­PME.   To   this   end   I  
examined   how   pathogenic   Membrin   mutations   impacted   ER-­to-­Golgi  
trafficking   in   patient-­derived   fibroblasts,   and   developed   novel   Drosophila  
models   of   GOSR2-­PME   to   study   neuronal   pathophysiology.   Intriguingly,  
while   ER-­to-­Golgi   trafficking   was   remarkably   preserved   in   G144W   mutant  
Membrin   fibroblasts,   neuronal   integrity   was   severely   disturbed   in  GOSR2-­
PME  model  Drosophila,  where  dendrites  were  significantly  shorter.  Neurons  
have  special  secretory  demands  owing  to  their  very  large  surface  area,  and  
hence   appear   selectively   vulnerable   to   partial   loss   of   function  mutations   in  
Membrin.   Thus,   the   results   presented   in   this   thesis   provide   a   possible  
explanation  for  the  nervous  system  specificity  of  GOSR2-­PME.     
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MFI         Mean  Fluorescence  Intensity  
MOPS        3-­(N-­Morpholino)Propanesulfonic  acid  
MRI         Magnetic  Resonance  Imaging  
NA         Numerical  Aperture  
NBD         7-­Nitro-­2-­1,3-­Benzoxadiazol-­4-­yl  
NCBI         National  Center  for  Biotechnology  Information  
NCL         Neuronal  Ceroid  Lipofuscinosis  
NMJ         Neuromuscular  Junction  
NSF         N-­ethylmaleimide-­Sensitive  Factor  
nsyb         neuronal  synaptobrevin  
PBS         Phosphate  Buffered  Saline  
PBT         Phosphate  Buffer  Triton  X-­100  
PCC         Pearson’s  Correlation  Coefficient  
PCR         Polymerase  Chain  Reaction  
PDI         Protein  Disulfide  Isomerase  
PFA         Paraformaldehyde  
PMA         Progressive  Myoclonus  Ataxia  
PME         Progressive  Myoclonus  Epilepsy  
ppk         pickpocket  
PVDF        Polyvinylidene  Difluoride  
RFP         Red  Fluorescent  Protein  
RNA         Ribonucleic  Acid  
ROI         Region  of  Interest  
SCA         Spinocerebellar  Ataxia  
Sco         Scutoid  
SD         Standard  Deviation  
SDS         Sodium  Dodecyl  Sulfate  
SEM         Standard  Error  of  the  Mean  
SIFT         Sorting  Tolerant  From  Intolerant  
SM         Sec1/Munc18-­like  
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SNAP        Soluble  NSF-­Attachment  Protein  
SNAP-­25      Synaptosomal-­associated  Protein  25  
SNARE      SNAP  Receptor  
SNP         Single  Nucleotide  Polymorphism  
ssDNA      single  stranded  DNA  
Tb         Tubby  
TBST         Tris-­Buffered  Saline  Tween  20  
tdGFP        tandem  GFP  
TeNT         Tetanus  Neurotoxin  
TGN         Trans-­Golgi  Network  
TM2/3/6B      Third  Multiple  2/3/6B  
TMR         Tetramethylrhodamin  
TRAPP      Transport  Protein  Particle  
UAS         Upstream  Activating  Sequence  
ULD         Unverricht-­Lundborg  Disease  
UTR         Untranslated  Region  
v-­/t-­SNARE      vesicle-­/target-­SNARE  
VAMP        Vesicle-­Associated  Membrane  Protein  
VSV         Vesicular  Stomatitis  Virus  
VTC         Vesicular  Tubular  Clusters  
w         white  
WT         Wild-­Type  
y         yellow  
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Chapter  1.            Introduction  
Scientific   endeavor   aims   to   provide   a   better   understanding   of   the   ‘inner  
workings’   of   the  world.   This   knowledge   allows   predictions   to   be  made   and  
targeted   interventions   to   be   undertaken   in   an   attempt   to   benefit   mankind.  
Especially   in  disease   research   this  notion   is  a  common  driving   force.  Here,  
the  ultimate  aim  consists   in  developing  better  treatments  to  alleviate  human  
suffering.   To   discover   such   treatments   one   can   either   take   a   brute-­force  
approach  and  test  for  treatments  that  reduce  phenotypes  in  disease  models  
or   rationally   design   compounds   that   interfere   with   a   previously   discovered  
disease  mechanism.   The   power   of   the   latter   approach   is   illustrated   by   the  
potency  of   the  anti-­cancer  drug   imatinib,  which   is  a  specific   tyrosine-­kinase  
inhibitor  that  targets  the  Bcr-­Abl  oncogene.  It  thereby  directly  interferes  with  a  
previously  discovered  molecular  cause  of  chronic  myeloid   leukemia  (Druker  
et  al.,  2001;;  1996).  
Also   in  neurology   research  our  highest-­resolution  understanding  of  disease  
mechanisms   stem   from   investigating   the   malfunctions   of   individual  
molecules,  which   can   serve  as  a   fundament   for   drug  design.  An   incredible  
number  of  such  culprit  molecules  has  been  uncovered  by  extensive  studies  
into   the   genetics   of   neurological   disorders,   yet   often   the   precise   causal  
chains   that   lead   to   the   respective   phenotypic   changes   are   unclear.   Thus,  
important   lessons   about   disease   pathways   can   be   learned   by   in   depth  
functional   investigations   of   such   genetic   variants.   These   findings   in   turn  
might   one   day   serve   as   a   stepping   stone   to   ultimately   be   able   to   design  
treatments  for  the  same  or  related  disorders.  
In  the  present  study  we  are  aiming  to  provide  one  such  mechanism  –  ideally  
the   most   proximal   causal   ‘bottleneck’   –   which   bridges   the   gaping   gorge  
between  genotype  and  phenotype.  The  disease  at  hand  is  one  specific  form  
of  progressive  myoclonus  epilepsy  (PME)  caused  by  mutations   in   the  Golgi  
SNAP   receptor   complex  member  2   (GOSR2)   gene.  Even   though   this   is  an  
extremely   rare   disorder   it   captured   my   attention   because   of   its   striking  
phenotype,   that   cannot   intuitively   be   linked   with   the   mutated   gene’s  
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physiological  function.  The  nervous  system  of  GOSR2-­PME  patients  is  in  an  
almost   constant   state   of   hyperexcitablity,   as   they   suffer   from   generalized  
action-­myoclonus.   In   addition,   they   are   severely   uncoordinated,   yet   no  
profound   neurodegeneration   is   apparent.   Interestingly,   these   changes   are  
the   result   of   the  mutation   in   a   Golgi   SNARE   protein,   which   at   first   glance  
appears   as   an   unlikely   candidate   to   cause   a   disorder   restricted   to   the  
nervous   system.   Because   the   neuronal   intricacies   of   Golgi   trafficking   has  
received   comparably   little   attention,   it   seemed   that   studying   the  
pathophysiology  of  GOSR2-­PME  was  not  only  interesting  from  a  disease  but  
also   from   a   general   cell   biological   point   of   view.   The   notion   that   in-­depth  
disease   studies   can   teach   important   lessons   in   physiology   is   prominently  
exemplified  by  the  discovery  of  receptor-­mediated  endocytosis   in  fibroblasts  
derived   from  patients  with   familial  hypercholesterinemia,  which  harbor  LDL-­
receptor  mutations  (Brown  and  Goldstein,  1986).  
In  this  section  I  will  introduce  the  group  of  progressive  myoclonus  epilepsies;;  
focus  more  specifically  on  GOSR2-­PME;;  summarize  the  physiological  role  of  
Membrin,   which   is   encoded   by   the   GOSR2   gene;;   and   discuss   SNARE  
proteins,  the  secretory  pathway  and  its  intricacies  within  neurons.  
1.1          The  progressive  myoclonus  epilepsies  
The  progressive  myoclonus  epilepsies  (PME)  are  a  heterogeneous  group  of  
severe   neurological   disorders   characterized   by   myoclonus   and   epileptic  
seizures  with  a  progressive  disease  course  often  involving  cerebellar  ataxia,  
and  the  development  of  dementia  in  some  but  not  all  forms  (Michelucci  et  al.,  
2012).   Overall,   they   are   rare   entities   and   their   abundance   varies   with  
geographical   location   (Marseille  Consensus  Group,   1990).   These  disorders  
often   manifest   for   the   first   time   in   childhood   and   thereafter   relentlessly  
progress,  with  no  effective  treatment  available  to  reverse  or  halt  the  disease  
course.  While  generalized  seizures  may  be  reduced  with  currently  available  
antiepileptic  drugs,  myoclonus  is  often  only  poorly  controllable  (Michelucci  et  
al.,  2016).  These  myoclonic   jerks  are  characterized  by  sudden,   involuntary,  
brief   muscle   contractions   leading   to   small   movements.   Also   ‘negative  
myoclonus’  occurs  in  PME,  where  muscle  tone  is  transiently  lost  (Kojovic  et  
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al.,  2011).  These  movement  disorder   features  of  PME  are  of  cortical  origin,  
and   therefore   constitute   ‘cortical   myoclonus’.   The   causative   cortical  
hyperactivity  can  appear  subtle  in  EEG  recordings.  Averaging  the  EEG  signal  
prior  to  the  muscle  jerks  as  detected  by  electromyography  (EMG)  in  a  time-­
locked  manner  increases  sensitivity  (Avanzini  et  al.,  2016).  While  myoclonus  
is  a  defining  feature  of  PME,  other  forms  of  epilepsy  such  as  generalized  or  
focal   seizures   can   be   infrequent   or   absent,   and   instead   ataxia   more  
dominant.   Such   syndromes   are   therefore   rather   referred   to   as   progressive  
myoclonus   ataxias   (PMA),   which   are   phenotypically   continuous   with   the  
PMEs   (Marseille   Consensus   Group,   1990).   For   simplicity,   I   will   use   the  
concept  PME  collectively   for   this   spectrum.  Because  PME   is   a   very  widely  
encompassing  term  –  it  broadly  describes  neurological  syndromes  of  cortical  
myoclonus   and   epilepsy   with   progressive   disease   features   such   as  
deteriorating   ataxia   and   often   cognitive   decline   –   this   group   of   disorders  
exhibits   large   phenotypic   variability   and   contains   many   different   individual  
diseases.  The  known  causes  of  PME  are  mutations  in  single  genes,  of  which  
several   have   been   discovered   to   date.   A   large   fraction   of   PME   cases   still  
lacks  molecular  diagnoses  despite   thorough   investigation,  which  makes   the  
discovery  of  more  genes  linked  to  this  syndrome  likely  (Franceschetti  et  al.,  
2014;;  Muona  et  al.,  2015).  Amongst   the  PMEs  two  main  subcategories  can  
phenotypically  be  distinguished.  One  group  of  PMEs  deteriorates  cognitively  
to   a   substantial   degree   during   the   course   of   the   disease   while   the   other  
group   largely   retains   normal   cognitive   abilities   or   only   develops   mild  
impairment  (Michelucci  et  al.,  2012).    
1.1.1          PMEs  with  dementia  
One   common   group   of   disorders   within   the   PMEs   that   cause   cognitive  
impairment   are   the   neuronal   ceroid   lipofuscinoses   (NCLs),   where   currently  
14  loci  are  known  (CLN1-­14;;  for  an  overview  of  PME  syndromes  see  Table  
1)   (Nita   et   al.,   2016).   These   disorders   are   the   most   frequent   causes   of  
childhood  neurodegeneration   (Nita  et  al.,  2016).  According   to  age  of  onset,  
infantile,   late-­infantile,   juvenile   and   adult   onset  NCL   are   distinguished   from  
each   other.   Several   NCLs   also   affect   the   retina,   leading   to   blindness.   The  
defining   feature   of   these   disorders   is   the   accumulation   of   auto-­fluorescent  
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lipofuscin   in   neurons   and   non-­neuronal   cells.   Characteristically,   in   electron  
microscopy,   distinct   aggregate   profiles   can   frequently   be   seen   (Minassian,  
2014).   Interestingly,  many  of  the  NCL  genes  encode  lysosomal  degradation  
enzymes,   therefore   linking   these   disorders   to   the   lysosomal   compartment  
(Nita  et  al.,  2016).  Another  common  PME  with  dementia   is  Lafora  disease,  
caused  by  mutations  of  the  genes  encoding  laforin  and  malin  (Turnbull  et  al.,  
2016).  In  this  disorder  abnormal  insoluble  glycogen  accumulates  in  neurons  
and  also  outside   the  brain   (Girard  et  al.,  2013).  These  deposits  are   termed  
Lafora  bodies  and  can  be  diagnostic  if  detected  in  skin  biopsies  (Turnbull  et  
al.,  2016).  Mutations  in  the  mitochondrial  genome  can  also  give  rise  to  PME  
with   cognitive   decline,   such   as   in   Myoclonic   Epilepsy   with   Ragged   Red  
Fibers   (MERRF),   which   is  most   commonly   causes   by   an   A>G  mutation   at  
position   8344   in   the  mitochondrial   lysine   tRNA   gene  MT-­TK   (Lamperti   and  
Zeviani,   2016).   Sialidoses,   which   are   caused   by   NEU1   mutations,   are  
amongst   the  more  common   forms  of  PME.  Of   the   two  subforms   the  milder  
sialidosis  I  has  a  more  typical  PME  phenotype  while  type  II  exhibits  additional  
disease   features,   such   as   dysmorphic   facial   features   or   hepatomegaly  
(Franceschetti  and  Canafoglia,  2016).  Due  to  sialidase-­1  (encoded  by  NEU1)  
deficiency,   lysosomal   sialic   acid   removal   is   impaired   in   this   disorder   and  
therefore   leads   to   storage   of   incompletely   degraded   macromolecules  
(Franceschetti   and   Canafoglia,   2016).   Also   dentatorubral-­pallidoluysian  
atrophy  due   to  mutations   in   the  DRPLA   (ATN1)  gene  can  give   rise   to  PME  
with  cognitive  decline,  with   the  additional  clinical   feature  of  choreoathetosis  
(Tsuji,  2012).  
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Table  1.  List  of  different  PMEs  
This   heterogeneous   group   of   disorders   –   commonly   characterized   by  
myoclonus,   ataxia,   epilepsy   and   a   progressive   disease   course   –   was   further  
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1.1.2          PMEs  without  dementia  
The   paradigmatic   PME   with   generally   preserved   cognition   is   Unverricht-­
Lundborg  disease  (ULD).  It  is  regarded  the  ‘purest’  form  of  PME  due  to  lack  
of  additional  neurological  features  and  was  the  first  disorder  that  was  named  
PME  (Genton  et  al.,  2016).  The  pathogenic  changes  that  give  rise  to  ULD  are  
homozygous   mutations   in   the   Cystatin-­B   encoding   gene   CSTB   or   repeat  
expansions   close   to   its   transcription   start   site   (Lalioti   et   al.,   1997a;;   1997b;;  
Pennacchio   et   al.,   1996).   Cystatin-­B   deficient   mice   exhibit   myoclonic  
seizures   and   mild   ataxia,   with   apoptosis   of   cerebellar   granule   cells  
(Pennacchio  et  al.,  1998).  In  human  ULD  patients  phenotypic  severity  varies  
widely   from   fully   wheelchair   bound   states   to   mild   disease   courses   with  
normal   professional   employment   (Crespel   et   al.,   2016).   Besides   CSTB,  
several   other   genes   have   been   linked   to   PME   with   largely   preserved  
cognition.  Mutations   in  SCARB2,   the   gene   encoding   the   lysosomal   sorting  
receptor  (LIMP-­2)  for  b-­glucocerebrosidase,  have  originally  been  discovered  
as  the  cause  of  action-­myoclonus  renal  failure  syndrome  (AMRF)  (Balreira  et  
al.,   2008;;   Berkovic   et   al.,   2008).   This   PME   form   exhibits   as   distinguishing  
features   proteinuria   and   renal   failure.   Later,   homozygous  mutations   in   this  
gene  have  been  shown  to  also  cause  PME  without  renal  failure  (Dibbens  et  
al.,   2009).   Peripheral   neuropathy   and   auditory   changes   have   infrequently  
been   reported   in   this   disease,   thereby   partially   recapitulating   features   of  
Limp2  knock-­out  mice,  which  otherwise  do  not  exhibit  myoclonus  or  epilepsy  
(Berkovic   et   al.,   2008;;   Dibbens   et   al.,   2016).      Despite   rapid   disease  
progression  with   premature   death   approximately   one   decade   after   disease  
onset,   cognitive   function   remains   remarkably   preserved   in   SCARB2-­PME  
(Dibbens  et  al.,  2016).  Also  mutations  in  PRICKLE1,  a  gene  involved  in  the  
planar  cell  polarity  pathway,  have  been  shown  to  cause  PME  without  gross  
intellectual   impairment   (Bassuk   et   al.,   2008).   The   first   symptom   typically   is  
ataxia   around   4   years   of   age   and   impaired   upgaze   and   mild   sensory  
neuropathy   have   been   reported   as   additional   features   in   some   of   these  
patients.  Pronounced  cognitive  decline  seems  not   to  be  part  of  PRICKLE1-­
PME   (Bassuk   et   al.,   2008).   Recently,   mutations   in   KCNC1,   encoding   the  
Kv3.1   potassium   channel   subunit,   have   been   shown   to   cause   PME   with  
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largely   preserved   intellect   (Muona   et   al.,   2015).   This   syndrome   is   also  
referred  to  as  myoclonus  epilepsy  and  ataxia  due  to  potassium  (K+)  channel  
mutation  (MEAK).  In  contrast  to  autosomal-­recessive  inheritance  in  the  other  
PMEs   without   dementia,   MEAK   is   caused   by   the   same   R320H   dominant-­
negative  loss  of  function  mutation,  which  typically  arises  de  novo  and  rarely  
is  transmitted  across  generations  (Oliver  et  al.,  2017).  It  was  suggested  that  
KV3.1   has   an   important   role   in   fast-­firing   GABAergic   interneurons   and  
therefore  it  was  speculated  that  hyperexcitability  in  MEAK  could  be  explained  
by   preferential   impairment   of   inhibitory   neurotransmission   (Muona   et   al.,  
2015).  
Several  other  genetic  mutations  can  give  rise  to  a  PME  phenotype,  which  are  
rare   and/or   unlike  GOSR2-­PME  and   therefore   not   elaborated  upon  here   in  
further  detail.    
  
1.2          GOSR2-­PME  
Mutations   in   GOSR2   were   first   described   as   a   novel   cause   of   PME   by  
Corbett   and   colleagues   (Corbett   et   al.,   2011).   They   applied   homozygosity  
mapping   to  an  Australian  PME  patient  with   second-­cousin   consanguineous  
British   parents   and   subsequently   identified   the   same   homozygous   G144W  
(c.430G>T)  GOSR2  mutation  in  four  further  pedigrees.  Subsequently  Lomax  
et  al.  provided  a  more  detailed  clinical  description  of   this  disorder  based  on  
the  previous  six  and  an  additional  six  patients   (Boissé  Lomax  et  al.,  2013).  
Because  the  birthplaces  of   the  patients’  parents  all  clustered   in  proximity  of  
the  North  Sea  –   they  originated   form   the  Netherlands,  Germany,  Denmark,  
Belgium,   the  UK  and  Norway  –   they   termed   this  disorder   ‘North  Sea  PME’.  
Van  Egmond  et   al.   published  an  additional   five  GOSR2-­PME  patients   (van  
Egmond   et   al.,   2015;;   2014).   All   of   these   17   patients   exhibited   the   same  
homozygous  G144W  GOSR2  mutation,  which  likely  originated  approximately  
3600  years  ago  in  a  single  founder  (Boissé  Lomax  et  al.,  2013;;  Corbett  et  al.,  
2011).   The  GOSR2-­PME   summary   below   is   based   on   information   derived  
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from  these  four  reports  (Corbett  et  al.,  2011;;  Boissé  Lomax  et  al.,  2013;;  van  
Egmond  et  al.,  2015;;  2014).  
The   clinical   characteristics   of   the   GOSR2-­PME   patients   are   remarkably  
uniform.  Typically,   the   first   symptom   is   ataxia  with   onset   between  one   and  
five   years   of   age.   Subsequently,   within   the   first   decade   of   life,   cortical  
myoclonus  develops.  These  muscle   jerks  are  pronounced  upon  action,   less  
frequent   or   absent   if   patients   are   at   rest   or   relaxed,   can   be   focal   or  multi-­
focal,   and   often   are   generalized.   Furthermore,   they   are   sensitive   to   photic,  
tactile  and  auditory  stimuli  and  emotional  stress  (Boissé  Lomax  et  al.,  2013;;  
van  Egmond  et  al.,  2014).  Usually  after  the  onset  of  myoclonus  other  forms  
of   seizures   develop.   Generalized   tonic-­clonic   seizures   are   present   in  most  
GOSR2-­PME   patients,   also   absence   seizures   are   frequently   observed   and  
other   seizure   types   such   as   febrile   seizures,   status  myoclonicus,   nocturnal  
myoclonus,   clonic   seizures,   tonic   seizures   and   drop   attacks   have   been  
reported.   Due   to   rapid   disease   progression   patients   are   wheelchair-­bound  
mostly   by   their   second   decade   of   life.   This   is   usually   not   due   to   a   lack   of  
strength,   but   rather   because   of   the   highly   disabling   action-­myoclonus   and  
ataxia   (Boissé   Lomax   et   al.,   2013).   Because   of   the   relentless   motor  
deterioration,   premature   death   in   the   third   or   fourth   decade   of   life   has  
frequently   been   reported.   In   contrast   to   this   rapid   worsening   of   movement  
disorder   features   in   GOSR2-­PME,   cognitive   functions   remain   mostly  
unchanged,  except  in  some  patients  where  mild  deficits  have  been  reported  
in  the  last  years  prior  to  their  death  (Boissé  Lomax  et  al.,  2013).  The  absence  
of  deep-­tendon  reflexes  –  areflexia  –  has  been  reported  in  most  patients  with  
GOSR2-­PME,  which  seems  to  be  specific  to  this  PME  subtype.  Furthermore,  
the   development   of   scoliosis   prior   to   adolescence   is   very   common.   The  
presence   of   early   onset   areflexia   and   scoliosis   in   a   PME   patient   without  
dementia   thus   can   be   important   clinical   clues   towards   an   underlying  
pathogenic   GOSR2   mutation.   In   addition   to   scoliosis,   also   other   skeletal  
abnormalities  have  been  described.  Four  GOSR2-­PME  patients  have  been  
reported  to  have  pes  cavus,  a  distinct  foot  shape  with  an  unusually  high  arch.  
This   deformity   is   also   seen   in   peripheral   neurological   disorder   such   as  
Charcot-­Marie-­Tooth   disease   (Saporta   et   al.,   2011).   Three   GOSR2-­PME  
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patients  have  been  reported  with  syndactyly,  where  fingers  or  toes  are  fused  
to   each   other   (Boissé   Lomax   et   al.,   2013;;   van   Egmond   et   al.,   2014).  
Neurodegeneration  appears  not   to   be  a  prominent   feature  of  GOSR2-­PME  
as   MRI   scans   were   mostly   reported   to   be   normal.   Neuropathological  
examination  of   the  Australian  case   revealed  only  a  minor   loss  of  cerebellar  
Purkinje   cells   and   no   abnormal   storage   material,   such   as   Lafora   bodies  
(Corbett  et  al.,   2011).  One  characteristic   laboratory   finding   in  GOSR2-­PME  
patients   is   the   elevation   of   serum   creatine   kinase   levels,   which   has   been  
reported   in   most   patients.   However,   muscle   biopsies   were   usually   normal  
(Boissé   Lomax   et   al.,   2013;;   van   Egmond   et   al.,   2014).   Nerve   conduction  
studies  revealed  neuropathy   in  some  patients.  While  Corbett  et  al.   reported  
mostly   normal   electromyography   (EMG),   van   Egmond   et   al.   found   in   the  
majority   of   their   patients   clear   signs   of   neuromuscular   junction   motor   unit  
abnormalities   (Corbett   et   al.,   2011;;   van   Egmond   et   al.,   2014).   EEG  
recordings  typically  exhibit  generalized  epileptic  discharges  in  GOSR2-­PME,  
which  are  often  accentuated  in  the  posterior  regions  of  the  brain  and  can  be  
triggered   with   photic   stimulation.   Also   focal   and   multi-­focal   discharges   are  
frequently   present.   Furthermore,   concomitant   EEG-­EMG   recordings   in  
several  patients  have  revealed  that  cortical  epileptic  discharges  precede  the  
muscle   jerks,   which   is   neurophysiological   evidence   of   cortical   myoclonus  
(Corbett   et   al.,   2011;;   van  Egmond   et   al.,   2015).   This   finding   illustrates   the  
epileptic   nature   of   these   myocloni.   Because   they   are   so   frequent   and  
pronounced   and   GOSR2-­PME   patients   also   have   various   other   forms   of  
epilepsy,   it   is   clear   that   this   is   a   disorder   of   profound   nervous   system  
hyperexcitability.   Given   the   treatment   difficulty   inherent   to   many   forms   of  
PME,  GOSR2-­PME  patients   typically   require  a  combination  of   several  anti-­
epileptic  drugs  (Boissé  Lomax  et  al.,  2013).  One  recent  study  suggested  that  
some  GOSR2-­PME  patients  might  benefit  from  the  modified  Atkins  diet.  This  
is   based   on   health-­related   quality   of   life   improvements   in   one   out   of   four  
tested  patients,  however  with  no  effect  on  seizure  frequency  (van  Egmond  et  
al.,  2017).  
Taken  together,  mutations  in  GOSR2  cause  an  almost  exclusive  neurological  
disorder   characterized   by   early   onset   ataxia   and   severe   hyperexcitability,  
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with   a   rapid   deterioration   of   motor   function.   Despite   our   knowledge   of   the  
causative  genetic  mutations,  we  have  no  understanding  as  how   this  ataxia  
and  hyperexcitability  might   arise   from   these  genomic   sequence  alterations,  
as   the   known   function   of   GOSR2   is   not   intuitively   linked   to   a   selective  
neurological  ataxia-­epilepsy  disorder.    
1.3          Physiological  role  of  the  GOSR2  encoded  protein  Membrin  
The   GOSR2   gene   does   not   encode   an   ion   channel   or   neurotransmitter  
receptor,  which  would  directly  suggest  a  disease  mechanism  accounting  for  
alterations  in  nervous  system  excitability  and  motor  coordination.  It  encodes  
a  Golgi  SNARE  protein,  termed  Membrin,  which  mediates  membrane  fusion  
at   the  Golgi   apparatus   and   thereby   facilitates   anterograde   cargo   trafficking  
via   the  ER-­Golgi   route.   Because   this   is   a   fundamental   process   required   in  
every  cell  of  the  human  body,  it  is  surprising  that  GOSR2  mutations  result  in  
an  almost  purely  neurological  disease;;  indeed,  consistent  with  the  ubiquitous  
necessity   of   the   Golgi   apparatus,   many   mutations   affecting   this   organelle  
result   in  broad  syndromes  affecting  multiple  organ  systems  (De  Matteis  and  
Luini,  2011;;  Freeze  and  Ng,  2011).  
Membrin   is   a   212   amino   acid,   cytoplasmically   oriented   single-­pass  
transmembrane   protein   (Käll   et   al.,   2004).   Besides   its   critical   soluble   NSF  
attachement  protein  receptor  (SNARE)  motif  (residues  129-­182  (Kloepper  et  
al.,   2007)),  Membrin   is  also  predicted   to   form  a  coiled  coil   in   its  N-­terminal  
portion   (residues  61-­107  (Lupas  et  al.,  1991)),   the   function  of  which   is   thus  
far   unclear.   Along   its   SNARE   motif,   Membrin   forms   a   quaternary   SNARE  
complex  with  its  partner  SNAREs  Sec22b,  Syntaxin-­5  and  Bet1  and  thereby  
contributes  to  fusion  of  opposing  lipid  bilayers  (Xu  et  al.,  2000;;  Parlati  et  al.,  
2000).  
  
     25  
  
Figure  1.  Membrin  domain  structure  
Coiled   coil,   SNARE   and   trans   membrane   (TM)   domains   are   shown.   Arrows  
indicate  the  positions  of   the  two  pathogenic  SNARE  motif  mutations  studied  in  
this   thesis   as   well   as   a   coiled   coil  mutation,   that   is   associated   with   essential  
hypertension  (see  below).  
  
The   yeast   orthologue   of  GOSR2   (which   encodes   Membrin)   was   originally  
discovered  as  BOS1.  Following  up  on  Peter  Novick’s  and  Randy  Schekman’s  
seminal   genetic   screen   of   the   secretory   pathway   (Novick   et   al.,   1980;;  
Schekman   and   Novick,   2004),   Newman   and   Ferro-­Novick   modified   the  
selection  methods   for  EMS  mutated  yeast   in  order   to  specifically  enrich   for  
early   secretory   pathway   defects   (Newman   and   Ferro-­Novick,   1987).   They  
retrieved  the  temperature  sensitive  bet1-­1  mutant  –  which  is  ‘blocked  early  in  
transport’   –   and   subsequently   cloned   the   corresponding   BET1   gene  
(Newman  et  al.,  1990).   In  doing  so,   they  also  retrieved  BOS1,  which  was  a  
gene-­dosage   dependent   ‘bet   one   suppressor’   that   was   nonetheless  
incapable  of  functionally  replacing  the  BET1  gene  (Newman  et  al.,  1990).  In  
this   study,   they   also   established   the   genetic   interaction   with   a   third   early  
secretory  pathway  gene  –  SEC22  –  by  showing  that  overexpression  of  BET1  
or  BOS1   could   suppress   the   sec22-­3   phenotype   and   crossing   bet1-­1   and  
sec22-­3   caused   synthetic   lethality.   BET1,   BOS1   and   SEC22   mutants   all  
presented   phenotypically   in   a   similar   pattern   with   bloated   ER   and   an  
accumulation  of  vesicles,  thereby  suggesting  a  failure  of  fusion  of  ER-­derived  
vesicles  with  the  Golgi  apparatus  (Newman  et  al.,  1990;;  Novick  et  al.,  1980;;  
Shim   et   al.,   1991).   Indeed,   depletion   of   functional   Bos1   by   an   anti-­Bos1  
antibody   impaired   ER-­to-­Golgi   transport   (Lian   and   Ferro-­Novick,   1993).  
Disruption   of   BOS1   was   not   tolerated,   as   mutated   spores   could   not   be  
cultured   and   only   initiated   one   round   of   mitosis   (Shim   et   al.,   1991).   This  
finding   illustrates   that   BOS1   is   an   essential   gene   in   yeast.   Because   the  
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human  and  Drosophila  genomes  harbor  single  BOS1  orthologues  –  GOSR2  
and   membrin   respectively   –   a   central   importance   of   this   gene   in   the  
eukaryotic   taxon   can   be   inferred   (Kloepper   et   al.,   2007).   Consistently,  
homozygosity   for   a   membrin   null   allele   has   been   shown   to   cause   early  
developmental  lethality  in  Drosophila  (Ghabrial  et  al.,  2011).  
Mammalian   Membrin   was   first   described   as   a   protein   that   co-­immuno-­
precipitates  with  Syntaxin-­5,  Sec22b  and  Bet1   (and  GOS28,   rsly1)   (Hay  et  
al.,  1997).  This  name  was  chosen  because  Membrin  was  a  member  of   this  
complex  and  a  role  in  membrane  trafficking  was  hypothesized  by  the  authors  
of  this  study.  Another  group  named  the  same  protein  GS27  –  Golgi  SNARE  
protein   of   27   kDa   (Lowe   et   al.,   1997).   However,   its   calculated   molecular  
weight   is   approximately   25   kDa   and   also   Hay   et   al.   suggested   earlier   this  
comparably  lower  molecular  weight  (Gasteiger  et  al.,  2003;;  Hay  et  al.,  1997).  
It  is  thought  that  ER-­to-­Golgi  and  intra-­Golgi  trafficking  rely  upon  the  action  of  
two  sets  of  SNARE  proteins  which  share  the  t-­SNARE  heavy  chain  Syntaxin-­
5   (Malsam   et   al.,   2008).   The   Membrin-­Sec22b-­Syntaxin5-­Bet1   complex   is  
believed   to  mediate  early  membrane   fusion  between  ER  and  cis-­Golgi   and  
potentially   also   in   intra-­Golgi   transport.   In   contrast,   the   complex   GOS28-­
Ykt6-­Syntaxin5-­GS15  is  thought  to  act  at  later  stages,  within  Golgi  cisternae  
located   in   the  middle  and  the  trans  face.  This   idea   is  suggested  by  the  fact  
that   Membrin,   Bet1   and   Sec22b   localize   largely   to   the   ER,   ER-­Golgi  
intermediate   compartment   (ERGIC)   and   the   cis-­Golgi,  whereas   the   highest  
concentrations  of  the  GS15  SNARE  are  found  at  the  trans  cisternae  (Hay  et  
al.,  1998;;  Volchuk  et  al.,  2004).  Besides  being  critical  for  membrane  fusion  in  
the  early  secretory  pathway,  Membrin  also  appears   to  be  an  Arf1   receptor,  
which   is  an   important   regulator  of  ER-­Golgi   trafficking.  Thereby   it   facilitates  
the   localization  of  Arf1   to   the  Golgi  apparatus   (Honda  et  al.,  2005).  Also,  a  
direct   interaction   of   Membrin   with   the   conserved   oligomeric   Golgi   (COG)  
complex  subunits  COG6  and  8  has  been  described  (Willett  et  al.,  2013).  
1.4          SNARE  proteins  
To  understand  at  the  molecular  level  how  mutations  in  Membrin  cause  PME  
we  need  to  further  dissect  the  general  mode  of  action  of  SNARE  proteins,  as  
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Membrin  belongs  to  this  group.  The  function  of  SNARE  proteins  is  contained  
in  their  family  name  in  two  distinct  ways:  Firstly,  like  a  mechanical  trap/snare,  
these   proteins,   localized   on   opposing   lipid   bilayers,   rapidly   change  
confirmation   once   in   contact   with   each   other,   generating   a   force   that  
eventually   mediates   fusion   of   these   membranes   (Rothman,   2014;;   Südhof,  
2014;;   Südhof   and   Rothman,   2009).   Secondly,   ‘SNARE’   being   a   nested  
acronym,  the  direct  molecular  interaction  necessary  to  recycle  the  individual  
components   of   the   SNARE   complex   after   a   completed   round   of   fusion   is  
summarized:  These  proteins  are  SNAp  REceptors,  as  they  bind  the  adaptor  
protein  SNAP  (soluble  NSF  attachment  protein),  which  in  turn  binds  NSF  (N-­
ethylmaleimide  sensitive   factor),  which  hydrolyses  ATP   in  order   to  dissolve  
the  cis-­SNARE  complex  (Söllner  et  al.,  1993a;;  1993b).   Importantly,  SNARE  
proteins  are  sufficient   to  overcome  the  repulsive  forces  of  two  adjacent  lipid  
bilayers   on   their   own   and   thus   are   the   ‘minimal   machinery’   for   membrane  
fusion  (Weber  et  al.,  1998).  This  notion  is  underlined  by  experiments  where  
only  SNARE  proteins  and  no  accessory  regulatory  proteins  are  purified  and  
introduced   into   artificial   liposomes.   Even   in   such   a   reductionist   model  
SNARE  proteins   are   capable   of  mediating  membrane   fusion   (Weber   et   al.,  
1998).   However,   the   remarkable   speed   of   fusion   that   occurs   during  
stimulated   secretion   of   neurotransmitter   has   so   far   not   been   successfully  
replicated  in  cell-­free  systems  (Jahn  and  Scheller,  2006).    
1.4.1          SNARE  mode  of  action  
SNAREs  are  membrane-­anchored   proteins  with   the  majority   of   their   amino  
acid   residues   facing   the   cytoplasm,  where   the   force-­generating   complex   is  
formed.   Usually   the   C-­terminus   contains   a   single   transmembrane   domain  
and   only   few   residues   are   located   inside   the   lumen   of   intracellular  
compartments  or   in  the  extracellular  space  in  case  of  cell  surface  SNAREs.  
In  contrast,  SNAP-­25-­like  SNARE  proteins  are  attached  to   lipid  membranes  
via  a  palmitoyl  group  (Veit  et  al.,  1996).  Also  Syntaxin-­17  is  unusual  as  it  has  
two   C-­terminal   transmembrane   domains   (Kienle   et   al.,   2009a).   In   close  
proximity   of   the   membrane   anchors,   SNARE   proteins   harbor   stereotypic  
stretches  of  53  amino  acids  –  the  SNARE  domain.  When  a  single  v-­SNARE-­
containing   vesicle   approaches   its   target   compartment,   which   harbors   the  
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three   complementary   t-­SNARE  domains,   the  motifs   form  alpha-­helices   that  
tightly   interact   with   each   other,   giving   rise   to   a   stable   tetra   helical   bundle  
(Sutton  et  al.,  1998).  This   trans-­SNARE  complex,  or  SNAREpin,  exerts   the  
driving   force   to   overcome   the   repulsive   forces   of   the   two   adjacent   lipid  
bilayers   (Südhof   and   Rothman,   2009).   Ultimately,   this   process   leads   to  
membrane   fusion  and   to   the  SNARE  complex  being  deposited   in   the   target  
membrane  as  a  cis-­SNARE  complex.  
The   most   detailed   structural   and   biophysical   understanding   of   SNARE-­
mediated  membrane   fusion   stems   from   over   two   decades   of   research   into  
the  synaptic  SNARE  complex,  which  mediates  neurotransmitter  release  and  
thus   is   of   central   interest   to   neuroscience:   The   neurotransmitter-­loaded  
synaptic   vesicle   contains   the   v-­SNARE   VAMP2   (vesicle-­associated  
membrane   protein   2),   also   referred   to   as   Synaptobrevin-­2,   which   interacts  
with   the   target   membrane   t-­SNAREs   SNAP-­25   (synaptosomal-­associated  
membrane  protein  25)  and  Syntaxin-­1A  (see  Figure  5  of  Sutton  et  al.,  1998;;  
Südhof,   2014).  SNAP-­25   contributes   two  SNARE  domains   to   the   t-­SNARE  
complex,  which   is  different   to  other   intracellular   fusion  steps,  where  usually  
all   three   t-­SNARE   domains   are   contributed   by   distinct   proteins.   The  
intracellular  t-­SNAREs  thereby  are  comprised  of  one  Syntaxin-­1A  like  ‘heavy  
chain’   and   two   ‘light   chains’   (Fukuda   et   al.,   2000).   Because   the   folding  
energy  of   a   single   synaptic  SNARE  complex  amounts   to  68   (±4)  kBT   (kB   –  
Boltzmann’s   constant,   T   –   temperature),   which   is   approximately   the   same  
energy   that   repulses   membranes,   it   is   thought   that   even   one   SNARE  
complex  is  sufficient  to  mediate  membrane  fusion  (Gao  et  al.,  2012;;  Zhang,  
2017).  
1.4.2          SNARE  structure  
The  cytoplasmic  portions  of  VAMP2,  Syntaxin-­1A  and  SNAP-­25  are   largely  
unstructured  until   their   initial   engagement   (Fasshauer  et   al.,   1997a;;  1997b;;  
Margittai   et   al.,   2001).   They   then   form  alpha-­helices,  which   align   in   a   tetra  
helical  bundle.  Because  the  crystal  structure  of  this  synaptic  SNARE  complex  
was  reported  by  Sutton  et  al.  in  1998  at  2.4  Å  resolution  (see  Figure  2C  and  
Figure  5  of  Sutton  et  al.,  1998),  we  now  have  a  detailed  understanding  of  the  
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precise   molecular   interactions   (Sutton   et   al.,   1998).   The   SNARE   domains  
wrap  around  each  other  in  a  contorted  manner  and  form  a  120  Å  long,  stable  
four-­helix  bundle  of  cylindrical  shape  (Sutton  et  al.,  1998).  The  cross-­section  
is   circular   with   varying   radii   across   different   positions   of   the   complex.   All  
SNARE  motifs  are  aligned  in  a  parallel  manner  so  that  the  N-­  and  C-­termini  
of  the  VAMP2,  Syntaxin-­1A  and  both  SNAP-­25  SNARE  domains  are  aligned  
with   each   other’s   respective   counterpart   (Sutton   et   al.,   1998).   The  SNARE  
domains  interact  along  leucine-­zipper-­like  layers.  These  layers  are  positioned  
at  every   third  or   fourth   residue  and   frequently  are  occupied  by  hydrophobic  
residues.  They  range  from  the  identifying  residue  numbers  -­7  to  +8  from  the  
N-­   to  C-­terminus  of   the  SNARE  domains,  where   -­7   to   -­1  are  part  of   the  N-­  
and  +1  to  +8  part  of  the  C-­terminal  SNARE  domain  portions  (see  Figure  2C  
of  Sutton  et  al.,  1998).  The  C-­terminal  halves  of  the  Syntaxin-­1A/B,  VAMP1/2  
and   SNAP-­25   SNARE   domains   are   targets   of   clostridial   neurotoxins   (see  
Figure  5  of  Sutton  et  al.,  1998)  (Schiavo  et  al.,  1992;;  2000).  Eight  botulinum  
toxin  serotypes  and  tetanus  toxin  have  distinct  cutting  sites.  By  cleaving  the  
un-­   or   partially   assembled   synaptic   SNARE   complex   they   inhibit  
neurotransmission   and   thus   cause   the   very   severe   disorders   botulism   or  
tetanus  respectively  (Schiavo  et  al.,  2000;;  Sutton  et  al.,  1998;;  Zhang  et  al.,  
2017).  Between  layers  -­1  and  +1  is  the  central  ‘ionic  layer’  (layer  0)  with  the  
positively  charged  side  chain  of  an  arginine  residue  (R)  and  three  glutamine  
(Q)  side  chains.  The  presence  of  three  central  glutamines  and  one  arginine  is  
highly   conserved  across  different  SNARE  complexes  and  across  evolution.  
Therefore   an   additional   classification   of   SNARE   proteins,   besides   the  
topological  distinction  between  v-­  and  t-­SNAREs,  has  been  introduced,  which  
distinguishes  Q-­SNAREs   from  R-­SNAREs  (Fasshauer  et  al.,  1998).  The  Q-­
SNAREs   have   further   been   subdivided   into   three   distinct   classes   –  Qa,  Qb  
and   Qc-­SNARE   domains,   which   are   similar   to   the   Syntaxin-­1A,   N-­terminal  
SNAP-­25   and   C-­terminal   SNAP-­25   SNARE   domains   respectively   (Bock   et  
al.,  2001).  Typically,  fusogenic  SNARE  complexes  consist  of  one  R-­  and  one  
Qa-­,  one  Qb-­  and  one  Qc-­SNARE  domain.  The  R-­SNARE  is  also  often  the  v-­
SNARE,  as  is  the  case  for  the  synaptic  SNARE  complex.  However,  this  is  not  
true  for  all  SNARE  pairs.    
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The   synaptic   SNARE   complex   has   been   shown   to   ‘zipper   up’   along   the  
mostly  hydrophobic   layers   from   the  N-­   to   the  C-­terminus   (Gao  et  al.,  2012;;  
Melia   et   al.,   2002).   High   resolution   biophysical   studies   utilizing   optical  
tweezers   have   established   distinct   steps   in   the   assembly   of   SNARE  
complexes:   an   initial   slow  N-­terminal   assembly   followed   by   fast   C-­terminal  
zippering,   which   constitutes   the   energetically   important   driving   force   of  
membrane   fusion   (Gao   et   al.,   2012;;   Zorman   et   al.,   2014).   The   C-­terminal  
complex   formation   is   followed   by   assembly   of   the   linker   domain,   which  
bridges  the  SNARE  domains  with  the  transmembrane  domains  and  thus  is  of  
critical   importance   for   transmitting   the   fusion   force   upon   the   lipid   bilayers  
(Gao  et  al.,  2012;;  Stein  et  al.,  2009).  Between  N-­  and  C-­terminal  zippering,  
around  the  ionic  layer,  a  pause  in  complex  formation  has  been  noted,  which  
is   thought   to   allow   for   clamping   of   the   synaptic   SNARE   complex   by  
complexin   (Gao   et   al.,   2012;;   Giraudo   et   al.,   2006;;   Huntwork   and   Littleton,  
2007).    
1.4.3          SNARE  evolution  
SNAREs   are   ubiquitously   important   force-­generators   across   the   whole  
eukaryotic   taxon   and   act   at   many   diverse   intracellular   fusion   steps.  
Accordingly,   eukaryotic   genomes   encode   several   different  SNARE  proteins  
destined  for  distinct  compartments.  While  the  yeast  and  Drosophila  genomes  
contain  24  and  26  SNARE  genes  respectively,  the  human  genome  contains  
an   enlarged   set   of   44   (Bock   et   al.,   2001;;   Kienle   et   al.,   2009a).   The   first  
expansion  of  SNARE  proteins   is   thought   to  have   taken  place  between  uni-­  
and   multicellular   evolution   and   have   affected   mostly   endosomal   SNAREs.  
The   second   expansion   is   thought   to   have   occurred   in   vertebrate   evolution  
and   have   affected   primarily   secretory   SNARE   proteins   (Kloepper   et   al.,  
2008).    Importantly,  along  the  early  secretory  pathway,  where  Membrin  acts  
(see  below),  the  same  set  of  SNAREs  has  largely  been  preserved  throughout  
evolution  (Kloepper  et  al.,  2007).  This  supports  the  utility  of  simpler  models,  
such  as  Drosophila  and  yeast,  in  order  to  investigate  the  pathophysiology  of  
GOSR2-­PME.  
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1.4.4          Overview  of  different  SNAREs  in  a  cell  
SNARE   proteins   not   only  mediate  membrane   fusion   at   presynaptic   termini  
and   thereby   enable   neurotransmitter   release,   but   also   fuse  membranes   at  
several   distinct   intracellular   transport   steps.   They   act   at   the  ER,   the  Golgi,  
the  trans-­Golgi  network,  endosomes,  the  cell  surface,   lysosomes  in  animals  
and  the  vacuole  in  yeast  (Jahn  and  Scheller,  2006).  20  distinct  subgroups  of  
SNARE  proteins  have  been  determined  using  bioinformatics  tools  and  these  
SNAREs   can   be   allocated   to   five   steps   along   the   secretory   pathway  
(Kloepper   et   al.,   2007).   Accordingly,   the   eukaryotic   ancestor   is   thought   to  
have  contained  20  SNARE  proteins  (Kloepper  et  al.,  2007).  The  similarity  of  
the   crystal   structures   of   the   early   (Syntaxin-­13   (Qa),   Vti1a   (Qb),   Syntaxin-­6  
(Qc)  and  VAMP4   (R))  and   late   (Syntaxin-­7   (Qa),  Vti1b   (Qb),  Syntaxin-­8   (Qc)  
and   VAMP8   (R))   endosomal   SNARE   complexes   with   the   synaptic   SNARE  
complex   suggests   a   high   degree   of   structural   and   functional   stereotypy  
across   other   SNARE   complexes,   even   to   a   higher   degree   than   sequence  
similarities  would  suggest  (Antonin  et  al.,  2002;;  Zwilling  et  al.,  2007).    
Despite   a   high   degree   of   conservation   of   the   SNARE   domain   across   the  
SNARE  family,  specificity  of  distinct  intracellular  fusion  steps  is  necessary  to  
maintain  ordered  membrane  and  cargo   flow.  Thus   the   ‘SNARE  hypothesis’  
suggests   that   this   specificity   is   encoded   in   the   SNARE   protein   sequence  
(Rothman,  2014).  This   idea  has  been  systematically   tested   in   reconstituted  
liposomes,   where   only   v-­SNAREs   together   with   their   respective   t-­SNARE  
partners,  and  not  the  other  t-­SNAREs  of  the  SNARE  family,  mediated  fusion  
(McNew  et  al.,  2000).    
1.4.5          Early  secretory  pathway  SNAREs  
In  respect  to  the  Membrin-­containing  cis-­Golgi  SNARE  complex  we  can  infer  
its  functional  microanatomy  from  liposome  fusion  assays  performed  with  the  
yeast  orthologues  Bos1  (Membrin),  Sed5  (Syntaxin-­5),  Sec22  (Sec22b)  and  
Bet1  (Parlati  et  al.,  2000).  Only  one  out  of  eight  possible  combinations  was  
fusogenic,   hence   we   can   infer   that   in   mammals   the   situation   might   be  
analogous.  The  Qb-­SNARE  Membrin  and  the  R-­SNARE  Sec22b  would  thus  
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be  the  t-­SNARE  light  chains,  the  Qa-­SNARE  Syntaxin-­5  the  t-­SNARE  heavy  
chain  and  the  Qc-­SNARE  Bet1  the  v-­SNARE.  This  is  different  to  the  situation  
at   the  presynaptic   terminal,  where  an  R-­SNARE  –  VAMP2  –   is   also   the   v-­
SNARE.   Based   on   the   fact   that   Sec22b   is   an   R-­SNARE   it   was   previously  
proposed  that  similarly  to  the  synaptic  SNARE  complex,  the  v-­SNARE  at  the  
cis-­Golgi  would  be  Sec22b  (Xu  et  al.,  2000).  However,  only  binding  studies  of  
these  SNARE  proteins  have  been  reported,  and  not  liposome  fusion  assays.  
Interestingly,   Sec22b   is   not   only   part   of   the   cis-­Golgi   but   also   the   ER  
localized  SNARE  complex,  which  mediates   fusion  of  Golgi  derived  vesicles  
with   this   compartment   and   thus   facilitates   retrograde   transport   in   the   early  
secretory  pathway.  At  the  ER  it  acts  as  a  v-­SNARE  in  concert  with  Syntaxin-­
18,   Sec20   and   Use1   (Malsam   and   Söllner,   2011).   Also   within   the   Golgi  
apparatus  one  SNARE  protein  –  Syntaxin-­5  –  is  shared  between  two  distinct  
complexes.   Based   on   the   observation   that   mammalian   Syntaxin-­5   and   its  
yeast   orthologue   Sed5   formed   complexes   with   seven   SNARE   proteins,  
Parlati   et   al.   used   liposome   fusion   assays   to   systematically   search   for   the  
fusogenic   complexes   (Parlati   et   al.,   2002).   They   found   that,   besides  Bos1-­
Sed5-­Sec22-­Bet1,   also   Gos1-­Sed5-­Ykt6-­Sft1   (mammalian   orthologues:    
GOS28-­Syntaxin5-­Ykt6-­GS15)   formed   a   functional   Golgi   SNARE   complex  
(Parlati  et  al.,  2002).  These  complexes  are  thought  to  act  sequentially  along  
the   Golgi   apparatus   from   cis   to   trans   (Volchuk   et   al.,   2004).   Interestingly,  
subunits  of  these  cis-­  and  trans-­Golgi  SNARE  complexes  partially  inhibit  the  
non-­cognate  SNARE   complexes   in   a   concentration-­dependent  manner   and  
therefore   act   as   ‘i-­SNAREs’   (Varlamov   et   al.,   2004).   This   mechanism   is  
thought  to  further  increase  specificity  of  the  precise  site  of  membrane  fusion  
across  the  Golgi  stack  (Varlamov  et  al.,  2004).  
1.4.6          The  GOSR2-­PME  causing  Membrin  mutation  
Given   the   critical   importance   of   the   SNARE   domains   in   the   formation   of  
SNARE   complexes,   it   is   not   surprising   that   mutations   in   this   motif   –  
particularly  alterations  which  modify  the  interaction  of  layer  residues  –  disrupt  
SNARE   function.   Many   different   SNARE  mutations   have   been   reported   in  
different   organisms   such   as   yeast,   mouse   and   human   (Fasshauer   et   al.,  
1998;;  Jeans  et  al.,  2007;;  Rao  et  al.,  2001;;  Schubert  et  al.,  2014;;  Shen  et  al.,  
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2014).  Their  effects  upon  SNARE  complex   formation  and  membrane   fusion  
depend   upon   the   precise   position   in   respect   to   the   layers   of   the   SNARE  
complex  and  on  the  nature  of   the  change.  The  phenotypic  result   in  turn  will  
depend  upon  which  of  the  many  different  fusion  events  mediated  by  SNARE  
proteins  are  disrupted  as  a  result  of  the  SNARE  mutations.    
Prior   to  my   PhD   research,  GOSR2-­PME   had   only   been   associated   with   a  
single  homozygous  missense  mutation  –  G144W  (Corbett  et  al.,  2011).  This  
exchange  of  a  glycine   for  a   tryptophan  occurs  at   layer   -­3   in   the  N-­terminal  
half  of  Membrin’s  SNARE  domain.  Layer  -­3  is  a  position  of  comparably  small  
cross-­sectional  SNARE  complex  radius  in  the  synaptic  SNARE  complex  and  
is  occupied  by  one  large  and  three  small  residues  –  phenylalanine  (Syntaxin-­
1A),  methionine  (VAMP2),  glycine  and  alanine  (SNAP-­25)  (see  Figure  2D  of  
Sutton   et   al.,   1998   and   Figure   2   of   Fasshauer   et   al.,   1998)   (Sutton   et   al.,  
1998).  As  a   comparison,   the   central   layer   of   the   synaptic  SNARE  complex  
exhibits  a   larger  radius  (see  Figure  2D  and  Figure  3  of  Sutton  et  al.,  1998).  
The  amino  acid  composition  at  layer  -­3  is  conserved  in  the  orthologous  yeast  
secretory  complex  Sso-­Sec9-­Snc1,  where  the  exchange  of  the  small  glycine  
in   the  N-­terminal  SNARE  motif  of  Sec9  at   layer   -­3   for  aspartic  acid  causes  
exocytosis   defects   (Brennwald   et   al.,   1994;;   Novick   et   al.,   1980).   Layer   -­3  
glycine  to  glutamate  mutations  in  Drosophila  SNAP-­25  causes  temperature-­
induced   SNARE   complex   instability,   reduction   in   evoked   release   and  
paralysis   (Rao   et   al.,   2001).   Similarly,   layer   -­3   at   the   cis-­Golgi   complex  
consists  of  one  large  and  three  small  residues  -­  phenylalanine  (Syntaxin-­5),  
serine  (Bet1),  glycine  (Membrin)  and  methionine  (Sec22b)  (Figure  2).  Given  
the   presence   of   one   bulky   phenylalanine   in   this   complex   at   layer   -­3,   the  
exchange   of   a   small   hydrogen   for   a   large   indol   side   chain   in   the  Membrin  
SNARE  domain  at  this  position  suggests  that  the  N-­terminal  assembly  of  this  
complex   might   be   impaired   due   to   steric   constraints.   Also,   biophysical  
studies   of   the   synaptic   SNARE   complex   suggest   that   the   layer   -­3   G144W  
Membrin  mutation  might  be  disruptive,  as  it  highlights  special  vulnerability  of  
this   position   in   an   alanine   substitution   screen.   While   single   alanine  
replacements   of   all   tested   N-­terminal   layers   resulted   in   no   profound   N-­
terminal  SNARE  domain  assembly  deficiency,  only  the  methionine  to  alanine  
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substitution   at   layer   -­3   had   marked   detrimental   effects   in   the   synaptic  
complex   (Ma   et   al.,   2015).   Layer   +1   leucine   to   serine   substitution   in   the  
Membrin  yeast  orthologue  Bos1  has  been  reported   to   impair   the   respective  
SNARE  complex  and  interfere  with  trafficking  (Fasshauer  et  al.,  1998).  One  
mutation  outside  Membrin’s  SNARE  domain  and  within  its  coiled  coil  domain  
–   L76R   –   has   been   associated   with   essential   hypertension,   however   the  
mechanism   remains   unclear   (International   Consortium   for   Blood   Pressure  
Genome-­Wide  Association  Studies,  2011;;  Meyer  et  al.,  2009;;  Simino  et  al.,  
2014).   Taken   together,   the   position   and   nature   of   the   disease-­causing  
G144W   GOSR2-­PME   mutation   suggests   disruption   in   cis-­Golgi   SNARE  
complex  formation  and  in  turn  reduced  membrane  fusion  rates.  
  
Figure  2.  Alignment  of  cis-­Golgi  SNARE  domain  sequences  
SNARE  domains  of  Membrin  (uniprot  O14653-­1),  Bet1  (O15155-­1),  Syntaxin-­5  
(Q13190-­1)  and  Sec22b  (O75396-­1)  were  determined  as  previously  described  
and   subsequently   aligned   (Kloepper   et   al.,   2007).   Interacting   layers,   ranging  
from   -­7   to   -­1   in   the   N-­terminal   and   +1   to   +8   in   the   C-­terminal   halves   of   the  
SNARE  motifs  are  highlighted   in  green.  Central   layer  glutamines  and  arginine  
are  red.  The  PME-­associated  Membrin  G144W  mutation  causes  the  exchange  
of   a   small   glycine   for   a   large   tryptophan   at   layer   -­3,   which   physiologically  
harbors  a  bulky  phenylalanine.  
  
1.5          The  Golgi  apparatus  
The   Golgi   apparatus   was   first   described   in   1898   by   Camillo   Golgi   –   from  
whom   it   now   derives   its   name   –   as   an   ‘internal   reticular   apparatus’    
surrounding   the  nucleus  of  Purkinje  cells   (Farquhar  and  Palade,  1998).  Yet  
over  the  following  50  years  it  was  widely  argued  to  be  an  artifact  of  metallic  
impregnations   used   to   visualize   this   structure   and   thus   generally   not  
accepted  as  a  novel  cell  organelle   (Bechtel,  2006).  Only  with   the  advent  of  
thin-­section   electron   microscopy   could   the   light   microscopic   metallic  
depositions   be   correlated   to   a   distinct   membrane   complex,   which   rapidly  
convinced   the   scientific   community   of   the   true   existence   of   the   Golgi  
apparatus  (Farquhar  and  Palade,  1981;;  1998).    
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The  Golgi  apparatus  is  a  central  distribution  and  modification  hub  within  the  
secretory  pathway,  which  is  the  protein,  lipid  and  carbohydrate  synthesis  and  
transport   route   within   eukaryotic   cells   (Palade,   1975).   To   increase  
compartmentalization   of   biochemical   reactions   and   facilitate   cellular  
secretion,   eukarya   have   developed   a   sophisticated   endomembrane   system  
separating  distinct  organelles  and  vesicular  shuttle  carriers  from  the  cytosol.  
Proteins  that  are  destined  for  such  intracellular  sub-­compartments,  as  well  as  
secreted   and   membrane-­associated   proteins   undergo   a   different   fate   than  
their  cytosolic  counterparts.  While  the  latter  proteins  are  synthesized  on  free  
cytosolic   ribosomes,   in   the   former   case   these  synthetic  machines  attach   to  
the   surface   of   the   endoplasmic   reticulum   (ER),  which   is   a   highly   branched  
tubular  network  that  is  continuous  with  the  nuclear  membrane  (Nixon-­Abell  et  
al.,   2016).   The   ER-­attached   ribosomes   confer   its   rough   appearance   when  
viewed  under   the  electron  microscope  –   therefore   termed   ‘rough  ER’  –  and  
allow   proteins   to   be   co-­translationally   translocated   into   the   ER   lumen  
(Palade,   1975;;   Walter   et   al.,   1984).   There,   protein   folding   and   correct  
formation  of  disulfide  bonds   facilitated  by  chaperones  and  oxidoreductases,  
and   carbohydrate   protein   modifications   are   undertaken   (Braakman   et   al.,  
2013;;  Bulleid  et  al.  2012).  Eventually,  proteins  and  ER-­synthesized  lipids  are  
selected  and  shuttled  to  the  Golgi  apparatus  and  transition  this  compartment  
from   its   cis   to   trans   face.  Finally,   at   the   trans-­Golgi   network   (TGN),   cargos  
are  again  selected  into  vesicular  carriers  and  shuttled  to  distinct  intracellular  
sites   such   as   lysosomes,   endosomes,   secretory   vesicles   and   the   cell  
surface.  The  discovery  of   this  directed  process  originating  in  the  ER  and  its  
underlying   microanatomy   was   pioneered   in   detailed   electron-­microscopic  
studies  and  pulse-­chase  experiments  by  George  Palade  (Palade,  1975).  The  
opposite  direction  of  cargo   flow  –   from  outside   to   inside  –   is  also  critical   in  
eukaryotic  cells.  This  process  is  termed  endocytosis  and  can  be  selective  or  
non-­selective   in   respect   to   the   endocytosed   molecules   (Goldstein   et   al.,  
1979;;  Silverstein  et  al.,   1977).  A  common  denominator  across   the  different  
transport  steps  of   the  secretory  pathway   is   the  necessity  of  vesicles   to  bud  
off   donor   membranes   to   then   be   transported   to,   and   fuse   with,   target  
membranes   (Rothman,   1994).   Specificity   in   cargo   selection   within   forming  
vesicles,   and   fusion   of   these   vesicles   with   target  membranes,   is   critical   in  
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maintaining   cellular   integrity   (Rothman,   2014).   The   former   is   mediated   by  
vesicle  coating  proteins  and  sorting  receptors,  while  the  latter  is  thought  to  be  
mediated  by   the  specificity  of   the  SNARE  fusion  machinery   (Barlowe  et  al.,  
1994;;  Bonifacino  and  Glick,  2004;;  Mancias  and  Goldberg,  2008;;  McNew  et  
al.,  2000;;  Rothman  and  Wieland,  1996).  
1.5.1          Golgi  apparatus  structure  
The  Golgi  apparatus,  also  called  ‘Golgi  complex’  or  simply  ‘Golgi’,  consists  of  
several  disc-­like  membrane  sacs  stacked  in  close  proximity,  which  appear  as  
stacked   tubuli   in   electron   microscopy   (EM)   sections   (Klumperman,   2011).  
These   individual   membrane   sheets   are   referred   to   as   Golgi   cisternae,   of  
which   there   usually   are   4-­11   per   Golgi   apparatus   in   mammalian   cells  
(Klumperman,  2011).  Centrally,  the  cisternal  diameter  often  amounts  to  only  
10-­20   nm,   while   the   rims   are   usually   wider   (Klumperman,   2011).   In  
mammalian   cells,   individual   complexes   can   be   laterally   connected   via   a  
reticular   network   termed   ‘non-­compact   zone’   and   thereby   form   ribbon-­like  
structures  (Klumperman,  2011).  In  Drosophila  tissues  usually  no  ribbons  are  
formed,   but   individual   stacks   rather   group   laterally   as   duplicates   (Kondylis  
and   Rabouille,   2009).   Cis-­   and   trans-­faces   of   the   Golgi   apparatus   are  
distinguished   from  each  other  based  on  distinct  biochemical  properties  and  
molecular  compositions   (Alberts,  2015).  The   trans-­most  cisterna   is   followed  
by   the   trans-­Golgi  network   (TGN).  Prior   to   the  cis-­most  cisterna  –  between  
ER   and   Golgi   –   vesicular   tubular   clusters   (VTCs)   can   be   found,   which  
comprise   the   biochemically   unique   ER-­Golgi   intermediate   compartment  
(ERGIC)   (Schweizer  et   al.,   1991).  Surrounding   the  Golgi,   vesicular   carriers  
are   abundantly   present,   with   different   molecular   identities.   At   the   EM-­level  
the  spiky  clathrin  coat  can  readily  be  distinguished  from  dense  COPI  coating.  
COPII   coated   vesicles   are   usually   found   at   the   ER-­Golgi   interface  
(Klumperman,  2011).  
1.5.2          Carbohydrate  processing  
The  Golgi   apparatus   is   a   central   processing   station   for   carbohydrate   side-­
chains,  which  are  common  post-­translation  protein  modifications   initiated   in  
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the  ER  (Stanley,  2011).  In  a  highly  sequential  process,  sugars  are  removed  
and   added,   which   ultimately   radically   alters   the   glycosylation   profile   of  
glycoproteins.  These  step-­wise  biochemical  alterations  are   facilitated  by   the  
compartmentalization   of   glycosyltransferases   and   glycosidases   into   distinct  
cisternae.   Due   to   the   stacked   nature   of   the   Golgi,   the   subsequent  
carbohydrate-­processing  enzymes  are  in  close  proximity  while  being  spatially  
separated.  Unlike  in  mammals  and  Drosophila,  Golgi  cisternae  are  dispersed  
in   yeast,   which   suggests   that   a   stacked   conformation   is   not   absolutely  
necessary   to   facilitate   efficient   sequential   modifications   and   trafficking  
(Preuss   et   al.,   1992).   Several   different   protein   glycosylation   pathways  
operate   in   mammalian   cells,   and   also   lipids   can   by   modified   with  
carbohydrates   (Freeze  and  Ng,  2011).  Sugars  can  either  be  N-­  or  O-­linked  
onto  asparagine  or  serine/threonine  amino  acid  side  chains  (Stanley,  2011).  
To  illustrate  the  sequential  action  of  glycosylation  enzymes  and  glycosidases  
in   the   ER   and   Golgi,   I   will   to   briefly   summarize   the   key   steps   of   the   N-­
glycosylation   pathway.   Initially,   an   oligosaccharide   consisting   of   three  
glucose   (Glc),   9   mannose   (Man)   and   two   N-­acetylglucosamine   (GlcNAc)  
groups   is   attached   via   the   latter   sugar   group   to   asparagine   residues   of  
nascent   proteins   in   the   ER   lumen   (Freeze   and   Ng,   2011).  Within   the   ER,  
three   Glc   and   subsequently   one   Man   unit   are   enzymatically   removed.  
Thereafter,  as  a   first  step   in   the  Golgi,   ‘Golgi  mannosidase   I’   cleaves   three  
Man   after   which   N-­acetylglucosamine   transferase   I   (GlcNAcT-­I)   adds   one  
GlcNAc.   This   is   followed   by   the   action   of   ‘Golgi   Mannosidase   II’,   which  
removes  two  Man  (Alberts,  2015).  Up  to  this  point  N-­glycans  are  regarded  as  
‘high  mannose’.  Thereafter,  a  further  GlcNAc  can  be  added  and  the  glycan  is  
now   referred   to   as   ‘complex’.   Further   to   this,   additional   sugars   such   as  
galactose,  fucose,  GlcNAc  and  sialic  acid  can  be  added  (North  et  al.,  2010;;  
Stanley,   2011).   The   sequential   nature   of   this   glycosylation   pathway   can  
effectively  be  exploited  in  the  study  of  Golgi  trafficking.  One  widely  used  tool  
is   Endo   H   (endoglycosidase   H),   which   cleaves   asparagine-­linked   ‘high  
mannose’  glycans  only  and  therefore  only  carbohydrate  side  chains  prior   to  
modifications   undertaken   by   Golgi   mannosidase   II.   With   this   tool,   the  
experimenter   can   assess   whether   a   secretory   cargo   has   been   transported  
past  the  medial  Golgi,  where  this  enzyme  is  enriched  (Velasco  et  al.,  1993).  
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The  lack  of  GlcNAcT-­I  in  the  15B  chinese  hamster  ovary  (CHO)  cell  line  has  
been  utilized  to  develop  a  cell-­free  transport  model  of  the  vesicular  stomatitis  
virus   (VSV)   glycoprotein   from   15B   cells   infected   with   VSV   into   wild-­type,  
uninfected   CHO   cells   (Balch   et   al.,   1984).   This   system   has   provided  
pioneering  insights  into  vesicular  cargo  trafficking  (Rothman,  2014).  
1.5.3          ER-­Golgi  anterograde  transport  
ER-­derived   secretory   pathway   cargo   molecules   are   first   packaged   into  
transport  vesicles,  then  translocate  to  the  cis-­Golgi  (and  ERGIC,  see  below),  
where   they   fuse   in   a   Membrin-­dependent   manner   and   thus   deposit   their  
contents   into   the   cisternal   lumen   and   membrane   (Brandizzi   and   Barlowe,  
2013).  These  are  highly  orchestrated  processes  with  much  of  the  underlying  
molecular  machinery  known  today.  Vesicle  budding  and  accompanying  cargo  
selection  occurs  at  specialized  ER  exit  sites   (ERES)   (Bannykh  et  al.,  1996;;  
Brandizzi   and   Barlowe,   2013).   There,   the   Sec12   guanine   nucleotide  
exchange  factor  (GEF)  converts  the  inactive  Sar1-­GDP  into  the  active  Sar1-­
GTP,   which   then   becomes   membrane-­associated   (Brandizzi   and   Barlowe,  
2013).   Sar1-­GTP   recruits   the   Sec23/Sec24   pre-­budding   complex   and   an  
outer  layer,  which  is  comprised  of  a  Sec13/31  octahedral  cage  that  deforms  
the  membrane  to  form  an  approximately  60  nm  COPII  vesicle  (Barlowe  et  al.,  
1994;;  Bi  et  al.,  2002;;  2007;;  Fath  et  al.,  2007).  Sec24  isoforms  are  critical  for  
selecting  the  cis-­Golgi  SNAREs  into  COPII  vesicles  (Mancias  and  Goldberg,  
2008).  While   initially   it  was   reported   that  Membrin   residues   I118  and  M120  
directly   interact  with  Sec24C/D,  a   later   study  suggested   that  Membrin   itself  
does   not   directly   bind   to   Sec24   but   is   sorted   indirectly   via   binding   to  
Syntaxin-­5   (Mancias  and  Goldberg,  2008;;  Adolf  et  al.,  2016).  After  budding  
off   the   ERES   cargo   carriers   are   transported   towards   the   cis-­Golgi.   This  
process   involves   the   dynein-­dynactin   complex,   which   translocates   the  
attached   containers   along   microtubules   towards   their   minus   ends   at   the  
microtubule   organizing   centre,   where   the  Golgi   resides   (Allan   et   al.,   2002;;  
Yadav   and   Linstedt,   2011).   If   microtubules   are   disrupted   by   nocodazole  
treatment,  Golgi  mini-­stacks   form  at  ERES   in  mammalian  cells   (Cole  et  al.,  
1996;;  Presley   et   al.,   1997).  However,   this  microtubule-­dependent   transport  
appears  not  to  occur  in  plant  cells  (Brandizzi  and  Barlowe,  2013).  Transport  
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vesicles   are   then   captured   by   tethering   proteins   prior   to   SNARE-­mediated  
membrane   fusion,   which   occurs   at   close   proximity   between   vesicle   and  
target  membrane.  One  important  multi-­domain  elongated  tethering  protein  is  
p115   (Uso1   in   yeast),  which   is   recruited   by  Rab1-­GTP   (Lorente-­Rodríguez  
and  Barlowe,  2011;;  Wang  et  al.,  2015).  Rab1-­GTP  and  its  yeast  orthologue  
Ypt1  in  turn  are  activated  by  the  multi-­component  transport  protein  particle  I  
(TRAPP   I),   which   is   also   capable   of   binding   Sec23   –   a   component   of   the  
COPII  coat  –  and  therefore  represents  a  central  component  of  the  cis-­Golgi  
cargo  entry  machinery  (Cai  et  al.,  2007a;;  2007b;;  2008).  The  final  Membrin-­
Sec22b-­Syntaxin5-­Bet1   (yeast   Bos1-­Sec22-­Sed5-­Bet1)   fusion   reaction   is  
thought   to   be   regulated  and   facilitated   by   the  Sec1/Munc18-­1   (SM)   protein  
Sly1,   which   binds   a   distinct   region   of   the   Syntaxin-­5   N-­terminus   (Dascher  
and  Balch,  1996;;  Lorente-­Rodríguez  and  Barlowe,  2011;;  Yamaguchi   et   al.,  
2002).  
1.5.4          The  ER-­Golgi  intermediate  compartment  (ERGIC)  
COPII-­mediated  anterograde  cargo  transport  from  the  ER  directly  to  the  cis-­
Golgi   is   a   simplified  model,   which   holds   true   for   yeast,   but   omits   a   critical  
intermediate  step  in  mammalian  cells.  There,  the  ERGIC/VTC  serves  as  the  
first  sorting  station  after  exit   from  ERES.  This  compartment   is  characterized  
by   ERGIC-­53,   which   is   the   procathepsin   Z   sorting   receptor   (Appenzeller-­
Herzog  and  Hauri,  2006;;  Schweizer  et  al.,  1988).  These  ERGIC-­53  positive  
membranes   can   be   found   both   in   vicinity   to   ERES   and   close   to   the  Golgi  
apparatus   (Ben-­Tekaya   et   al.,   2005).   With   a   15°C   block,   cargo   can   be  
trapped  in  this  compartment  and  subsequently  released  at  32°C  (Schweizer  
et  al.,  1990).  Two  models  of  ER-­to-­Golgi  transport  via  the  ERGIC  have  been  
proposed   (Appenzeller-­Herzog   and   Hauri,   2006).   The   transport   complex  
model  posits  that  ERES-­derived  COPII  vesicles  undergo  homotypic  fusion  –  
alternatively,  it  has  been  suggested  that  larger  membrane  saccules  can  form  
at   the   ER,   which   do   not   appear   to   fuse   in   a   SNARE-­dependent   manner  
(Mironov   et   al.,   2003)   –   and   these   transport   complexes   then   translocate  
towards   the  Golgi   apparatus   (Appenzeller-­Herzog   and   Hauri,   2006).   There  
two  mechanisms  have  been  proposed:  Either  the  transport  carriers  fuse  with  
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each  other  and  mature  into  the  cis-­Golgi  cisternae,  or  they  fuse  with  the  latter  
compartment  directly  (Appenzeller-­Herzog  and  Hauri,  2006).  The  alternative  
model   for   ER-­to-­Golgi   trafficking   suggests   that   the   ERGIC   is   a   stable  
compartment   and   that   it   receives   cargo   via   COPII   vesicles.   Secretory  
molecules  would   then  exit   the  ERGIC  and   translocate   towards   the  Golgi   in  
anterograde  carriers  (Appenzeller-­Herzog  and  Hauri,  2006).  This  latter  stable  
compartment   model   is   favored   by   live-­imaging   experiments,   which   have  
revealed   long-­lived   stationary   GFP-­ERGIC-­53   labelled   structures   (Ben-­
Tekaya   et   al.,   2005).   Given   that   Membrin,   Sec22b,   Syntaxin-­5   and   Bet1  
localize   to  VTC/ERGIC   it   is   likely   that   the  Membrin-­Sec22b-­Syntaxin5-­Bet1  
complex  not  only  mediates  cargo  entry  into  the  cis-­Golgi,  but  also  membrane  
fusion  at   the  ERGIC  (Volchuk  et  al.,  2004).   Indeed,   it  has  been  shown   that  
COPII  homotypic  fusion  is  dependent  upon  Syntaxin-­5  and  Sly1  (Rowe  et  al.,  
1998;;  Xu  and  Hay,  2004).    
1.5.5          Golgi-­ER  retrograde  transport  
To   enable   a   net   balance   of   ER   and   Golgi   size,   and   to   maintain   their  
molecular  compositions,   transport  not  only  occurs   from   the  ER   to   the  Golgi  
but  also  from  the  Golgi  to  the  ER.  While  anterograde  cargo  transport  from  the  
ER  to  the  Golgi  is  mediated  by  COPII  coated  vesicles,  the  reverse  transport  
axis   is   thought   to   rely   upon   a   different   vesicle   population   –   COPI   coated  
cargo   carriers   (Brandizzi   and   Barlowe,   2013).   This   coat   consists   of   seven  
subunits.   Similar   to   the   clathrin   coat,   an   inner   and   outer   shell   can   be  
distinguished  (Popoff  et  al.,  2011).  The  cycle  of  COPI  assembly  and  vesicle  
budding  off   the  cis-­Golgi   is   initiated  by  Arf1   (Brandizzi  and  Barlowe,  2013).  
Arf1’s  activity   in   turn   relies  upon   its  conversion   from  the  GDP   into   the  GTP  
bound  state  by  guanine  nucleotide  exchange  factors  (GEF)  such  as  GBF1  –  
which  is  inhibited  by  the  drug  brefeldin  A  (BFA)  and  golgicide  A  (Helms  and  
Rothman,   1992;;   Lippincott-­Schwartz   et   al.,   1989;;   Lorente-­Rodríguez   and  
Barlowe,  2011;;  Sáenz  et  al.,  2009).  At  the  ER,  cargo  is  thought  to  enter  this  
compartment   via   the   Sec20-­Use1-­Syntaxin18-­Sec22b   SNARE   complex  
(Malsam   and   Söllner,   2011).   That   reverse   transport   of   proteins   and   lipids  
from   the   Golgi   to   the   ER   is   critical   for   maintaining   organellar   identity   is  
illustrated   by   the   KDEL   retrieval   pathway   for   ER   lumen-­residing   proteins.  
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When  escaped  into  the  early  secretory  pathway  they  are  recognized  via  a  C-­
terminal   lysine-­aspartate-­glutamate-­leucine   (KDEL)   sequence   by   the   KDEL  
receptor,  which  in  turn  associates  with  the  COPI  coat  and  thereby  relocates  
these  proteins   into  their   target  ER  compartment  (Majoul  et  al.,  2001;;  Munro  
and  Pelham,  1987).  
1.5.6          Intra-­Golgi  transport  
The  mode  of  cargo  transport   from  cis   to   trans  across  the  Golgi  stack   is  still  
unresolved  and  an  area  of  ongoing  controversy  (Emr  et  al.,  2009;;  Glick  and  
Luini,  2011).  Two  main  models  have  been  proposed,  which  either  regard  the  
individual  Golgi  cisternae  as  fixed  entities  or  as  cargo  carriers  themselves.  In  
the  first  model  cargo  is  thought  to  be  transported  by  COPI  vesicles  between  
successive   cisternae,  while   resident   proteins  must   be   excluded   in   order   to  
maintain  the  individual  enzymatic  signatures  (Glick  and  Luini,  2011).  Such  a  
view   is   supported   by   findings   that   small   cargos   are   still   capable   of  moving  
across   a   modified   Golgi   apparatus,   where   individual   cisternae   are  
synthetically  ‘glued’  to  each  other  and  therefore  cannot  themselves  progress  
(Dancourt   et   al.,   2016).   Alternatively,   the   cisternal   progression/maturation  
model   posits   that   entire   cisternae   shuttle   cargos   within   them   and   change  
their  molecular  make-­up  by  recycling  the  resident  enzymes  via  COPI  vesicles  
(Glick   and   Luini,   2011).   Such   transitions   have   been   visualized   in   yeast,  
where  an  un-­stacked  Golgi  allows   for   live   imaging  of  distinct   cisternae  with  
diffraction   limited   optics   (Losev   et   al.,   2006;;  Matsuura-­Tokita   et   al.,   2006).  
However,   in   the   stacked   mammalian   Golgi   apparatus   cisternal   maturation  
cannot  be  optically  resolved  by  conventional  means.  Progress  in   live  super-­
resolution   microscopy   may   ultimately   allow   to   directly   assess   whether  
cisternal  progression  facilitates  anterograde  cargo  transport  across  the  Golgi  
complex   (Rothman,   2010).   As   of   now   the   main   argument   for   cisternal  
progression  is  the  finding  that  large  procollagen  fibrils,  which  extend  the  size  
of   typical   COPI   vesicles   several-­fold,   are   efficiently   transported   across   the  
Golgi  apparently  without  leaving  the  cisternal  lumen  (Bonfanti  et  al.,  1998).  In  
a   more   recent   study   it   was   suggested   that   the   dilated   cisternal   rims   are  
capable   of   progression   –   which   therefore   could   account   for   the   rapid  
transport  of  large  molecules  –  while  the  more  central  parts  remained  in  place  
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(Lavieu  et  al.,  2013).   It  has  also  been  suggested   that   inter-­cisternal   tubules  
might  contribute  to  efficient   intra-­Golgi   transport  (Marsh  et  al.,  2004;;  Trucco  
et   al.,   2004).  While   the   precise  mode   of  Golgi   trafficking   is   still   debated,   it  
should  be  said  that  at  a  joint  meeting  of  several  leading  Golgi  researchers  in  
2009  extensive  support  was  voiced  for  a  cisternal  progression  model  (Emr  et  
al.,  2009).  
Once  the  anterograde  secretory  pathway  cargo  has  reached  the  trans-­Golgi  
network   (TGN),   it   is   distributed   to   various   intracellular   locations   or   guided  
towards   the   plasma  membrane   (Alberts,   2015).  One  well   established   post-­
Golgi   trafficking   pathway   is   the   receptor-­mediated   selective   delivery   of  
lysosomal  enzymes,  which  serves  here  as  an  example  (reviewed  in  Ghosh  et  
al.,   2003   and   Kornfeld,   1987).   Within   the   Golgi   a   mannose-­6-­phosphate  
(M6P)   group   is   added   to   acid   hydrolases,   which   then   is   recognized   in   the  
TGN  by  one  of  two  M6P  receptors.  The  receptor-­acid  hydrolases  complexes  
then  pinch  off  the  TGN  in  clathrin  coated  vesicles  and  are  delivered  to  early  
endosomes   (Ghosh   et   al.,   2003).   There,   the   enzymes   dissociate   from   the  
M6P-­receptors   due   to   the   lower   pH,   which   allows   for   recycling   of   the  
receptors  back  to  the  TGN  and  acid  hydrolase  delivery  to  lysosomes.    
1.6          Secretory  pathway  in  neurons  
Despite  the  Golgi  apparatus  having  been  originally  discovered  in  the  nervous  
system   more   than   a   hundred   years   ago,   most   of   the   seminal   work   in  
understanding   this   organelle   has   been   carried   out   in   non-­neuronal   cells  
(Farquhar   and  Palade,   1998).   This   is   not   surprising,   as   non-­neuronal   cells  
are  experimentally  more  easily  accessible.  Yet   the  secretory  pathway  faces  
special  challenges  in  neurons,  as  their  great  size,  intricate  shape  and  highly  
specialized  functions  pose  unique  demands.  Nerve  cells  have  up  to  10  000  
times  larger  surface  areas  than  many  non-­neuronal  cells,  which  requires  high  
rates   of   secretory   trafficking   –   especially   during   development   –   in   order   to  
provide  sufficient  lipid  and  protein  supplies  (Ehlers,  2013;;  Horton  and  Ehlers,  
2004).   In   addition,   neurons   are   often   highly   branched   and   elongated,   with  
their  most   distal   processes   far   away   from   the   nucleus,   which   contains   the  
     43  
blueprints   for   proteins   that   are   required   at   these   remote   locations.   Thus,  
long-­range  transport  must  occur  at  the  RNA  and/or  protein  levels.    
1.6.1          Secretory  pathway  in  dendrites  
In  neuronal  dendrites,  the  full  machinery  of  the  secretory  pathway  has  been  
described  (Hanus  and  Ehlers,  2008).  They  contain  mostly  smooth  ER  –  also  
some  attached   ribosomes  can  be  observed  –  ERGIC  as  well  as  Golgi  mini  
stacks,   termed   ‘Golgi   outposts’   (Hanus   and   Ehlers,   2016;;   Valenzuela   and  
Perez,  2015).  Diffusion  of  secretory  cargo  within  the  continuous  dendritic  ER  
lumen  is  restricted  by  local  zones  of  increased  ER  complexity  mainly  around  
dendritic   branch  points,  which  are  also   the  primary   sites   for  Golgi   outposts  
(Cui-­Wang  et  al.,  2012).  These  stacked  mini  Golgi  complexes  are  not  present  
in  all  neurons  and  overall  are   infrequent   (Horton  et  al.,  2005).  Moreover,   in  
dendritic  spines  a   ‘satellite  secretory  pathway’  has  been  described   (Gardiol  
et  al.,  1999;;  Pierce  et  al.,  2001;;  2000).  The  complete  secretory  machinery  as  
well   as   the   presence   of   mRNAs   encoding   secretory   pathway   dependent  
proteins   in   dendrites   suggest   local   trafficking   of   such   proteins   as   an  
additional   path   besides   canonical   trafficking   via   the   somatic   rough  ER   and  
Golgi  apparatus  (Cajigas  et  al.,  2012).  Also,  long-­range  retrograde  trafficking  
occurs,   where   cargo   transitions   through   the   somatic   Golgi   after   local  
synthesis   at   dendritic  ER-­associated   ribosomes   (Horton   and  Ehlers,   2003).  
Post-­ER  trafficking  has  been  shown  to  be  spatially  restricted   in  response  to  
increased  neuronal  activity  (Hanus  et  al.,  2014).  Interestingly,  it  has  recently  
been   suggested   that   many   proteins   might   bypass   the   Golgi   apparatus   in  
neurons   (Hanus   et   al.,   2016).   This   idea   is   based   on   the   finding   that   in  
neurons,   unlike   in   non-­neuronal   cells,   hundreds   of   cell   surface   proteins  
harbor   ‘high  mannose’   type  carbohydrates  side-­chains  (Hanus  et  al.,  2016).  
Such   a   glycosylation   pattern   is   otherwise   found   on   proteins   that   have   not  
transitioned   the  Golgi   apparatus  and   thus  were  not   turned   into   complex  N-­
glycans   (see   above   ‘Carbohydrate   processing’)   (Freeze   and   Ng,   2011;;  
Stanley,  2011).  
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1.6.2          Secretory  pathway  in  axons  
In  contrast  to  dendrites,  classical  Golgi  stacks  have  not  been  found  in  axons  
or  at  the  presynaptic  termini,  yet  Golgi  apparatus  resident  proteins  have  been  
detected  by  means  of  immuno-­fluorescence  microscopy  in  axons  (González  
and  Couve,  2014;;  González  et  al.,  2016;;  Merianda  and  Twiss,  2013).  While  
the   smooth   ER   is   present   also   in   axons,   attached   ribosomes   are   either  
scarce  or  absent  (Cornejo  et  al.,  2017).  Nevertheless,  proteins  critical  for  ER-­
associated  protein   synthesis,   such  as  Sec61,   ribophorin   I  &   II,  SRP54  and  
PDI  have  been  immuno-­localized  in  axons  (González  et  al.,  2016;;  Merianda  
and  Twiss,  2013;;  Merianda  et  al.,  2009).  Also,  the  ER-­exit  protein  Sar1,  the  
COPII   component   Sec23   and   the   ERGIC   marker   ERGIC53   have   been  
detected   in   axons   (Aridor   and   Fish,   2009;;   González   et   al.,   2016).   These  
observations,  and  the  finding  that  many  mRNAs  encoding  secretory  pathway  
dependent   transmembrane   proteins   are   present   in   axons,   suggest   that   a  
local  secretory  pathway  might  contribute  to  the  proteome  of  this  compartment  
(Cornejo  et  al.,  2017).  Indeed,  it  has  recently  been  shown  that  the  b2  voltage-­
gated   sodium   channel   subunit   can   be   trafficked   locally   from   the  ER   to   the  
plasma  membrane   in   axons   without   access   to   the   soma   (González   et   al.,  
2016).   We   can   speculate   that   such   a   route   might   involve   Golgi-­like  
membranes,  which  contain  a  similar  enzymatic  set-­up  as  the  somatic  Golgi,  
but   do   not   organize   in   a   classical   stacked   order.   Alternatively,   Golgi  
processing  might   be   by-­passed,   as   indicated   by   the   presence   of   immature  
carbohydrates   on   many   neuronal   cell   surface   proteins.   Amongst   them   are  
also  several  voltage-­gated  sodium  channel  subunits  (Hanus  et  al.,  2016).  
1.7          Aims  and  research  questions  
The  aims  of  my  PhD  were   to   study   the  genetics  of   progressive  myoclonus  
epilepsy,  which  led  to  the  discovery  of  the  novel  K164del  GOSR2  mutation,  
and  to  shed  light  upon  the  obscure  pathophysiology  of  GOSR2-­PME.    
Expanding  the  genotype  of  GOSR2-­PME  is  not  only  relevant  to  the  study  of  
clinical   genotype-­to-­phenotypes   relationships,   but   is   also   important   for  
disease   mechanism   research.   The   availability   of   additional   alleles   with  
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varying   severity   aids   interpretation   of   experimental   results   and   thereby  
facilitates  investigating  the  pathophysiology  of  this  disorder.    
Solely  by  looking  at  the  molecular  change  in  the  SNARE  domain  of  Membrin  
due   to   the   G144W   and   K164del   mutations,   one   can   hypothesize   that  
membrane  fusion  mediated  by  the  Membrin-­Sec22b-­Syntaxin5-­Bet1  complex  
might   be   reduced.   This   in   turn   might   abolish   or   reduce   the   rates   of  
membrane   fusion   at   the   cis-­Golgi,   and   thus   block   or   reduce   the   rates   of  
anterograde   cargo   transport.   Taking   into   account   that   the   GOSR2-­PME  
mutations  do  not  cause  zygote  or  early  embryonic  lethality  –  otherwise  these  
patients   would   not   be   alive   –   a   complete   trafficking   interruption   seems  
unlikely.  Yet,  if  an  anterograde  cargo  trafficking  defect  is  indeed  at  the  heart  
of   the   pathophysiology   of   GOSR2-­PME,   then   we   are   facing   the   difficult  
challenge  of  explaining  how  this  might  disturb  human  physiology  in  a  nervous  
system   restricted   manner.   GOSR2   is   required   for   every   cell's   basic  
physiology  and  expressed   throughout   the  human  body   to  similar   levels,  yet  
patients   present   with   a   phenotype  mostly   restricted   to   the   nervous   system  
(Corbett  et  al.,  2011;;  Su  et  al.,  2004;;  Wu  et  al.,  2016).  If  we  assume  a  broad  
trafficking  defect,  why  do   these  patients  not  present  with   immunodeficiency  
or  exocrine  pancreas  insufficiency?  After  all,  antibody  secreting  plasma  cells  
and  digestive  enzyme  secreting  pancreatic  acinar  cells  depend  heavily  upon  
the   function  of   the  secretory  pathway   (Farquhar  and  Palade,  1981;;  Palade,  
1975).   Therefore,   the   central   aim  of   this  PhD  was   to   unravel   the   ‘neuronal  
bottleneck’  of  this  disorder,  which  promised  to  hold  the  key  to  understand  the  
genotype-­to-­phenotype  relationship  of  GOSR2-­PME.    
To   achieve   these   aims   I   have   used   Sanger   sequencing   of   a   cohort   of  
patients  with  PME-­like  phenotypes,  and  disease  modelling  in  patient-­derived  
fibroblasts  and  Drosophila.  Chapter  2  will  summarize  how  I  have  identified  a  
novel   K164del   GOSR2-­PME   mutation.   Chapter   3   will   describe   how   the  
pathogenic   Membrin   mutations   affect   SNARE   function   and   basic   non-­
neuronal   cell   biology.   Chapter   4   finally   summarizes   our   investigations   into  
how  Membrin  mutations   impact  neuronal  development  and   function.  To   this  
end,   I   have   introduced   the   disease  mutations   into  Drosophila   and   thereby  
generated   the   first   multicellular   model   of  GOSR2-­PME.   In   Chapter   5   I   will  
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summarize  our  main   insights   into  GOSR2-­PME  that  are  derived   from  these  
studies,  their  relevance  to  neuronal  cell  biology,  and  potential  future  research  
avenues  related  to  this  work.  
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Chapter  2.            Expanding   the  mutational   spectrum  of  GOSR2  
mediated  progressive  myoclonus  epilepsy  
2.1          Introduction  
During  my  first  3  month  PhD  laboratory  rotation  I  was  working  on  the  human  
genetics   of   a   very   severe   set   of   neurological   disorders   –   the   progressive  
myoclonus  epilepsies  (PME).  This   is  a  broad  group  of  diseases  with  similar  
core  symptoms,  i.e.  epilepsy,  myoclonus,  ataxia,  dementia  and  a  progressive  
disease  course   (Michelucci  et  al.,  2012).  The   initial  aim  was   to  assemble  a  
cohort  of  patients  with  PME-­like  presentations   from  DNA  samples  stored  at  
the   National   Hospital   for   Neurology   and   Neurosurgery   and   Institute   of  
Neurology.   Such   a   collection   of   patient   DNAs   could   then   be   Sanger  
sequenced   for   target   genes   and   ultimately   subjected   to   next   generation  
sequencing.   Because   the   initial   aim   was   to   uncover   novel   variants   and  
potentially   broaden   the   phenotype   of   SCARB2,   we   loosely   assembled   a  
cohort  around  the  phenotype  of  SCARB2-­PME,  which  belongs   to   the  group  
of  PMEs  without  prominent  dementia  (Berkovic  et  al.,  2008;;  Michelucci  et  al.,  
2012).  The  paradigmatic  disorder  of  this  PME  subset  is  Unverricht-­Lundborg  
disease   (ULD),   which   is   caused   by   mutations   in   the   CSTB   gene,   most  
commonly  by  a  dodecamer  expansion  in  the  promoter  region  (Crespel  et  al.,  
2016;;   Lalioti   et   al.,   1997b).  Other,  much   rarer   forms   of  PME  without   gross  
cognitive   decline   are   due   to  PRICKLE1   and  GOSR2  mutations   (Bassuk   et  
al.,   2008;;   Corbett   et   al.,   2011).   While   all   of   the   above   are   autosomal-­
recessive   disorders,   recently   also   a   dominant   form   has   been   described,  
which  is  caused  by  mutations  in  the  KCNC1  potassium  channel  gene  (Muona  
et   al.,   2015,   Oliver   et   al.,   2017).   Because   my   initial   sequencing   of   all   12  
SCARB2  exons  in  this  cohort  did  not  reveal  any  novel  pathogenic  mutations,  
I   subsequently   investigated   the   GOSR2   gene   for   sequence   alterations.  
Initially   I   focused   on   the   only   known   GOSR2-­PME   associated   c.430G>T  
(p.G144W)   mutation   and   discovered   one   patient   heterozygous   for   this  
mutation  (Corbett  et  al.,  2011;;  Praschberger  et  al.,  2015).  Because  GOSR2-­
PME   is   an   autosomal-­recessive   disorder   this   sequence   alteration   was   not  
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sufficient  to  explain  the  phenotype.  Given  the  phenotypic  resemblance  of  this  
patients  with  other  GOSR2-­PME  cases,  we  hypothesized   that  an  additional  
mutation  located  in  a  different  exon  might  be  present  in  the  second  GOSR2  
allele.  Indeed,  I  identified  a  novel  c.491_493delAGA  (p.K164del)  mutation  by  
screening  the  remaining  exons  in  this  patient.  In  the  following  chapter  I  detail  
the   involved   genetic   screening   that   led   to   this   discovery   and   outline   the  
phenotype   of   this  GOSR2-­PME   patient,   who   harbored   the   second  GOSR2  
mutation  currently  associated  with  PME.  
2.2          Statement  of  Contribution  
I  assembled  the  final  cohort  of  patients  screened  in  this  study  and  performed  
the   Sanger   sequencing   under   the   guidance   of   Niccolo   Mencacci.   Henry  
Houlden   and   Joshua   Hersheson   provided   an   initial   selection   of   potential  
patients   for   this   study.   Bettina   Balint   and   Kailash   Bhatia   contributed  
extensive   clinical   data   and   examinations   for   the   compound   heterozygous  
GOSR2-­PME   patient   that   we   describe   here.   I   also   investigated   the   clinical  
phenotype  of  this  patient  based  on  medical  records.  
This   work   has   already   been   published   under   the   title   ‘Expanding   the  
Phenotype   and   Genetic   Defects   Associated   with   the   GOSR2   Gene’  
(Praschberger  et  al.,  2015).  
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2.3          Materials  and  Methods  
2.3.1          Patient  cohort  
We  assembled  a  cohort  of  43  patients  with  a  clinical  presentation  suggestive  
of  progressive  myoclonus  epilepsy/ataxia.  These  patients  were  negative   for  
mutations   in  ATN1   and   the   8344   and   3243  mutations   in   the  mitochondrial  
lysine   and   leucine   tRNA   genes,   respectively.   DNA   had   previously   been  
extracted   and   stored   at   the   National   Hospital   for   Neurology   and  
Neurosurgery.   The   study   was   approved   by   the   local   ethical   board   and  
informed  consent  was  given  by  all  patients.    
2.3.2          Sanger  Sequencing  
Oligonucleotide   primers   used   in   this   study  were   designed  with   the  Primer3  
software   (Koressaar   and   Remm,   2007;;   Untergasser   et   al.,   2012)   (Table   2  
and  Table  3).  The  SCARB2  and  exon  5  GOSR2  primers  were  designed  prior  
to  my  arrival  to  the  project.  The  subsequent  GOSR2  primers  were  designed  
by  myself.  
Exon   Forward  primer  (5’-­3’)   Reverse  primer  (5’-­3’)  
1   TCCCTCCTTGCAGTTGGATC   TGTAGCAGCAGGGATGGGAG  
2   GATCTAGGAGGTCAGAATAGGGG   GAAAGTGTGCTCCCACACAG  
3   TTGCTTATTAAAGTGGTGTC   ACTTAATGGCTCCTAAATG  
4   CCCCTTTGCTATGGGGTAG   AGTTAATCTGGCTTGGGGTG  
5   CTTCACCACACCATCTGGG   TGTTTTACCACCATCTTGATTTG  
6   GACAGCTCCAGTTAAATCTTGC   TCCTCATGCTTTTGGTGGTC  
7   TGCTAACTTGCGGATTTCG   AGCTGGGACTGTAGGTGTGC  
8   CTTTAGGAACCAGGCTGTGG   CAGGACTAAACTGGTGAACAATG  
9   GGACTACACAGAAATGGTGCTC   ACTCCTCCTGACATCAACCC  
10   GTCTGTCCGGGAAAGTGTG   TTTTGCCCTTCTGTCATAACTTAC  
11   GCTAACAGGAGGACATTCCC   AGCTGACAGCCCTTCAGTG  
12   ACTCCCCACCCAAACTTTTC   CTTTCAACAGGCAACAAGCC  
Table  2.  SCARB2  primers  
These  primers  bind  intronic  regions  flanking  the  exons  of  the  SCARB2  gene.  
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Exon   Forward  primer  (5’-­3’)   Reverse  primer  (5’-­3’)  
1   CAACCACTGCTAGTAAGGCG   AAAACTCGGCCTCTACCCTG  
2   GGACCTAAAGTGCCACATACA   AGAGTGCAGTCAGGAAGCC  
3   ACAACATTTACGGCCTAACTTGA   AACATGTACGTTGGTTTTCAGAA  
4   TCCTCAGTACAAAGCCTGGC   CAAAACAGATGGCGCTCAGA  
5   AAGACAGAGCAGTGAGACCC   TCAAGGGCTCTGTCTTGTCA  
6   GTTGGCAAAGCTCCATCTCC   AAACATTTCAAAAGGCGGCC  
7   TCCATTACACACAGCACTGC   TCAAAGCCAACCACTGTCAAG  
Table  3.  GOSR2  primers  
These  primers  bind  intronic  regions  flanking  the  exons  of  the  GOSR2  gene.    
  
The  PCR  reaction  mixture  consisted  of  50  ng  of  DNA,  0,5  µM  of  forward  and  
reverse  primer  and  10  µl  FastStart  PCR  Master  (Roche)   in  a  20  µl   reaction  
volume.   1  µl   of   DMSO  was   added   to   the   PCR   reaction   in   order   to   enable  
amplification  of  GOSR2  exon  1.  One  of  two  touch-­down  PCR  protocols  was  
used  –  65td55  (SCARB2  exon  5  and  7)  or  60td50  (SCARB2  exon  1-­4,  6,  8-­
12  and  all  GOSR2  exons)  (Korbie  and  Mattick,  2008)  (Table  4).  
   65td55   60td50  
initial   94°C  5  min   94°C  5  min  
8x   94°C  30  s  
65°C  30  s  
72°C  60  s  
94°C  30  s  
60°C  30  s  
72°C  60  s  
16x   94°C  30  s  
65°C*  30  s  
72°C  60  s  
94°C  30  s  
60°C‡  30  s  
72°C  60  s  
16x   94°C  30  s  
55°C  30  s  
72°C  60  s  
94°C  30  s  
50°C  30  s  
72°C  60  s  
final   72°C  7  min   72°C  7  min  
  
Table  4.  PCR  cycling  conditions  
The   two   above   cycling   protocols   were   trialed   for   each   primer   pair   outlined   in  
Table  2  and  Table  3  with  and  without  the  addition  of  DMSO  and  one  successful  
condition  used  for   the  screening.  */‡  denotes  that   in  each  subsequent  step  the  
annealing  temperature  was  reduced  by  0.5/0.6°C.  
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After   confirmation   of   successful   PCR   reaction   via   visualisation   of  
amplification  products  on  a  2%  agarose  gel,  excess  dNTPs  and  ssDNA  were  
inactivated   by   the   addition   of   Fast-­AP   (Thermo   Fisher   Scientific)   and  
Exonuclease  I   (Thermo  Fisher  Scientific)  and   incubation  for  30  min  at  37°C  
and  15  min  at  80°C.  3  µl  of   the  cleaned  PCR  product  was   then  mixed  with  
0,5  µl  BigDye  Terminator  v.3.1   (Thermo  Fisher  Scientific),  2  µl  Sequencing  
Buffer,  500  nM  primer  and  subjected  to   thermal  cycling  (Table  5)   in  a  10  µl  
total   volume.   The   resulting   product   was   cleaned   with   Sephadex   G-­50  
(Sigma)  filled  Corning  FiltrEX  plates  (Sigma).  
initial   94°C  1  min  
16x   94°C  30  s  
50°C  15  s  
60°C  4  min  
Table  5.  Cycling  condition  for  Sanger  sequencing  reaction  
  
Capillary  gel  electrophoresis  and  fluorescent  dye  detection  was  performed  on  
the  ABI  3730  DNA  Analyser  (Life  Technologies)  and  the  resulting  sequences  
where  viewed  with  the  Sequencher  software  (Gene  Codes).  
2.3.3          Repeat-­primed  PCR  
To  screen  our  PME  cohort   for   the  CSTB   dodecamer  expansion  we  utilized  
repeat-­primed   PCR   (Lalioti   et   al.,   1997b).   This   technique   is   designed   to  
identify   large  DNA   repeat  expansions,  which  would  otherwise  be  difficult   to  
amplify   (Warner   et   al.,   1996).   Therefore,   the   PCR   reaction   contains   three  
primers,   one   flanking   the   expansion,   one   corresponding   to   the   repeat  
sequence   plus   an   additional   overhang   and   a   third   primer   recognizing   this  
overhang.  This  combination  allows  for  priming  from  multiple   locations  within  
the  repeat  expansion  and  subsequent  amplification  of  these  differently  sized  
fragments.   A   fluorescent   tag   on   one   of   the   primers   then   allows   for   the  
visualization  of  the  varying  fragment  sizes  in  this  amplification  reaction.  The  
same   repeat-­primed   PCR   primers   for   the  CSTB   expansion   were   used   as  
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previously   described   (Table   6)   (Krysa   et   al.,   2012).   For   thermal   cycling,  
reactions  contained  12  µl  of  Extensor  Long  PCR  Master  Mix  (Thermo  Fisher  
Scientific),  2  M  betaine,  330  nM  of  the  CSTB_R  and  P3R  primers  and  33  nM  
of  the  CSTB_rpF  primer  in  a  25  µl  total  reaction  volume.    
Name   Primer  sequence  (5’-­3’)   Description  
CSTB_R   [6FAM]GGCCGGGGAGGAGGCACT  
  
Reverse   primer   flanking   the  
expansion   +   5’   fluorescence  
tag  
CSTB_rpF   TACGCATCCCAGTTTGAGACGCC  
CCGCCCCGCGCCCCGCCCCGCG  
  
Forward   primer   recognising  
the   expansion   (underscore)  
+  5’  overhang  
P3R   TACGCATCCCAGTTTGAGACG   Additional   reverse   primer  
recognising   the   above  
overhang  
Table  6.  CSTB  expansion  repeat-­primed  PCR  primers  
  
  
Cycling   condition  were   based   on   a   previous   protocol   amplifying   a   different  
disease-­associated  expansion  (Table  7)  (Hantash  et  al.,  2010).  
Initial   98°C  10  min  
10x   97°C  35  s  
53°C  2  min  
68°C  2  min  
25x   97°C  35  s  
53°C  2  min  
68°C  2  min  +  20  s/cycle  
Final   68°C  10  min  
Table  7.  CSTB  expansion  repeat-­primed  PCR  cycling  conditions  
  
2  µl  of  these  PCR  products  where  then  mixed  with  0.3  µl  of  Liz  500  (ABI)  and  
9.2   µl  HiDi   formamide   (ABI),   incubated   at   95°C   for   3  min   and   immediately  
afterwards   placed   on   ice   for   a   minimum   of   5   min.   Fragments   were  
subsequently   run   on   an   ABI   3730   (ABI)   and   analysed   with   GeneMapper  
(ABI).     
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2.4          Results  
In   the   present   study   we   screened   a   cohort   of   43   patients   exhibiting   a  
progressive   myoclonus   epilepsy/ataxia-­like   presentation   for   mutations   in  
genes   associated  with   this   phenotype.   Patients  with   previously   established  
CSTB   mutations   and   additional   cases   revealed   by   repeat-­primed   PCR  
accounted   for   13   cases   and   were   excluded   from   further   analysis.   The  
remaining  30  patients  did  not  harbour  pathogenic  mutations  in  any  of  the  12  
SCARB2  exons  or  their  adjacent  splice  sites,  while  four  previously  reported,  
heterozygous   single   nucleotide   polymorphisms   (SNPs)   were   detected  
(rs143655258,  rs180948007,  rs2228380  and  rs143699909).  When  these  30  
patients  were  also  screened  for  the  c.430G>T  mutation  in  exon  5  of  GOSR2,  
one  patient  was  discovered,  who  carried  this  allele  in  the  heterozygous  state  
(Figure  3A,  B).  Given  that  GOSR2  mediated  PME  is  a  recessive  disease,  this  
finding  did  not  fully  explain  the  patient’s  phenotype.  We  therefore  sequenced  
the   remaining  GOSR2   exons   in   this   patient   and   discovered   a   novel,   three  
base-­pair  deletion  (c.491-­494delAGA)  in  exon  6  resulting  in  the  deletion  of  a  
lysine  (p.K164del)  in  the  functionally  important  and  highly  conserved  SNARE  
domain   of   the   encoded   SNARE   protein   Membrin.   None   of   the   other   29  
patients   in   the   cohort   harboured   this   variant.  Because   the  patient’s   healthy  
son  was  heterozygous   for  c.491-­494delAGA,  but  not   for  c.430G>T,  we  can  
infer   that   these   mutations   are   on   separate   alleles   and   that   the   patient  
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Figure  3.  Chromatograms  of  the  novel  GOSR2-­PME  mutation  
(A)  Family  tree  depicting  the  patient’s  (arrow)  healthy  children  and  brother,  who  
suffered  from  cervical  dystonia.  
(B)   Chromatograms   of   one   child   and   the   brother   indicate   that   the   novel   and  
previously   described  GOSR2  mutations   segregate   independently   and   that   the  
patient  therefore  carries  them  in  the  compound  heterozygous  state.  
  
She  also  harboured  a  c.7C>T  missense  variant,  encoding  the  substitution  of  
a  proline  residue  for  a  serine  (p.P3S).  This  change  is  classified  as  benign  by  
the  in  silico  tools  PolyPhen-­2  and  SIFT  (Adzhubei  et  al.,  2010;;  Kumar  et  al.,  
2009).   Furthermore,   an   A/C   polymorphism   (rs12944167)   –   resulting   in   the  
similar  P3T  (both  threonine  and  serine  are  characterised  by  a  hydroxyl  side  
chain)   –   has   been   reported   in   the   1000  Genomes   Project   phase   3   with   a  
minor  allele  frequency  of  1%,  which  further  suggests  that  the  P3S  change  in  
our  patient  is  non-­pathogenic.  
The  G144W-­K164del  compound  heterozygous  GOSR2-­PME  patient  reported  
here  was  a  British-­Caucasian  woman  who  passed  away  at  62  years  of  age.  
Prior   to   this   this   she   lived   in   a   care   facility,   largely   bed-­bound   and   fully  
supported   for   all   activities   of   daily   living.   Her   disease   started   with   ataxia  
around  age  2  with  motor  deterioration  associated  with   infections  and   febrile  
episodes.   Subsequently   the   patient   developed   myoclonus   and   the   first  
seizure   was   reported   at   the   age   of   14.   She   was   able   to   attend   a   normal  
school  until  11  years  of  age  and  retained  some  fine  motor   tasks  during  her  
second  decade  of  life.  Owing  to  progressive  motor  deterioration  she  became  
fully  wheelchair-­bound  around  age  30.    
Clinical  examinations  by  Bettina  Balint  revealed  that  the  patient’s  speech  was  
interrupted   by   myoclonus   and   highly   dysarthric.   She   also   displayed   other  
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signs  consistent  with  ataxia,  such  as  broken  pursuit,  gaze-­evoked  nystagmus  
and   profound   limb   dysmetria.   Myoclonus   was   very   prominent,   of   cortical  
origin,  worse   under   action,   less   pronounced   at   rest,   stimulus   sensitive   and  
affected   the   patient’s   face,   neck   and   upper   limbs.   Interestingly,   she   also  
displayed  both  areflexia  and  scoliosis,  which  have   frequently  been  reported  
in  GOSR2-­PME.  However,  she  did  not  have  syndactyly  or  pes  cavus,  which  
have  been  reported  in  a  minority  of  GOSR2-­PME  patients  (Boissé  Lomax  et  
al.,  2013;;  van  Egmond  et  al.,  2014).  Cognitive  function  was  largely  preserved  
in   this   patient,   with   only   a   mild   cognitive   decline   reported.   However,   brain  
imaging  revealed  cerebral  and  cerebellar  atrophy  (Figure  4).  
  
Figure  4.  Brain  imaging  
(A)  Sagital  and  (B)  axial  MRI  images  of  the  GOSR2-­PME  depicting  cerebral  and  
cerebellar  atrophy.  
  
While   EEG   revealed   generalized,   epileptiform   activity,   a   photo-­paroxysmal  
response  and  an  overall   slowed  background,  nerve  conduction  studies  and  
EMG   recordings   were   normal.   The   patient’s   serum   creatine   kinase   levels  
were   within   normal   limits,   as   opposed   to   several   previous   GOSR2-­PME  
patients   who   displayed   significant   elevations   (Boissé   Lomax   et   al.,   2013).  
Seizures  were  effectively  supressed  and  myoclonus  partially  reduced  with  a  
combination  of  valproate,  clonazepam,  primidone  and  levetiracetam.  
Prior  to  our  finding  of  this  novel  GOSR2  mutation  several  other  genetic  tests  
had  been  performed  on  this  patient.  No  CSTB  expansion  could  be  detected,  
and  sequencing  of  all  CSTB  exons  did  not  reveal  any  mutation.  Sequencing  
of   the   exons   and   the   flanking   intronic   regions   of  PRICKLE1   did   not   reveal  
any   sequence  alterations,   and  no  expansion   could  be  detected   in  SCA1-­3.  
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No  other   family  member  was  reported   to  suffer   from  a  similar  syndrome  as  
the  patient  described  here.  Her  brother  suffers  from  primary  cervical  dystonia  
and   he   is   heterozygous   for   the   c.430G>T  mutation   but   does   not   carry   the  
novel   c.491-­494delAGA  mutation.   A  maternal   uncle   was   reported   to   suffer  
from  ‘athetoid  cerebral  palsy’.  The  patient  had  two  healthy  sons.  One  of  them  
was   genetically   tested   and   found   to   be   heterozygous   for   c.491-­494delAGA  
and  not  carry  c.430G>T.     
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2.5          Discussion  
In   the   present   study   I   identified   a   novel   c.491-­494delAGA   (p.K164del)  
GOSR2  mutation  in  a  patient  suffering  from  progressive  myoclonus  epilepsy,  
who  harboured  the  previously  described  c.430G>T  (p.G144W)  variant  on  her  
second  GOSR2   allele.   Importantly,   this   is   thus   far   the   only   variant   besides  
the   previously   reported   G144W   mutation,   which   was   homozygous   in   all  
GOSR2-­PME   patients   described   previously   (Boissé   Lomax   et   al.,   2013;;  
Corbett  et  al.,  2011;;  van  Egmond  et  al.,  2014;;  2015).  
The   clinical   presentation   of   our   patient   recapitulates   many   characteristic  
features  of  GOSR2-­PME,  including  an  early  disease  onset  around  2  years  of  
age  with  ataxia,  as  well   as  areflexia,  worsening  of   symptoms  during   febrile  
episodes   and   remarkably   preserved   cognitive   function   with   only   a   mild  
deterioration   later   in   the   disease   course.   Other   GOSR2-­PME   associated  
features  were  not  present   in  the  patient  presented  herein.  She  did  not  have  
elevated   creatine   kinase   levels,   nor   EMG   abnormalities,   syndactyly   or   pes  
cavus.   While   MRI   studies   in   previous   GOSR2-­PME   cases   were   mostly  
unremarkable  –  except  in  two  patients  where  atrophy  of  the  cerebellar  vermis  
or  asymmetric  cerebral  and  cerebellar  atrophy  was  reported  (Boissé  Lomax  
et  al.,  2013)  –  the  compound  heterozygous  patient  described  here  displayed  
cerebral   and   cerebellar   atrophy.   This   could   not   be   solely   attributed   to   her  
comparable   high   age,   because   these   changes   were   already   noted   in   her  
thirties.  Our  patient  appears   to  have  suffered   from  a  milder  disease  course  
given   that   she   lived   up   to   62   years   and   several   other   patients   with   this  
syndrome   died   around   30   years   (Boissé   Lomax   et   al.,   2013).   She   was  
ambulant   until   her   thirties   and   not   wheelchair   bound   since   the   second  
decade   of   life   as   several   other   patients   with   this   disease,   which   further  
suggests   a   less   aggressive   disease   course.   This   might   be   due   to   normal  
variability  within  the  phenotypic  spectrum  of  GOSR2-­PME.  Alternatively,  this  
could   also   be   a   consequence   of   the   different   mutation   (K164del)   that   this  
patient  carries  in  the  compound  heterozygous  state  with  the  original  mutation  
(G144W).   This   possibility   was   addressed   in   experimental   studies  
investigating   the   functional   consequences   of   both   disease   associated  
mutations  and  is  summarized  in  the  following  two  chapters.  However,  solely  
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by  a  priori  assessment  of  the  location  of  both  mutations,  we  would  expect  the  
novel  c.491-­494delAGA  variant  to  confer  more  severe  defects,  not  less.  This  
mutation  causes  the  deletion  of  one  of  two  consecutive  lysines  (either  K163  
or  K164)   in  Membrin’s  C-­terminal  half  of   the  SNARE  domain.  Given  that  C-­
terminal  SNARE  zippering  is  critical  for  force  generation,  this  change  should  
result  in  more  profound  lipid  fusion  rate  deficiencies  as  compared  to  G144W,  
a  missense  mutation  in  the  N-­terminal  half  of  Membrin  SNARE  domain  (Gao  
et  al.,  2012).  
In  summary,   I  discovered  a  novel  PME  associated  GOSR2  mutation,  which  
further   reinforces   the   relevance   of   this   gene   to   PME   and   provides   an  
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Chapter  3.            Investigating   the   pathophysiology   of   GOSR2  
mediated  progressive  myoclonus  epilepsy   in  patient-­derived  
fibroblasts  
3.1          Introduction  
Chapter  3  and  Chapter  4  summarize  the  main  project  carried  out  during  my  
PhD   research,   where   we   investigated   how   mutations   in   the   Golgi   SNARE  
protein   Membrin   –   encoded   by   the   GOSR2   gene   –   cause   the   severe  
neurological   syndrome   progressive   myoclonus   epilepsy   (PME).   When   I  
started   my   PhD,   the   G144W  GOSR2   mutation   had   been   demonstrated   to  
cause  PME  (Boissé  Lomax  et  al.,  2013;;  Corbett  et  al.,  2011;;  van  Egmond  et  
al.,   2014).   In   the   first   year   of   my   research   I   identified   a   novel   K164del  
GOSR2   mutation   associated   with   this   syndrome   (see   previous   chapter)  
(Praschberger   et   al.,   2015).   Yet   how   these   mutations   give   rise   to   this  
complex  neurological  disorder  was  completely  obscure.  Thus,  we  set  out   to  
answer   this   question.   At   a   first   glance   this   question   appears   to   be   quite  
narrow.  However,  upon  closer  examination  it  turns  out  to  be  broad.  This  has  
its  origins   in   the   fact   that  a  human  disease  phenotype  always   is  a  complex  
phenomenon   where   several   cellular   processes   –   downstream   of   the   initial  
pathogenic   ‘insult’   –   interact   to   give   rise   to   symptoms   and   clinical   signs.  
Accordingly,   we   can   understand   and   study   any   human   disorder   at   varying  
degrees   of   magnification.   As   in   microscopy,   the   most   zoomed   view   will  
provide  exquisite   details   but   necessarily   omit   the  wider   context.  Vice   versa  
will   a   zoomed   out   perspective   provide   a   high   level   understanding   but  
overlook   relevant   details.   Each   of   these   levels   of   understanding   will   have  
their  own  disease  mechanisms  at  heart,  which  together  will  ultimately  provide  
a   comprehensive   explanation   of   an   observed   disease   phenotype.  
Fortunately,  we  know  which  are   the   first  causes  of   this   form  of  progressive  
myoclonus   epilepsy   –   they   are   sequence   alterations   in   the  GOSR2   gene,  
which  will  eventually  translate  into  SNARE  domain  mutant  forms  of  the  Golgi  
SNARE  protein  Membrin.  Given  that  every  molecule  in  a  cell  and  every  cell  
in  a  multicellular  organism   is  embedded   in  a  plethora  of   direct   and   indirect  
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interdependencies,   these   Membrin   mutations   (and   every   other   pathogenic  
insult  at  the  heart  of  different  disorders)  will  have  a  wide  range  of  molecular  
and   cellular   consequences.   Some   of   these   consequences   will   be   directly  
relevant   for   the   disorder   at   hand,   others   unimportant   byproducts.   This  
complexity   and   high   degree   of   interdependency   of   physiological   processes  
makes  the  study  of  their  diseased  states  inherently  blurry.  Therefore,  I  want  
to  rephrase  our  prime  study  aim  and  specify  the  levels  of  understanding  we  
wished   to   achieve.   The   important   paradox  which   needed   to   be   resolved   is  
how  mutations   in   the  ubiquitously   important  Golgi  SNARE  protein  Membrin  
can  give  rise   to  a  selective  neurological  syndrome  with   the  core   features  of  
ataxia  and  hyperexcitability.  Which  aspect  of  the  neuronal  secretory  pathway  
is   special   and   sufficiently   different   to   non-­neuronal   cell   types   such   that   a  
Golgi  defect  would  show  up  almost  exclusively   in   the  nervous  system?  And  
how   would   such   a   defect   broadly   relate   to   a   lack   of   coordination   and   an  
epileptic  phenotype?  
In  order  to  comprehensively  link  the  mutant  GOSR2  genotype  with  the  PME  
phenotype  we  have  to  start  with  the  most  upstream  cause  and  test  how  the  
Membrin  mutations  impact  its  ability  to  perform  its  role  as  a  SNARE  protein.  
From   there   we   need   to   carry   on   and   test   how   such   alterations   impact  
Membrin’s   function   in   facilitating  anterograde  cargo   trafficking   via   the  Golgi  
apparatus  in  a  non-­neuronal  cell  (this  Chapter  3).  After  these  steps,  we  have  
to   enter   terra   incognita   and   unravel   the   ‘neuronal   bottleneck’   of   these  
mutations  (Chapter  4).  These  investigations  have  the  potential  –  if  successful  
–  to  provide  the  key  to  resolve  the  seeming  paradox  of  how  mutations  in  an  
integral   Golgi   protein   can   give   rise   to   a   neurological   disorder.   They   might  
thereby   uncover   the   most   critical   disease   mechanism   underlying  GOSR2-­
PME.  After   this  step,  we  can  aim  to   take  our  understanding  of   this  disorder  
one   level   higher   and   try   to   provide   a   preliminary   explanation   how   these  
neuronal  abnormalities  might   impact  a  complex  neuronal  circuit   in  a  way   to  
give  rise  to  ataxia  and  hyperexcitability.  
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3.2          Statement  of  contribution  
The   study   summarized   in   Chapter   3   and   Chapter   4   of   this   thesis   is   a  
collaborative   effort   with   several   scientists   having   made   important  
contributions,  both   intellectually  and  experimentally.  James  Jepson  was  not  
only  my  primary  supervisor  but  also  a  prolific  experimenter  on  this  project.  He  
extensively   characterized   the   effects   of   membrin   mutations   upon  
neuromuscular   junction   (NMJ)   morphology   and   proteome,   upon   the   distal  
axonal   secretory   pathway   and   also   contributed   to   Drosophila   stock  
generation.   Nancy   Malintan   in   James   Rothman’s   lab   performed   liposome  
fusion   assays   to   characterize   the   effects   of   the   PME-­associated   Membrin  
SNARE  motif  mutations  in  the  yeast  Bos1  orthologue.  She  thereby  provided  
key   insight   into   the   pathophysiology   of   GOSR2-­PME   at   this   ‘highest  
resolution’  perspective.  Simon  Lowe  in  James  Hodge’s  and  Maria  Usowicz’s  
labs  performed  a  detailed  analysis  of  the  effects  of  the  pathogenic  Membrin  
mutations   upon   synaptic   transmission   at   the   L3  Drosophila   neuromuscular  
junction   (NMJ).   He   thus   added   crucial   insights   into   the   GOSR2-­PME  
pathophysiology   at   a   higher   level.   Carlo   Giachello   in   Richard   Baines’   lab  
provided  experimental  evidence  for  seizure-­like  phenotypes  of  GOSR2-­PME  
model  Drosophila.  Nian  Patel  studied  the  phenotypic  consequences  of  wild-­
type   and  mutant  Membrin   overexpression   in  wild-­type  membrin   animals   as  
well   as   the   consequences   of   global   Membrin   knock-­down.   Shyam  
Krishnakumar,   Andreas   Ernst   and   James   Rothman   have   been   critical   in  
developing   ideas   and   experimental   strategies   for   this   study.   Several   other  
scientists  have  contributed   important  guiding   thoughts,  either  as  a   result   of  
meetings  or  informal  conversations.  
My  contributions  to  this  project  are  several-­fold.  Being  struck  by  the  severity  
of   the   disorder   during   my   human   genetics   work   on   GOSR2-­PME   (see  
above),  I  introduced  it  to  the  experimental  neuroscience  realm  and  assumed  
a  leading  role  in  intellectually  and  experimentally  pushing  towards  unraveling  
a   comprehensive   disease   mechanism.   Experimentally,   I   performed   the  
fibroblast  work  comprising  of  subcellular  localization  studies,  Golgi  trafficking  
assays  and  protein  quantification.  Furthermore,  I  generated  the  GOSR2-­PME  
Drosophila   models,   analyzed   their   core   organismal   phenotypes   (except  
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seizure-­like   behavior,   see   above)   and   uncovered   the   consequences   of  
membrin  mutations  upon  dendrite  growth.  
In   the   results  section  of   this  chapter   I  will   primarily   focus  on  my  own  work.  
However,  for  completeness,  I  will  also  include  results  from  other  researchers.  
When  results  were  not  obtained  by  myself,  I  will  explicitly  state  the  source  of  
the   experimental   contribution.   For   an   overview   of   the   experimental   figures,  
that  are  not  based  on  results  generated  by  myself,  please  refer  to  Table  8.    
Figure  6   Nancy  Malintan  
Figure  27C,  Figure  28A   Nian  Patel  
Figure  29C   Carlo  Giachello  
Figure  33D-­G,  Figure  36   James  Jepson  
Figure  37   Simon  Lowe  
Table  8.  Experimental  figures  contributed  by  other  researchers  
  
Also,   each   of   the   respective   figure   legends   contains   a   statement   of   the  
source  of  the  contribution.  
A   complete   and   concise   overview   of   the   entire   project   has   already   been  
published   under   the   title   ‘Mutations   in   Membrin/GOSR2   reveal   stringent  
secretory   pathway   demands   of   dendritic   growth   and   synaptic   integrity’  
(Praschberger  et  al.,  2017).    
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3.3          Materials  and  Methods  
3.3.1          Plasmids  
Human  GOSR2  coding  sequence  (CDS  of  NCBI  cDNA  NM_004287.3)  were  
custom  synthesized  by  GeneArt   (Thermo  Fisher  Scientific).  A  cgac  Kozac’s  
sequence  is  5’  of  the  initial  ATG  to  facilitate  efficient  translation  initiation.  The  
start  codon  is  directly  followed  by  a  FLAG  tag  coding  sequence  and  therefore  
gives   rise   to  N-­terminal   FLAG   tagged  Membrin   isoforms.   These   constructs  
were  5’/3’   flanked  by  NotI/KpnI  restriction  sites  (for  annotated  sequences  of  
the  custom  synthesized  fragments,  see  Appendix)  and  delivered  to  us  by  the  
company  in  a  pMA  vector,  which  contains  an  ampicillin  resistance  gene.  To  
enable   transient  overexpression  of  wild-­type  and  mutant  Membrin  (encoded  
by   the   GOSR2   gene)   in   mammalian   cells   these  
pMA_FLAG::GOSR2[WT]/[G144W]/[K164del]   inserts   were   subcloned   into  
pcDNA3.1(-­),   giving   rise   to   pcDNA3.1(-­)_FLAG::GOSR2[WT]  
/[G144W]/[K164del].   To   this   end,  
pMA_FLAG::GOSR2[WT]/[G144W]/[K164del]   plasmids   were   transformed  
into  chemically  competent  E.  coli  such  as  XL1-­blue  (Agilent)  and  amplified  by  
overnight   liquid  bacterial   culturing.  The  pcDNA3.1(-­)  backbone  was  derived  
from   pcDNA3.1(-­)   mouse   C/EBP   beta   (LAP)   (Addgene   plasmid   #12557),  
which  was  provided  as  a  bacterial  stab  culture  and  subsequently  amplified  by  
overnight   liquid  bacterial  culturing.  Plasmids  where  then  extracted  using  the  
PureYield   Plasmid   Miniprep   kit   (Promega)   and   DNA   concentrations  
determined   with   a   NanoDrop   1000   spectrophotometer   (Thermo   Fisher  
Scientific).   Approximately   1   µg   of  
pMA_FLAG::GOSR2[WT]/[G144W]/[K164del]   and   pcDNA3.1(-­)   mouse  
C/EBP   beta   (LAP)   plasmids   where   then   double   digested   with   NotI-­KpnI  
(NEB)   according   to   the   manufacturers   recommendations.   Cut   fragments  
were  electrophoretically  separated  on  a  1%  agarose  gel  supplemented  with  
[1/10000]   GelRed   (Biotium).   After   visualization   on   a   Benchtop   UV  
transilluminator   (UVP),   bands   were  manually   excised   and   purified   with   the  
Wizard  SV  Gel  and  PCR  clean-­up  kit   (Promega).  Subsequently,   the   inserts  
from  the  pMA  plasmids  were  ligated  into  the  cut  pcDNA3.1(-­)  backbone  with  
T4   ligase   (Promega),   transformed   into   chemically   competent   E.   coli.   and  
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individual   colonies   screened   for   successful   subcloning  by   restriction  digest.  
The   presence   of   the   correct   open   reading   frame   was   then   validated   by  
Sanger   sequencing   with   the   forward   (CMVF_pCDNA3:   5’-­
CAACGGGACTTTCCAAAATG-­3’)   and   reverse   (bGH_R:   5’-­
TGTCCAATTATGTCACACCACAG-­3’)  primers  by  Source  Biosciences.  
The   Halo::FM4::hGH   containing   plasmid   was   previously   cloned   in   the  
Rothman   lab   (Lavieu   et   al.,   2013).   GalT::RFP   was   a   kind   gift   from   Derek  
Toomre   and   encodes   mTagRFP   N-­terminally   fused   to   the   first   82   amino  
acids  of  the  human  Beta-­1,4-­galactosyltransferase  1.  
3.3.2          Bioinformatics  
SNARE  motifs   in   human   and  Drosophila  Membrin,   as   well   as   yeast   Bos1,  
were   identified   as   described  previously   (Kloepper   et   al.,   2007)   and  aligned  
with   Clustal   Omega   (McWilliam   et   al.,   2013).   Conserved   residues   were  
highlighted  using  BoxShade.  
3.3.3          Cell  culture  and  transfections  
Primary  skin-­derived  fibroblasts  from  the  first  described  GOSR2-­PME  patient  
were   kindly   shared  by  Mark  Corbett   (Corbett   et   al.,   2011).  As   controls,  we  
used   fibroblasts   from  healthy   individuals  of  either   the  same  sex  and  similar  
age,   or   opposing   sex   and   divergent   age   (control   1   =   23   year   old   female;;  
control  2  =  60  year  old  male  at  time  of  biopsy;;  the  G144W  mutant  Membrin  
fibroblasts  were  derived  from  a  32  year  old  female  patient).  Fibroblasts  and  
HEK293T   cells   were   grown   in   DMEM   (Thermo   Fisher   Scientific)  
supplemented  with  10%  fetal  bovine  serum  (FBS)  (Thermo  Fisher  Scientific)  
at  37°C  and  humidified  air  with  5%  CO2.  Fibroblast  transfections  were  carried  
out  with  Lipofectamine  2000  (Thermo  Fisher  Scientific).   In  order   to  obtain  a  
sufficient   number   of   transfected   cells   of   these   hard   to   transfect   cells,   the  
following   approach  was   taken.   For   paraformaldehyde   (PFA)   fixed   analysis,  
5000-­7000  fibroblast  cells  were  seeded  onto  19  mm  #1.5  barosilicate  cover  
glasses  (VWR)   in  12-­well  plates  and  allowed  to  grow  until  80%  confluence.  
For  live  imaging,  cells  were  seeded  into  35  mm  #1.5  CELLView  glass  bottom  
dishes  (Greiner).  3  µg  of  plasmid  DNA  and  6  µl  of  Lipofectamine  2000  were  
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each   diluted   in   75   µl   Opti-­MEM,   mixed   and   incubated   for   at   least   5   min  
before   addition   to   the   cultures.   To   avoid   excessive   Lipofectamine   toxicity  
complexes  were   removed  after  approximately  6-­8.5  hours  and  washed  with  
Dulbecco’s   phosphate   buffered   saline   (DPBS)   (Thermo   Fisher   Scientific).  
Human  embryonic   kidney   (HEK293T)   cells  were   transfected  with  Effectene  
(Qiagen).  
3.3.4          Fibroblast  imaging  
3.3.4.1          Immuno-­fluorescence  microscopy  
Cells  were   grown   on   13/19  mm  #1.5   glass   coverslips   (VWR)   in   24/12-­well  
plates  and  fixed  in  4%  PFA  (Alfa  Aesar)  for  15  min  followed  by  3x  phosphate  
buffered   saline   (PBS)   washes   and   a   3   min   permeabilization   step   in   PBS  
supplemented   with   0.3%   NP40,   0.05%   Triton-­X   100   and   0.1%   IgG   free    
bovine  serum  albumin  (BSA)  (Sigma).  Subsequently,  cells  were  rinsed  3x  in  
wash  buffer  (PBS  +  0.05%  NP40  +  0.05%  Triton-­X  100  +  0.2%  IgG  free  BSA)  
and  blocked  for  45  min  in  blocking  buffer  (PBS  +  0.05%  NP40  +  0.05%  Triton  
X-­100  +  5%  goat  serum).  Primary  antibodies  were  diluted  in  blocking  buffer  
and   incubated   overnight   rocking   at   4°C   followed   by   3x   5   min   washes   in  
washing   buffer.   Secondary   antibodies   were   diluted   in   blocking   buffer   and  
incubated   for   1   h   rocking   at   room   temperature.   Before   mounting   in   2   µl  
SlowFade  Gold  (Thermo  Fisher  Scientific),  cells  were  washed  3x  in  washing  
buffer   for   5   min,   then   3x   briefly   with   PBS   and   finally   immersed   once   in  
deionized   water.   The   following   antibodies   were   used:  mouse   anti-­Membrin  
(clone  25,  BD  Biosciences;;  1:500;;  this  antibody  was  raised  against  Membrin  
residues   5-­124   and   therefore   should   not   be   affected   by   the   G144W  
mutation.),   mouse   anti-­FLAG   (clone   M2,   Sigma;;   1:1000),   rat   anti-­FLAG  
(Agilent;;  1:1000),  rabbit  anti-­GPP130  (Cambridge  Bioscience;;  1:1000),  rabbit  
anti-­PDI   (Sigma;;   1:500),   mouse   anti-­GM130   (clone   35,   BD   Biosciences;;  
1:1000),   mouse   anti-­p230   (clone   15,   BD   Biosciences;;   1:250),   rabbit   anti-­
ERGIC-­53   (Sigma,   1:500)   and   goat   anti-­mouse/rabbit/rat   Alexa   Fluor  
488/555/647   conjugated   secondaries   (Thermo   Fisher   Scientific;;   1:500).  
Samples   were   imaged   on   inverted   confocal   Zeiss   LSM710   or   LSM880  
microscopes  with  63x  1.4NA  oil  immersion  objectives.  
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3.3.4.2          hGH  Golgi  trafficking  assay  
For   Golgi   trafficking   studies   cells   were   loaded   with   HaloTag  
tetramethylrhodamin   (TMR)   Ligand   (Promega)   24   h   post   transfection   with  
Halo::FM4::hGH  according   to   the  manufacturer’s   protocol.   Fibroblasts  were  
incubated   for   15  min  with   [1/1000]   TMR   ligand,   subsequently  washed  with  
medium  3x  and   incubated   for  a   further  30  min  at  37°C   to   remove  unbound  
ligand.  Thereafter  medium  containing  1.5  µM  D/D  solubilizer  (Clontech)  was  
added   in   order   to   release   the   aggregated   and   therefore  ER   retained  Halo-­
TMR::FM4::hGH  cargo.  Subsequently  fibroblasts  were  PFA  fixed.  In  order  to  
microscopically  correlate   the  cargo  derived  TMR  signal  with   the  cis-­Golgi,   I  
stained   this   compartment   with   an   anti-­GM130   antibody   as   outlined   above.  
Imaging  was  carried  out  with  a  Plan-­Apochromat  63x  1.4  NA  oil   immersion  
objective  on  a  Zeiss  confocal  LSM880  microscope.  Halo-­TMR::FM4::hGH  –  
GM130   Pearson’s   correlation   coefficients   (PCC)   were   extracted   with   the  
Coloc  2  ImageJ  plugin.  
3.3.4.3          GalT::RFP  FRAP  
For   fluorescence   recovery   after   photobleaching   (FRAP)   studies   I   imaged  
GalT::RFP   transfected   fibroblasts   in   35  mm  glass  bottom  dishes  24  h  post  
transfection  with  a  Plan-­Apochromat  63x  1.4  NA  oil  immersion  objective  on  a  
Zeiss  confocal  LSM880  microscope.  The  phenol  red  containing  DMEM  used  
for  culturing  these  cells  was  exchanged  for  DMEM  without   this  pH   indicator  
(Thermo   Fisher   Scientific)   in   order   to   reduce   background   fluorescence.  
Temperature   was   maintained   at   37°C   throughout   the   experiment   with   an  
environmental  chamber  and  a  stage  heater.  The  temperature  of  the  imaging  
system  was  allowed  to  equilibrate  for  at  least  30  min  in  order  to  warrant  that  
all   microscope   parts   in   proximity   to   the   cells   –   such   as   the   objective   –  
reached   37°C.   In   addition,   the   imaging   chamber   was   perfused   with  
humidified  air  supplemented  with  5%  CO2.  The  pinhole  was   fully  opened   in  
order   to   also   collect   photons   derived   from  Golgi   resident  GalT::RFP  above  
and  below  the  optical  plane.  Every  30  s  one  frame  was  acquired  –  4  pre-­  and  
40  post-­bleach.  To  achieve  effective  focus  correction  and  thereby  remain   in  
the  intended  optical  plane  over  this  comparably  long  acquisition  time,  Definite  
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Focus   (Zeiss)   was   used.   Photobleaching   was   carried   out   by   scanning   the  
entire  Golgi   resident  GalT::RFP   twice  at   100%   transmission  of   the  561  nm  
laser   line,   which   decreased  mean   fluorescence   intensity   in   this   area   by   at  
least  84%.  Only  cells  with  low  GalT::RFP  expression  levels  were  selected  for  
these  experiments.  All  image  processing  and  analysis  was  carried  out  in  Fiji.    
3.3.5          Western  blot  
For   western   blot   studies,   fibroblasts   were   grown   in   10   cm   dishes   and  
HEK293T  cells  in  6-­well  plates.  200/300  µl  lysis  buffer  (HEPES-­NaOH  pH  7.5  
20   mM,   KCl   100   mM,   glycerol   5%,   EDTA   10   mM,   Triton   X-­100   1%,   1x  
PhosSTOPTM   phosphatase   inhibitor   cocktail   (Roche),   1x   cOmpleteTM  
protease   inhibitor   cocktail   (Roche))  was  added   to  each  10cm  dish/6-­well  of  
PBS   washed   fibroblasts   or   FLAG::GOSR2[WT]   overexpressing   or   native  
HEK293T  cells  and   incubated  at   -­80°C  for  1  min   followed  by  resuspension.  
Lysed  cells  were  centrifuged  at  16  000  g,  4°C  for  10  min  and  the  liquid  phase  
transferred  to  a  fresh  Eppendorf  tube.  Protein  concentrations  were  quantified  
with   the   Pierce   660   nm   Protein   Assay   (Thermo   Fisher   Scientific).   Equal  
amounts   of   protein   (5   µg   for   fibroblasts,   15   µg   for  HEK293T   lysates)  were  
used  per   lane  of  a  10-­well,  1.5  mm  NuPAGE  Novex  4-­12%  Bis-­Tris  Protein  
Gel   (Thermo  Fisher  Scientific).  Prior   to  electrophoresis   in  a  XCell  SureLock  
Mini-­Cell   with   1x   NuPAGE   MOPS   SDS   running   buffer   and   NuPAGE  
Antioxidant  (Thermo  Fisher  Scientific),  protein  was  denaturated  for  10  min  at  
70°C   in   1x   NuPAGE   LDS   Sample   Buffer   (Thermo   Fisher   Scientific)  
supplemented  with  50  mM  DTT  (Sigma).  Protein  was  allowed  to  enter  the  gel  
at  80V  for  10  min  and  then  separated  for  90  min  at  160  V.  The  transfer  onto  
an  Immobilon-­P  PVDF  (Millipore)  membrane  was  carried  out  with  the  XCell  II  
Blot   Module   (Thermo   Fisher   Scientific)   in   Tris-­glycine-­methanol   transfer  
buffer  (20  mM  Tris,  150  mM  glycine,  20%  methanol)  at  30  V  for  90  minutes.  
Successful  transfer  was  validated  by  visualizing  protein  bands  with  Ponceau  
S  solution  (Sigma).  Remaining  Ponceau  S  solution  was  removed  by  washing  
the  membrane   in   tris   buffered   saline  Tween   20  TBST   (Tris  HCl   pH  7.5   10  
mM,  NaCl   140  mM,  Tween  20  0.1%)  and   then  blocked   in   a   rotating  50  ml  
Falcon  tube  in  TBST  supplemented  with  5%  dried  skimmed  milk  powder  for  1  
h   at   room   temperature.   Primary   and   secondary   antibodies   were   diluted   in  
     68  
TBST+5%   dried   skimmed   milk   powder   and   incubated   in   a   50   ml   rotating  
Falcon   tube   overnight   4°C   and   2   h   at   room   temperature   respectively.   The  
following   antibodies   were   used:   mouse   anti-­Membrin   (clone   25,   BD  
Biosciences;;  1:2000),  rabbit  anti-­Membrin  (Synaptic  Systems,  1:2500),  rabbit  
anti-­hamster  Syntaxin-­5  (Rothman  lab;;  1:1000;;  Orci  et  al.,  2000),  rabbit  anti-­
Sec22b   (Rothman   lab;;   1:1000;;   Volchuk   et   al.,   2004),   rabbit   anti-­rat   Bet1  
(Rothman   lab;;  1:1000;;  Volchuk  et  al.,  2004),  mouse  anti-­b-­actin   (clone  AC-­
74,   Sigma;;   1:5000)   and   HRP-­conjugated   anti-­mouse/rabbit   secondaries  
(Jackson  Immuno;;  1:2500-­8000).  In  case  PVDF  membranes  were  re-­probed  
for   proteins   of   similar   molecular   weight   as   previously   tested   proteins   they  
were   stripped   with   Restore   Western   Blot   stripping   Buffer   (Thermo   Fisher  
Scientific),   followed  by  a  1  h  blocking  step  and   the  above  outlined  antibody  
incubations.   For   semi-­quantitative   western   blots,   detection   was   carried   out  
with   SuperSignal   West   Pico   Chemiluminescent   Substrate   (Thermo   Fisher  
Scientific)   and   a  ChemiDocTM   Imaging   system   (Bio-­Rad).   Band   intensities  
were   extracted   with   Image   Studio   Lite   (Li-­cor).   Alternatively,   signal   was  
detected  with  FUJI  RX  X-­Ray   films  after   incubation  with  SuperSignal  West  
Pico  Chemiluminescent  Substrate  (Thermo  Fisher  Scientific).  
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3.4          Results  
3.4.1          GOSR2-­PME  mutations  cause  partial  SNARE  dysfunction  
To  assess   the  disease  mechanism  of  GOSR2-­PME  at   the  highest  possible  
resolution,   we   first   have   to   turn   our   investigation   towards   the   molecular  
changes   encoded   by   the   GOSR2   mutations.   Both   pathogenic   mutations  
result   in   amino   acid   changes   within   the   evolutionarily   conserved   Membrin  
SNARE   domain   (Figure   5).   Such   alterations   suggest   impaired   SNARE  
complex   formation   with   its   cis-­Golgi   partner   SNAREs   Bet1,   Sec22b   and  
Syntaxin-­5.   Physiologically   this   process   is   thought   to   occur   via   N-­   to   C-­  
terminal  zippering  along  stereotypically  spaced  interacting  layer  amino  acids  
(ranging   from   -­7   to   +8)   within   the   respective   SNARE   domains   (Figure   5)  
(Fasshauer   et   al.,   1998;;   Gao   et   al.,   2012).   Both   GOSR2-­PME   disease  
mutations  –  G144W  and  K164del  –  affect  this  critical  layered  structure,  which  
directly   suggests   that   cis-­Golgi   SNARE   complex   assembly   might   be  
impaired.  
  
Figure  5.  Membrin  SNARE  domain  sequence  alignment  
SNARE   domain   alignment   of   Homo   sapiens   (Hs),   Drosophila   melanogaster  
(Dm)   and   Saccharomyces   cerevisiae   (Sc)   Membrin   (uniprot   ID   O14653-­1),  
Membrin   (Q9VRL2)   and  Bos1   (P25385)   respectively.  Conserved   residues   are  
highlighted   in   black,   similar   residues   in   grey.   Layer   amino   acids   critical   for  
forming   the   tetrameric   cis-­Golgi   SNARE   complex   are   indicated   in   green.   The  
disease-­causing   G144W   and   K164del   (one   of   two   consecutive   lysines   is  
deleted)  and  their  Drosophila  and  yeast  orthologous  residues  are  highlighted  in  
blue  and  red.  
  
This  hypothesis  was  tested  by  Nancy  Malintan  in  James  Rothman’s  lab  and  I  
will   briefly  summarize  her  key   findings,  as   they   represent   the   fundament  of  
the  experimental  pyramid  described  in  this  thesis.  Nancy  Malintan  performed  
liposome   fusion   assays   with   the   wild-­type   and   mutant   Membrin   yeast  
orthologue  Bos1  and  its  respective  yeast  partner  SNAREs  (Bet1,  Sec22  and  
Sed5).   Yeast   proteins   where   chosen   because   of   inherent   difficulties   of  
working   with   purified   mammalian   Syntaxin-­5   and   because   yeast   Golgi  
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SNARE   liposome   fusion   assays   represent   a   well   established   experimental  
system   (Parlati   et   al.,   2000;;   2002).   Golgi   SNARE   proteins   are   conserved  
throughout   eukaryotic   evolution,   which   is   why   our   experimental   results  
derived   from   yeast  will   likely   also   be   applicable   to   human   (Kloepper   et   al.,  
2007).  The  validity  of  our  approach  is  further  reinforced  by  observations  that  
mammalian  and  yeast  Golgi  SNARE  can  be   functionally   interchangeable   in  
liposome   fusion   assays   and   living   cells   (Fischer   von  Mollard   and   Stevens,  
1998;;   McNew   et   al.,   1997;;   Varlamov   et   al.,   2004).   To   determine   the  
functional   impact  of  Bos1/Membrin  SNARE  motif  mutations  Nancy  Malintan  
introduced   purified   Bet1   into   one   liposome   population,   wild-­type   or  
G176W/D196del  (orthologous  to  G144W/K164del  in  human  Membrin)  mutant  
Bos1,   Sec22   and   Sed5   in   another   population   and   read   successful   fusion  
after  mixing  of  the  two  populations  with  a  Förster  resonance  energy  transfer  
(FRET)  based  approach.  This   readout   is  based  on   the  de-­quenching  of   the  
NBD-­rhodamine  FRET  pair  as  a  result  of  fusion  induced  spatial  separation  of  
the   lipid   tethered   fluorophores   (Struck   et   al.,   1981).   Consistent   with   the  
predictions   Nancy   Malintan   found   that   both   yeast   orthologous   Bos1  
mutations  caused  reduced  fusion  rates,  which  were  nevertheless  larger  than  
negative  control,  where  Bet1  was  omitted  (Figure  6A,  B).  
  
Figure  6.  Reduced  liposome  fusion  rates  due  to  GOSR2-­PME  mutations  
(A)   Example   traces   showing   increase   in   NBD   fluorescence   due   to   liposome  
fusion   between   wild-­type   and   G176W/D196del   mutant   Bos1   containing  
liposome   fusion   reactions.   Expressed   as   a   fraction   of   maximal   NBD  
fluorescence  after  addition  of  detergent.  
(B)   Endpoint   (120   min)   quantification   of   experiment   as   described   in   (A),  
normalized   to   wild-­type.   n   =   8,   8,   7   for  WT,   G176W   and   D196del.   Replicate  
values   derived   from   repeat   experiments,   mean   and   SD   are   shown.   **,   ***  
represent  p  <  0.01,  0.001;;  ANOVA  with  Dunnett’s  multiple  comparison  test.  
These  experiments  were  performed  and  analysed  by  Nancy  Malintan  in  James  
Rothman’s  laboratory.  
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These   findings   suggest   that   the  GOSR2-­PME  mutations   cause  partial,   and  
not   complete   loss   of   function.   In   addition,   Nancy   Malintan   found   that   the  
effect   size   scaled   with   the   nature   of   the   change.   The   missense   mutation  
(G176W)   in   the   N-­terminal   half   of   the   Bos1   SNARE   domain   had   a   more  
subtle  effect,  while   the  deletion  mutation  (R196del)   in   the  C-­terminal  half  of  
the   Bos1   SNARE   domain   was   more   deleterious   (Figure   6A,   B).   This   is  
consistent   with   the   critical   importance   of   SNARE   complex   C-­terminal  
zippering  for  force  generation  (Gao  et  al.,  2012)  and  a  probable  misalignment  
of  the  C-­terminal  layers  +3  to  +8  as  a  result  of  the  single  amino  acid  deletion.  
In  summary,  we  can  infer  from  these  yeast   liposome  fusion  studies  that  the  
G144W  and  K164del  Membrin  mutations   likely   cause  a  partial   decrease  of  
cis-­Golgi  SNARE  complex   formation,  and   in   turn   reduced  membrane   fusion  
of  ER-­derived  vesicles  with   the  Golgi  apparatus  and  ER-­Golgi   intermediate  
compartment  (ERGIC).    
3.4.2          Mutant  Membrin  retains  the  capability  to  localize  to  the  cis-­
Golgi  
Only  Membrin  localized  to  the  Golgi  and  ERGIC  will  be  capable  of  mediating  
ER-­to-­Golgi   transport   via   fusing   opposing   lipid   bilayers   together   with   its  
partner   SNAREs   Bet1,   Syntaxin-­5   and   Sec22b.   Previous   electron  
microscopy   immuno-­gold   studies   have   established   that   Membrin  
physiologically   localizes   primarily   to   the   cis-­Golgi   as  well   as   to   the   ERGIC  
(Hay   et   al.,   1998;;   Volchuk   et   al.,   2004).   Thus,   in   a   first   step   –   in   order   to  
serve  as  an  internal  control  and  to  confirm  these  findings  in  the  experimental  
system   of   this   study   –   I   have   tested   these   findings   with   indirect   immuno-­
fluorescence  confocal  microscopy   in  primary  skin   fibroblasts  derived   from  a  
healthy  human.  It  has  to  be  noted  however,  that  by  doing  so,  we  are  pushing  
the  boundaries  of  diffraction  limited  optics  (maximum  200  nm  resolution)  and  
therefore  will  not  be  able   to  unambiguously  distinguish  between  the  ERGIC  
in  Golgi  proximity  –  as  opposed  to  the  peripheral  ERGIC  next  to  ER  exit  sites  
–   as   well   as   cis-­   from   trans-­Golgi.   Nevertheless,   this   system   is   sensitive  
enough   to  evaluate  whether  Membrin   is   correctly   localized  within   the  Golgi  
area   and   if   so,   whether   it   is   shifted   towards   the   cis-­Golgi/ERGIC   or   trans-­
Golgi/trans-­Golgi  network.  At  the  light  microscopy  level  I  found  a  high  degree  
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of  colocalization  of  endogenous  Membrin  with  the  cis-­Golgi  marker  GPP130,  
the  ERGIC  marker  ERGIC-­53  and  a   less  colocalization  with   the   trans-­Golgi  
marker  p230  (Figure  7A,  B).  These  findings  are  consistent  with  the  previously  
established  predominant  localization  of  Membrin  in  the  cis-­Golgi  and  ERGIC,  
and  therefore  confirm  the  validity  of  my  imaging  approach.    
  
Figure  7.  Subcellular  localization  of  endogenous  Membrin  
(A)  Example  confocal  slices  of  human  control  fibroblasts  co-­stained  for  Membrin  
and   the   ERGIC,   cis-­   and   trans-­Golgi   markers   ERGIC53,   GPP130   and   p230  
respectively.  
(B)  Pearson’s  correlation  coefficients  (PCC)  of  experiment  as  outlined  in  (A).  N  
=  6,  6  and  7   for  ERGIC53,  GPP130  and  p230.  Replicate  values  derived   from  
individual  cells  of  one  experiment,  mean  and  SD  are  shown.  ***  represents  p  <  
0.001;;  ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
Corbett  et  al.  suggested  that  G144W  mutant  Membrin  fails  to  localize  to  the  
Golgi   apparatus   (Corbett   et   al.,   2011).   This   observation   implies   that   the  
G144W   Membrin   mutation   confers   complete   loss   of   function   due   to   an  
absence   from   its   target   compartment,   which   however   would   not   be  
compatible   with   organismal   life.   In   addition,   the   partial   membrane   fusion  
defects  observed   in   liposome   fusion  studies  are  only   relevant   for   impacting  
ER-­to-­Golgi  trafficking  rates  if  mutant  Membrin  also  localizes  to  its  native  site  
of  action  –  the  ERGIC  and  cis-­Golgi.  This  is  why  we  tested  whether  Membrin  
harboring   the   SNARE   motif   mutations   could   in   principle   localize   to   these  
sites.   To   this   end   I   overexpressed   wild-­type   or   G144W/K164del   mutant  
Membrin  in  primary  human  skin  fibroblasts  derived  from  a  healthy  control  and  
assessed   their   subcellular   localization   with   confocal   microscopy.   The  
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Membrin  constructs  were  N-­terminal  fused  to  a  FLAG  tag  in  order  to  be  able  
to   distinguish   the   transgenically   expressed   Membrin   from   the   endogenous  
protein.   Overexpressed   wild-­type   as   well   as   mutant   Membrin   successfully  
exited   the   ER,   which   is   apparent   from   confocal   images   where   the   FLAG  
staining   did   not   overlap   with   the   ER   resident   enzyme   protein   disulfide  
isomerase  (PDI)  (Figure  8A,  B).  
  
Figure  8.  Mutant  Membrin  successfully  exits  the  ER  
(A)   Example   confocal   slices   of   wild-­type,   G144W   and   K164del   FLAG-­tagged  
Membrin  overexpressed   in  control   fibroblasts.  Cells  were  co-­stained   for  FLAG  
and   the   ER   resident   protein   PDI.   Comparable   results   were   obtained   in  
HEK293T  cells.  
(B)  Pearson’s  correlation  coefficients  (PCC)  of  experiment  as  outlined  in  (A).  N  
=  12,  13,  13  for  WT,  G144W,  K164del.  Replicate  values  derived  from  individual  
cells  of  one  experiment,  mean  and  SD  are  shown.  ***  represents  p  <  0.001, ns  
=  not  significant  (p  >  0.05);;  ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
In   contrast,   overexpressed   wild-­type   and   mutant   Membrin   localized   to   the  
cis-­Golgi,  as  colocalization  of  all  FLAG::Membrin  variants  with   the  cis-­Golgi  
marker   GPP130   was   apparent   (Figure   9A).   Nevertheless,   a   subtle   but  
statistically  significant  decrease  of  colocalization  was  present  in  G144W  and  
K164del   compared   to   wild-­type   Membrin   when   Pearson’s   correlation  
coefficients  were  extracted  (Figure  9B).  I  speculate  that  this  finding  might  be  
explained  by  a  decrease  of  cis-­Golgi  entry  of  mutant  Membrin  due  to  SNARE  
defects   and   a   consecutive   build-­up   of  mutant  Membrin   containing   vesicles  
adjacent   to   the   cis-­Golgi.   To   confirm   this   idea   immuno-­gold   electron  
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microscopy   would   have   to   be   carried   out,   which   however   surpasses   the  
scope  of  these  experiments.  
  
Figure  9.  Mutant  Membrin  localizes  to  the  cis-­Golgi  
(A)   Example   confocal   slices   of   wild-­type,   G144W   and   K164del   FLAG-­tagged  
Membrin  overexpressed   in  control   fibroblasts.  Cells  were  co-­stained   for  FLAG  
and  the  cis-­Golgi   resident  protein  GPP130.  Comparable  results  were  obtained  
in  HEK293T  cells.  
(B)  Pearson’s  correlation  coefficients  (PCC)  of  experiment  as  outlined  in  (A).  N  
=  16,  16,  17  for  WT,  G144W,  K164del.  Replicate  values  derived  from  individual  
cells  of  one  experiment,  mean  and  SD  are  shown.  *,  **  represent  p  <  0.05,  0.01;;  
ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
To  test  whether  also  endogenous  G144W  mutant  Membrin  could  localize  to  
this   compartment,   we   re-­examined   the   patient   fibroblasts   from   the   original  
GOSR2-­PME   study   (Corbett   et   al.,   2011).   Prior   to   performing   experiments  
with   these   fibroblasts,   which   where   kindly   shared   by   Mark   Corbett,   I  
confirmed   the   presence   of   the   GOSR2   gene   alteration   that   gives   rise   to  
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Figure  10.  Sequence  confirmation  of  G144W  mutant  Membrin  fibroblasts  
Fibroblasts   derived   from   a   GOSR2-­PME   patient   were   sequenced   prior   to  
performing   experiments   in   order   to   confirm   the   presence   of   the   pathogenic  
c.430G>T   nucleotide   alteration   in   exon   5   of   the  GOSR2   gene.   This   change  
gives  rise  to  G144W  mutant  Membrin.  
  
Next,   I   examined   the   specificity   of   commercially   available   anti-­Membrin  
antibodies.   A   mouse   monoclonal   Membrin   antibody   purchased   from   BD  
Biosciences  appeared  specific  in  western  blot,  as  it  detected  a  band  around  
the   expected   25   kDa   molecular   weight   (Figure   11A).   Also,   in   immuno-­
fluorescence   microscopy   it   clearly   recognized   the   overexpressed   protein  
(Figure   11B).   This   antibody   was   used   for   western   blot   quantifications   and  
immuno-­fluorescence  microscopy  presented  in  this  thesis.  Exceptions  to  this  
are   the   anti-­p230   co-­staining   (Figure   7),  which   required   a   non-­mouse   anti-­
Membrin   antibody   and   one   control   western   blot   (Figure   13D).   For   these  
experiments   I   used   a   Synaptic   Systems   polyclonal   rabbit   anti-­Membrin  
antibody,   which   detected   Membrin   in   western   blot   and   recognized   the  
overexpressed  protein  in  immuno-­fluorescence  microscopy  (Figure  11C,  D).    
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Figure  11.  Anti-­Membrin  antibody  validation  
(A)  The  mouse   (ms)  monoclonal  Membrin  antibody  used   in   this  study  exhibits  
specificity  in  western  blot.  Only  one  band  around  the  expected  molecular  weight  
of  approximately  25  kDa  is  apparent.  Equal  total  protein  amounts  of  HEK293T  
cell  lysate  (lane  2)  or  HEK293T  cells  overexpressing  WT  FLAG::Membrin  (lane  
1)  were  probed.    
(B)   The   mouse   monoclonal   Membrin   antibody   used   in   this   study   recognizes  
wild-­type   FLAG::Membrin   overexpressed   in   control   fibroblasts   and   processed  
with   the   same   immuno-­fluorescence   protocol.   Top   row   shows   an  
overexpressing   cell,   where   Membrin   and   FLAG   signal   clearly   colocalize.   At  
identical   settings,   endogenous   Membrin   cannot   be   seen   in   an   untransfected  
cell.  Boundaries   of   nuclei   and  Golgi   region   (*),   as   seen  by  Membrin   signal   at  
much  higher  contrast  settings,  are  outlined.  
(C)   Western   blot   of   HEK293T   cell   lysate   (lane   2)   or   HEK293T   cells  
overexpressing   WT   FLAG::Membrin   (lane   1)      with   the   rabbit   (rb)   polyclonal  
Membrin  antibody,  which  was  used   in   this  study.  One  strong  band  around   the  
expected   molecular   weight   of   approximately   25   kDa   is   apparent.   Also,   one  
lower  molecular  weight  band  and  several  of  higher  molecular  weight  are  visible,  
albeit  of  much  weaker  signal  intensity.    
(D)  Two  HEK293T  cells  overexpressing  WT  FLAG::Membrin  are  shown,  where  
FLAG  and  rabbit  anti-­Membrin  staining  colocalise.    
  
  
Utilizing  this  validated  antibody,  Membrin  could  clearly  be  detected  at  the  cis-­
Golgi   of   G144W  mutant   fibroblasts   (Figure   12A,   B)   and   did   not   appear   to  
accumulate   in   the  ER   (Figure  12C),   thereby   confirming  our   overexpression  
results  also  in  patient  cells  harboring  endogenous  G144W  mutant  Membrin.  
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Figure  12.  Endogenous  G144W  mutant  Membrin  localizes  to  the  Golgi  
(A)  Example  confocal  slices  of  control  and  G144W  mutant  Membrin  fibroblasts  
co-­stained   for  Membrin   and  GPP130.  Membrin   in   control   and  G144W  mutant  
fibroblasts  localized  to  the  Golgi  apparatus.  However,  G144W  Membrin  levels  in  
the  Golgi  area  was  greatly  reduced  as  compared  to  both  controls.  This  was  also  
seen  in  several  repeat  anti-­Membrin  stainings.  
(B)   Pearson’s   correlation   coefficients   between   endogenous   Membrin   and  
GPP130  signals  of   the  experiment  described  in  (A)  are  shown.  N  =  12,  13,  15  
for  control  1,  control  2,  G144W.  Replicate  values  derived  from  individual  cells  of  
one   experiment,  mean   and   SD   are   shown.   **,   ***   represent   p   <   0.01,   0.001,  
ANOVA  with  Dunnett’s  multiple  comparison  test.  
(C)  Example  confocal  slices  of  control  and  G144W  mutant  Membrin  fibroblasts  
co-­stained  for  the  ER  resident  protein  PDI.  
  
Taken  together  our  subcellular  localization  experiments  suggest  that  both  the  
G144W  and  K164del  mutant  forms  of  Membrin  retain  their  intrinsic  capability  
to   localize   to   their   cis-­Golgi   target   compartment.   This   suggests   that   the  
partial   SNARE   domain   deficiencies   as   found   in   liposome   fusion   assays   by  
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Nancy   Malintan   are   likely   also   relevant   in   determining   lipid   bilayer   fusion  
rates  at  the  cis-­Golgi  in  a  living  cell.  
3.4.3          Reduced  levels  of  G144W  mutant  Membrin  
While   overexpressed   and   endogenous  G144W  mutant  Membrin   could   also  
be   detected   at   the   cis-­Golgi,   Membrin   levels   in   the   Golgi   area   of   G144W  
mutant   fibroblasts  were   significantly   decreased  when   compared   to   controls  
as   measured   by   quantitative   immuno-­fluorescence   (Figure   13A).   Western  
blots  confirmed  an  overall   reduction  of  Membrin   levels   in  mutant   fibroblasts  
(Figure  13B,  C).  Because  Corbett  et  al   reported  unchanged  Membrin   levels  
in   the  same  cell   line,   I  utilized  an   independent   rabbit  polyclonal  antibody   to  
confirm  this  finding  (Figure  13D).  
  
Figure  13.  Reduced  Membrin  levels  in  G144W  mutant  fibroblasts  
(A)  Membrin  mean  fluorescence  intensity  in  the  Golgi  region  as  demarcated  by  
GPP130  of  experiment  as  described  in  Figure  12A.  N  =  12,  13,  15  for  control  1,  
control   2,   G144W.   Replicate   values   derived   from   individual   cells   of   one  
experiment,  mean  and  SD  are  shown.  
(B)   Western   blot   of   lysates   from   control   and   G144W   Membrin   fibroblasts   is  
shown.  
(C)   Quantification   of   experiment   as   described   in   (B).   N   =   8   replicate   values,  
derived   from   three   independent   lysates   per   genotype   and   immunoblotted  
twice/three  times.  Mean  and  SD  are  shown.    
(D)   Western   blot   of   lysates   from   control   and   G144W   Membrin   fibroblasts   is  
shown  utilizing  a  different  anti-­Membrin  antibody  as  in  (B).  
Replicate   values,  mean  and  SD  are   shown.   **,   ***   represent   p  <  0.01,   0.001,  
ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
If   fewer   cis-­Golgi   SNARE   complexes   are   formed,   either   due   to   a   SNARE  
domain  defect  or  the  presence  of  fewer  Membrin  molecules  at  the  cis-­Golgi,  
Membrin’s  partner  SNAREs  might  also  be  present  at  different  levels.  I  tested  
this   notion   with   western   blot,   where   Bet1,   Syntaxin-­5   and   Sec22b   levels  
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appeared  grossly  unchanged  between  G144W  mutant  fibroblasts  and  either  
control  (Figure  14).  
  
Figure  14.  Western  blot  of  Membrin’s  partner  SNAREs  
Equal   amounts   of   lysates   derived   from   healthy   control   or   G144W   mutant  
Membrin  fibroblasts  were  loaded  into  each  lane.  Immuno-­detection  was  carried  
out   with   anti-­Bet1,   Syntaxin-­5   and   Sec22b   antibodies.   b-­actin   served   as   a  
loading   control.   Note   that   Syntaxin-­5   exists   as   a   long   and   a   short   isoform.  
Similar  results  were  obtained  with  three  independent  lysates  using  each  of  the  
depicted  antibodies.  
  
In  summary,  we   found  reduced  Membrin   levels   in  G144W  fibroblasts,  while  
the   relative   amounts   of   its   partner   SNARE   proteins   remained   largely  
unchanged.  The  availability   of   fewer  G144W  mutant  Membrin  molecules  at  
the  ERGIC  and  cis-­Golgi  could  provide  an  additional  mechanism  –  besides  
the  SNARE  dysfunction  as  observed  in  liposome  fusion  studies  –  of  delaying  
membrane  fusion  at  the  ERGIC/cis-­Golgi.    
3.4.4          Intact  ER-­to-­Golgi  trafficking  in  G144W  fibroblasts  
To  assess  how  SNARE  dysfunction  –  and  potentially  how  reduced  amounts  
of  G144W  mutant  Membrin  at  the  cis-­Golgi  –  affect  ER-­to-­Golgi  transport  in  a  
non-­neuronal  cell,  I  performed  Golgi  trafficking  assays  in  control  and  G144W  
mutant   Membrin   fibroblasts.   Therefore   I   overexpressed   human   growth  
hormone  (hGH)  fused  to  four  FM  domains  and  a  Halo-­tag.  The  FM  domains  
self-­aggregate  in  the  absence  of  a  solubilizing  drug  and  thus  do  not  allow  ER  
exit  of  this  model  cargo  (Rivera  et  al.,  2000;;  Rollins  et  al.,  2000).  When  D/D  
solubilizer   is   added,   this   chimeric   protein   disaggregates   and   enters   the  
secretory  route,  where  it  can  be  optically  visualized  after  addition  of  a  Halo-­
tag  TMR  ligand.  
I   co-­stained   for   the  cis-­Golgi   resident  protein  GM130   in  order   to  be  able   to  
test   the   colocalization   of   the   cargo   with   this   compartment   as   a   function   of  
time.   To   obtain   quantitative   information   I   assessed   the   degree   of   TMR-­
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GM130   covariance   in   the  Golgi   region   by   computing   Pearson’s   correlation  
coefficients   (PCC).   The   validity   and   interpretation   of   this   measure   of  
colocalization   critically   depends   upon   well   controlled   image   acquisition  
conditions  (Dunn  et  al.,  2011),  which  is  particularly   important  when  trying  to  
assess   small   effect   sizes   such   as   are   expected   in   our   case.   Therefore   I  
performed   technical   controls   prior   to   commencing   the   extensive   image  
acquisition   for   this   experiment.   No   substantial   chromatic   shift   between   the  
two  acquisition  channels  –  green  and  red  –  were  detected  with  0.5  and  0.1  
µm   TetraSpeck   beads   (Figure   15A).   In   addition,   the   full   width   at   half  
maximum   of   the   X-­Y   point   spread   function   for   both   channels   indicated  
adequate   resolving   capabilities   for   the   employed   confocal   system   (Figure  
15B)  (Cole  et  al.,  2011).    
  
Figure  15.  Optical  properties  of  the  imaging  setup  
(A)  Confocal  slices  of  0.1  or  0.5  µm  TetraSpeck  beads  acquired  with  green  and  
red  acquisition  settings  as  used  for  the  TMR-­GM130  colocalization  studies  (see  
Figure  17).  
(B)  X-­Y  point  spread  function  derived  from  0.1  µm  TetraSpeck  beads  as  shown  
in   (A).  Normalized  pixel   values   (circles  and   triangles),  Gaussian   fit   (lines)  and  
full   width   at   half   maximum   (fwhm)   are   depicted.   N   =   13   beads   from   one  
experiment.  
  
Finally,   I  evaluated   the  prediction   that   ‘perfect’   colocalization  should  yield  a  
PCC  of  1,  while  no  colocalization  should  yield  0.  To  this  end  I  stained  control  
fibroblasts   with   a   rabbit   anti-­GPP130   primary   antibody   and   two   anti-­rabbit  
secondary   antibodies   –   one   conjugated   with   an   Alexa   Fluor   488   and   the  
other  one  with  Alexa  Fluor  555  (Figure  16A).   Indeed,   this  yielded  a  PCC  of  
approximately   1   (Figure   16B).   If   one   channel   was   turned   by   90°   and  
therefore   a   purely   random   relationship   modeled,   the   PCC   dropped   to  
approximately   0   (Figure   16B).   In   addition,   bleed-­through   or   potential   dye  
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cross-­reactivity   between   the   green   and   red   acquisition   channels   were   not  
present   in   my   sample   preparation   and   imaging   settings   (Figure   16C).   In  
summary,   these   technical   controls   suggested   that   the   experimental   system  
was   thoroughly   calibrated   and   therefore   capable   of   delivering   meaningful  
quantitative  results.  
  
Figure  16.  PCC  and  bleed  through  controls  
(A)  Healthy  control   fibroblasts  were  stained  with  an  anti-­GPP130  antibody  and  
colocalization   of   Alexa   Fluor   488   and   555   tagged   secondary   antibodies  
detected  in  single  confocal  slices.  
(B)   Pearson   correlation   coefficients   (PCC)   of   experiment   (A)   were   computed  
either   in   the  original  acquisition   image  orientation,  or  with  one  channel   rotated  
by   90°   in   respect   to   the   other   channel.      N   =   3   individual   cells   from   one  
experiment.  Mean  and  SD  are  shown.    
(C)  Confocal   control   images   showing  no  bleed-­through  or   dye   cross-­reactivity  
between   the   green   and   red   acquisition   channels.   Control   fibroblasts   were  
stained   with   anti-­GM130   (cis-­Golgi)   and   Halo-­tag   TMR   ligand.   They   were  
imaged  with  identical  laser  intensities  and  gain  settings  and  are  shown  with  the  
same  contrast  settings.  Image  one  depicts  an  experimental  image  as  analysed  
in  Figure  17,  were   the  artificial   secretory   pathway   cargo  Halo::FM4::hGH  was  
transfected   and   released   from   the  ER   via   the   addition   of  D/D   solubilizer   (see  
below).  Colocalisation  between  the  GM130  and  TMR  signals  is  apparent.  Image  
two  depicts  a  cell  that  was  not  transfected  with  Halo::FM4::hGH  but  loaded  with  
TMR.  Only  green,  but  no  red  fluorescence  can  be  observed.  Image  three  shows  
a   cell   where   Halo::FM4::hGH   was   transfected   but   not   released   from   the   ER.  
Thus,  GM130  and  TMR  anti-­localise  and  no  green  fluorescence  can  be  seen  in  
the  regions  were  red  signal  is  detected.  
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After   completion   of   the   above   technical   validations   and   thereby   gained  
confidence  into  the  accuracy  of  my  imaging  set-­up  I  imaged  G144W  mutant  
and   control   fibroblasts   with   no   release   and   10,   20   and   30  min   after   cargo  
release.   By   10   min   after   the   addition   of   D/D   solubilizer   cargo   appeared  
accumulated   in   the   cis-­Golgi   (Figure   17A).   After   20   and   30   min   cargo  
accumulated   adjacent   to   the   cis-­Golgi   and   colocalization   with   GM130   was  
reduced   compared   to   the   10   min   time   point   (Figure   17A).   In   addition,  
vesicular   structures   became   apparent,   consistent   with   cargo   that   has  
successfully  transitioned  the  Golgi  apparatus  and  is  now  being  distributed  via  
the   trans-­Golgi   network   towards   the   plasma   membrane.   Remarkably,   the  
pattern   of   prominent   TMR-­GM130   colocalization   after   10   min   of   D/D  
solubilizer  incubation,  and  a  decrease  by  20  and  30  min,  was  very  similar  in  
G144W  mutant  fibroblasts.  This  qualitative  observation  indicates  that  ER-­to-­
Golgi  trafficking  in  G144W  fibroblasts  is  not  grossly  abnormal.  
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Figure  17.  ER-­to-­Golgi  trafficking  in  G144W  mutant  Membrin  fibroblasts  
(A)   Example   confocal   slices   of   control   1   &   2   and   G144W   mutant   Membrin  
fibroblasts  overexpressing  the  artificial  Halo::FM4::hGH  cargo  loaded  with  TMR.  
When   no   D/D   solubilizer   was   present   the   cargo   remained   in   the   ER   due   to  
aggregation   of   the   FM   domains.   10   min   after   solubilization   significant  
colocalization  with  the  cis-­Golgi  marker  GM130  was  apparent,  which  decreased  
after   20   and   30   min   of   solubilization.   Remarkably,   also   G144W   mutant  
fibroblasts  appeared  to  traffic  this  cargo  efficiently.  This  was  also  observed  in  a  
small  pilot  experiment,  where  G144W  mutant  and  control  1  cells  were  studied.  
(B)   Quantification   of   experiment   as   described   in   (A).   Pearson’s   correlation  
coefficients  of  Halo-­TMR::FM4::hGH  and  GM130  were  calculated  for  each  time  
point.  Number  of   individual  cells  of  one  experiment  quantified  for  control  1  &  2  
and  G144W  are  as  follows:  no  solubilizer  –  23,  21,  23;;  10  min  –  27,  28,  27;;  20  
min  –  26,  29,  28;;  30  min  –  27,  26,  28.  Mean  and  SD  are  shown.  ***  represents  
p   <   0.001, ns   =   not   significant   (p   >   0.05);;   one-­way   ANOVA   with   Dunnett’s  
multiple  comparison  test.  
  
PCCs  at  each  time  point  quantitatively  confirmed  these  observations.  With  no  
D/D  solubilizer  present,  the  ER  retained  hGH  cargo  and  the  cis-­Golgi  marker  
GM130  were   negatively   correlated   (Figure   17B).   10  min   after   solubilization  
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PCCs  rose  to  approximately  0.7,  and  subsequently  significantly  decreased  to  
approximately  0.5  and  0.4  by  20  and  30  min  respectively.  Importantly,  ER-­to-­
Golgi   trafficking   in   G144W   fibroblasts   was   quantitatively   almost  
indistinguishable   from   both   controls   (Figure   17B).   Only   a   very   subtle  
decrease   in   colocalization   of   the   cargo  with  GM130  was   apparent   after   10  
min  of  disaggregation.  Conversely,  after  20  min,  a   trend   towards   increased  
PCCs  was  measured   in  G144W   fibroblasts.  Collectively,   these   effect   sizes  
were   marginal   and   did   not   consistently   reach   statistical   significance.  
Nevertheless,   their  pattern   suggests   a   very   subtle   rate   change  of   cis-­Golgi  
entry.   In  such  a  scenario  we  expect  the  peak  of  TMR-­GM130  colocalization  
to  appear  later  than  in  the  controls  and  therefore  to  maintain  high  PCCs  until  
later  time  points.    
To   complement   the   hGH   data   I   performed   fluorescence   recovery   after  
photobleaching   (FRAP)   experiments   as   an   additional   ER-­to-­Golgi   transport  
readout.  To  this  end  I  overexpressed  a  chimeric  reporter  construct  consisting  
of  an  N-­terminal  portion  of  a  trans-­Golgi  resident  galactosyltransferase  and  a  
RFP   tag   (GalT::RFP).   Thereafter   I   photobleached   the   entire   pool   of   Golgi  
resident  GalT::RFP   in   control  and  G144W   fibroblasts   in  order   to  assess   its  
recovery   through   ER-­to-­Golgi   transport   of   non-­bleached   molecules   (Figure  
18A)  (Sengupta  et  al.,  2015;;  Zaal  et  al.,  1999).  To  minimize  bleach-­artefact  
as  a  result  of  acquiring  44  frames  in  this  approximately  20  min   live   imaging  
experiment,   I   collected   photons   with   a   highly   sensitive   Gallium   arsenide  
phosphide   (GaAsP)  detector,  which  enabled  me   to  use  a   very   low  561  nm  
excitation   laser   power.   Indeed,   these   acquisition   settings   resulted   in  
comparably  stable  GalT::RFP  fluorescence  in  non-­bleach  control  acquisitions  
(Figure   18B).   GalT::RFP   fluorescence   recovered   by   approximately   50%   in  
the   Golgi   area   following   experimental   photo-­bleaching   by   scanning   this  
region   twice   with   100%   transmission   of   the   561   nm   laser   (Figure   18B).  
Recovery   kinetics   were   remarkably   similar   between   G144W   and   control  
fibroblasts.  Only  a  trend  towards  reduced  recovery  in  G144W  was  apparent.  
However,  no  statistically  significant  difference  after  10  or  19.5  min  recovery  
times  could  be  detected.  These  data  are  consistent  with  our  hGH  trafficking  
results  and  might  be  the  consequence  of  a  minor  trafficking  delay  in  G144W  
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fibroblasts,   which   is   too   small   to   conclusively   be   demonstrated   with   these  
common  ER-­to-­Golgi  trafficking  assays.    
  
Figure  18.  Golgi  FRAP  
(A)  GalT::RFP  in  the  entire  Golgi  region  of  control  and  G144W  mutant  Membrin  
fibroblasts  was  photo-­bleached  and  recovery  assayed  over   the  course  of  19.5  
min.  Example  images  of  pre-­bleach,  immediately  post-­bleach,  10  and  19.5  min  
recovery  time  points  are  shown  in  successive  order  for  each  genotype.  
(B)  Control  acquisition  with  the  same  settings  as  (A)  and  (C),  however  without  
experimental   photo-­bleaching.  Mean   fluorescence   intensity   (MFI)   in   the  Golgi  
area   of   two   individual   control   1   and   one   control   2   cells   are   shown.   Graph  
represents  mean  and  SD  for  each  time  point.    
(C)  Quantification  of  experiment  as  described   in   (A).  MFIs  of   the  Golgi   region  
were  extracted,  expressed  as  relatives   to  baseline   fluorescence  and  corrected  
for   post-­bleach   residual   fluorescence.  Mean   recovery   of   controls   and  G144W  
are   shown.   N   =   16,   16,   13   individual   cells   from   five   independent   imaging  
sessions  for  control  1,  control  2,  G144W.  ns  =  not  significant  (p  >  0.05)  after  10  
and  19.5  min  of  recovery;;  ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
Taken   together,   these  ER-­to-­Golgi   trafficking  studies  with  an  artificial   cargo  
that  is  synchronously  released  from  the  ER,  as  well  as  our  GalT::RFP  FRAP  
studies,   demonstrate   remarkably   preserved   Golgi   entry   kinetics   in   G144W  
fibroblasts.   This   finding   in   a   non-­neuronal   cell   type   is   consistent   with   the  
observation  that  GOSR2-­PME  almost  exclusively  affects  the  nervous  system  
and  does  not  manifest  as  a  broad  multi-­system  disorder  as  one  might  expect  
from   a   Golgi   disorder   (Freeze   and   Ng,   2011).   It   further   reinforces   the  
importance   of   studying   the   pathophysiology   of   GOSR2-­PME   in   neurons,  
which   might   display   differential   vulnerability   to   subtle   Golgi   trafficking  
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alterations  owing  to   their  very   large  secretory  demands  (Horton  and  Ehlers,  
2004;;  Pfenninger,  2009).     
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3.5          Discussion  
3.5.1          Necessary  steps  for  understanding  GOSR2-­PME  
To   gain   an   overarching,  multi-­level   insight   into   how  mutations   in   the  Golgi  
SNARE  protein  Membrin  ultimately   give   rise   to  PME,  we  have   to   trace   the  
effects  of   the  pathogenic   sequence  alterations   from  protein   to  organism.   In  
this  directional   endeavour  we  have   to   first   establish  a   solid   fundament  and  
thus  start   at   the  protein  and  basic   cellular   levels  –  which   is   summarized   in  
this   chapter.   Given   that   a   physiological   function   has   previously   been  
established  for  Membrin,  we  can  directly  test  how  this  function  changes  as  a  
consequence  of   the  GOSR2-­PME  mutations.  Only   then  will  we  move  on   to  
the  neuronal  and  organismal  levels  (Chapter  4),  which  deal  with  phenomena  
more   distant   of   the   first   cause   of   GOSR2-­PME   –   i.e.   GOSR2   sequence  
alterations.  However,  functional  roles  for  Membrin  are  not  well  established  at  
these   remote   levels.   The   current   literature   does   not   comprise   studies  
detailing   the   relationship   of  Membrin   and  neuronal   cell   biology   or  Membrin  
and  its  impact  upon  neural  circuits.  Thus,  it  is  the  more  important  to  start  with  
a  fixed  stepping  stone  in  proximity  of  the  first  cause  of  GOSR2-­PME  and  in  
the   realm  of   the  known  and  gradually  ascend   into   the  unknown   that   is  also  
further  downstream  of  the  initial  pathogenic  insults.  
Previous  research  has  established  that  Membrin  is  a  SNARE  protein,  which  
largely  acts  at   the  ERGIC  and  cis-­Golgi  and   thereby  mediates  anterograde  
cargo  trafficking  in  the  early  secretory  pathway  (Hay  et  al.,  1997;;  Volchuk  et  
al.,   2004).   SNARE   proteins   have   been   shown   to   represent   the   minimal  
machineries  responsible  for  fusing  opposing  lipid  bilayers  via  the  formation  of  
tight   hetero-­tetrameric   SNARE   complexes   along   conserved   SNARE  motifs  
(Südhof   and   Rothman,   2009).   The   known   role   of   Membrin   is   thus  
summarized  by  its  function  of  enabling  ERGIC/cis-­Golgi  cargo  deposition  via  
SNARE  complex  mediated  membrane   fusion.  Central   to   this  process   is   the  
structural  integrity  of  Membrin’s  SNARE  motif,  which  is  necessary  to  form  the  
cis-­Golgi   SNARE   complex.   Intriguingly,   both   pathogenic   disease  mutations  
alter   Membrin’s   SNARE   domain.   These   changes   thus   directly   suggest  
impaired   SNARE   complex   formation   and   resulting   alterations   in   secretory  
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trafficking.  We  therefore  set  out  to  test  these  predictions  with  liposome  fusion  
assays  and  Golgi  trafficking  studies.  We  also  tested  whether  mutant  Membrin  
localizes  to  the  ERGIC/Golgi  –  a  prerequisite  for  its  physiological  function.  
3.5.2          SNARE  defects  
Prior   to  my  PhD   research  only   one  GOSR2  mutation  had  been  associated  
with  PME,  i.e.  G144W.  I  discovered  the  novel  K164del  mutation,  which  gave  
rise   to   PME   in   the   compound   heterozygous   state   with   G144W.   Having   a  
second  disease  allele  at  hand  for  the  investigation  of  the  pathophysiology  of  
this  severe  neurological  condition  promised  to  be  a  useful  tool  and  a  valuable  
internal  control.  After  all,  both  alleles  are  expected  to  display  effects  with  the  
same  directionality.  They  are  both  expected   to  decrease  Membrin   function,  
because  GOSR2-­PME   is   an   autosomal-­recessive   disorder.   However,   their  
effect   sizes  might   vary,   particularly   if   we   consider   the   precise   location   and  
nature   of   the   mutations   within   Membrin’s   SNARE   domain.   G144W   is   a  
missense   mutation   in   the   N-­terminal   half   of   Membrin’s   SNARE   domain,  
K164del  a  single  amino  acid  deletion   in   its  C-­terminal  half.  Because   the  C-­
terminal  half  of  SNARE  domains   is   thought   to  generate   the   force  critical   to  
membrane   fusion   and   because   the   K164   deletion   likely   causes   the  
misalignment   of   several   interacting   residues   in   this   part   of   the   SNARE  
complex,   we   were   expecting   to   see   more   dramatic   consequences   upon  
SNARE  function  in  this  mutant  (Gao  et  al.,  2012;;  Zhang,  2017).  Indeed,  this  
is  what  Nancy  Malintan’s   liposome  fusion  assays  revealed.  Bos1  (the  yeast  
Membrin  orthologue)  carrying  either  mutation  was  capable  of  fusion,  yet  both  
mutations  caused  decreased  rates  of  liposome  fusion  mediated  by  yeast  cis-­
Golgi   SNARE   proteins.   Furthermore,   the   effect   size   of   this   reduction   was  
larger   in   the   D196del   allele   (orthologous   to   K164del).   These   experiments  
established  the  furthest  upstream  disease  mechanism  due  to  the  pathogenic  
GOSR2-­PME   mutations,   i.e.   membrane   fusion   deficits   as   a   result   of   the  
SNARE  motif  disruptions.    
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3.5.3          Mutant  Membrin  at  the  cis-­Golgi  
To  study  the  physiological  consequences  of   the   in  vitro  established  SNARE  
defects   in   a   living   cell,   I   utilized   healthy   control   and  GOSR2-­PME   patient-­
derived   skin   fibroblasts.   In   a   first   step,   I   wanted   to   know   whether   the  
pathogenic   Membrin   mutations   caused   abnormalities   of   its   subcellular  
localization,   which   was   suggested   in   previous   work   from   Corbett   et   al.  
(Corbett   et   al.,   2011).   Such   a   defect   would   be   physiologically   relevant,   as  
only   Membrin   localized   to   the   ERGIC/cis-­Golgi   is   capable   of   mediating  
membrane   fusion   at   this   site.   In   addition,   Membrin   localizing   to   different  
subcellular  compartments  might   interfere  with   resident  proteins  and   thereby  
contribute   to   the   disease   phenotype.   Therefore,   we   transiently  
overexpressed   N-­terminal   FLAG   tagged   wild-­type   and   mutant   Membrin   in  
healthy   control   fibroblasts   and   studied   its   subcellular   localization   with  
confocal  microscopy.  Both  mutants  clearly  exited  the  ER  and  localized  to  the  
cis-­Golgi   in   a   pattern   comparable   to  wild-­type  Membrin.  While   there  was  a  
clear  positive  correlation  between  G144W/K164del  mutant  Membrin  and  the  
cis-­Golgi  marker  GPP130,   it  was  nevertheless   significantly   decreased  by  a  
small  amount  compared  to  wild-­type  Membrin.  Such  a  result  is  not  surprising  
considering  that  Membrin  is  required  for  proteins  to  enter  the  Golgi.  If  mutant  
Membrin  is  overexpressed  it  presumably  enriches  in  the  ERGIC/Golgi,  which  
itself   might   cause   a   partial   membrane   fusion   deficit   and   therefore   a   peri-­
ERGIC/Golgi   enrichment   of   mutant   Membrin   enriched   membranes.  
Nevertheless,   because   of   the   observed   high   correlation   between   mutant  
Membrin   and  GPP130  we   conclude   that   the  G144W  and  K164del   disease  
mutations   do   not   impair   Membrin’s   capability   to   localize   to   the   Golgi   by   a  
large   degree.   From   this   it   follows   that   the   lipid   fusion   deficits   as   found   in  
liposome   fusion   assays   likely   have   a   direct   impact   upon   the   cargo   entry  
kinetics  at  the  ERGIC/Golgi.  
While   we   found   that   overexpressed  G144W  mutant   Membrin   could   clearly  
localize   to   the   cis-­Golgi,   Corbett   et   al.   reported   that   endogenous   G144W  
mutant   Membrin   failed   to   localize   to   this   compartment   in   patient-­derived  
fibroblasts   (Corbett   et   al.,   2011).   This   finding  has   far-­reaching   implications,  
as   it   suggests   that   the   G144W   mutation   –   even   though   it   only   partially  
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impairs   the   Membrin   SNARE   domain   –   could   be   a   true   null   allele   as   a  
consequence  of   its   inability   to   localize   to   its  physiological  site  of  action.  We  
therefore  sought  to  repeat  the  finding  of  Corbett  et  al.  using  the  same  patient  
cells  harboring  a  homozygous  G144W  Membrin  mutation.  However,  we  used  
a  different  antibody,  which  we  thoroughly  validated  before  commencing  with  
these   experiments.   Under   our   experimental   conditions   we   could   clearly  
detect  Membrin  at  the  cis-­Golgi  of  these  cells,  but  to  significantly  decreased  
levels.   It   appears   conceivable   that   under   low   contrast   conditions   this  
decrease  might  be  misinterpreted  as  an  absence  of  the  protein,  which  could  
be   an   explanation   for   the   discrepant   conclusions   of   Corbett   et   al.   and   our  
own.   This   significant   decrease   of   G144W   mutant   Membrin   at   the   Golgi  
apparatus   might   either   be   the   consequence   of   localization   to   a   different  
subcellular   compartment   or   an   overall   reduction,   possibly   due   to   increased  
protein   turn-­over.   Because   G144W   mutant   Membrin   did   not   appear  
accumulated   in   the   ER   nor   strikingly   enriched   elsewhere   within   mutant  
fibroblasts,   the   latter   notion   appeared   more   likely.   We   addressed   this  
hypothesis   with   western   blot   studies   and   found   significantly   decreased  
G144W   mutant   Membrin   levels   in   patient   fibroblasts   when   compared   to  
healthy  controls.  Also  this  finding  is  in  disaccord  with  the  study  of  Corbett  et  
al.,  who   reported  unchanged  Membrin   levels   in  G144W   fibroblasts   (Corbett  
et  al.,  2011).  The   fact   that  we  used  a   thoroughly  validated  antibody   for  our  
studies,   plus   an   additional   independent   antibody   and   furthermore   that   also  
our   immuno-­fluorescence  microscopy   studies   confirmed  decreased  G144W  
Membrin  levels,  argues  for  the  validity  of  our  results.  Whether  this  decrease  
is   functionally   relevant   is   presently   unclear,   especially   in   the   light   of  
substantial  Membrin   level   fluctuations   that  we   observed   also   between  both  
healthy   controls   (Figure   13B)   and   the   availability   of   only   a   single   patient  
fibroblast   line   in   this   study.  Of  note,  Bethani  et  al.   showed   that  10%  of   the  
physiological   endosomal   SNARE   levels   were   often   sufficient   for   unaltered  
endosomal  trafficking,  lending  support  to  the  idea  that  some  SNARE  proteins  
might   be  more   abundantly   expressed   than   required   (Bethani   et   al.,   2009).  
Such   a   scenario   could   also   be   true   for   the   cis-­Golgi   SNARE   proteins,   in  
which   case   our   finding   of   reduced   G144W   Membrin   would   likely   not  
contribute   to   the   disease   phenotype.   If   however   this   change   is   disease  
     91  
relevant,   then   its   effect   is   expected   to   further   aggravate   the   partial   loss   of  
function  nature  of  the  G144W  mutation.  
Unfortunately,   we   were   not   able   to   obtain   fibroblasts   from   the   G144W   –  
K164del   compound   heterozygous   patient   reported   in   this   thesis  
(Praschberger   et   al.,   2015).   This   fibroblast   line   would   have   served   as   an  
additional   validation   platform   of   our   studies,   although   disentangling   the  
relative  contribution  of  either  mutation  would  have  been  difficult.    
3.5.4          Unimpaired  ER-­to-­Golgi  trafficking  in  a  non-­neuronal  cell  
Nancy  Malintan’s   liposome   fusion   assays   revealed  SNARE  defects   caused  
by   the   GOSR2-­PME   mutations   and   my   subcellular   localization   studies  
suggested  that  the  disease  mutations  do  not  prevent  Membrin  from  reaching  
its  site  of  action  –  the  ERGIC  and  cis-­Golgi.  As  a  result,  lipid  fusion  rates  of  
ER-­derived,   cargo   loaded   COPII   vesicles   with   these   compartment   is  
expected   to   be   reduced   in   a  Membrin  mutant   cell.   To   test  whether   such   a  
lipid   fusion   deficit   leads   to   reduced   cis-­Golgi   cargo   entry   rates   I   performed  
two   independent   sets   of   ER-­to-­Golgi   trafficking   assays   in   G144W   mutant  
Membrin   fibroblasts.   In   one   experiment,   I   synchronously   released   ER-­
retained  model  cargo  into  the  secretory  pathway  and  assayed  its  arrival  time  
in   the  cis-­Golgi.   In  a  complementary  approach,   I  measured   the  ER-­to-­Golgi  
recycling   rates  of  a   fusion  construct  between  RFP  and  a  portion  of  a  Golgi  
enzyme  (Sengupta  et  al.,  2015;;  Zaal  et  al.,  1999).  Both  experiments  revealed  
remarkably   convergent   results,   as   they   showed  Golgi   entry   comparable   to  
two   fibroblast   lines  derived   from  healthy  control  subjects,  with  only  a  subtle  
trend   towards   reduced  rates.  This   finding  appears  surprising  at   first  glance,  
considering   the   pathogenic   SNARE   motif   defects.   Of   note   however,   the  
G176W   Bos1   mutation   (orthologous   to   the   G144W   Membrin   mutation)  
exhibited  very  mild  effects  in  liposome  fusion  studies.  Equivalent  changes  in  
lipid  fusion  kinetics  at  the  ERGIC/cis-­Golgi  of  a  living  cell  might  be  below  the  
detection   limit   of   the   employed   trafficking   assays.   In   addition,   this   subtle  
SNARE  defect  might  possibly  be  absorbed  by  the  physiological  presence  of  
supernumerous  Membrin  molecules   and   the   compensatory   engagement   of  
20%  more  cis-­Golgi  SNARE  complexes.  Maybe  such  partial  SNARE  defects  
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are   only   physiologically   relevant   under   conditions   of   very   large   trafficking  
rates,  while  not  being  functionally  relevant  for  providing  a  basic  ER-­to-­Golgi  
cargo   flux   as   required   by   most   cell   types.   Importantly,   the   finding   of  
unimpaired   early   secretory   pathway   trafficking   in   a   G144W   mutant   non-­
neuronal   cell  model   provides  a   likely  explanation  why  most   tissues  –  apart  
from  the  nervous  system  –  do  not  exhibit  symptoms  in  GOSR2-­PME,  despite  
the  disease-­causing  mutation  affecting  a  ubiquitously  important  protein.  
3.5.5          Considerations  about  the  fibroblast  studies  
Due  to  limited  availability,  I  was  only  able  to  obtain  one  GOSR2-­PME  patient-­
derived   fibroblast   line.   GOSR2-­PME   is   a   very   rare   disorder   with   only   18  
patients  worldwide  reported  and  thus  biological  material  is  scarce.  Therefore,  
the  interpretation  of  the  observed  results  is  more  difficult.  Given  that  we  are  
comparing   results   from   one   patient-­derived   fibroblast   line   with   fibroblasts  
derived  from  two  different  healthy  controls,  we  are  comparing  cells  which  not  
only  differ  in  the  pathogenic  mutation,  but  also  in  the  presence  of  thousands  
of  unrelated  SNPs.  Therefore,   the  observed  cellular  phenomena  might  also  
be  influenced  by  this  genetic  heterogeneity.  Further  disease  cell  lines  would  
thus   increase   the   confidence   of   attributing   observed   effects   to   the   disease  
mutation  and  rule  out  the  possibility  that  the  effects  are  caused  by  unrelated  
SNPs.  In  addition,  subtle  effects,  such  as  those  that  are  expected  for  the  ER-­
to-­Golgi   traffic   rate   change   due   to   G144W,   might   be   overshadowed   by  
natural   variation   in   the   kinetics   of   this   process.   These   changes  might   only  
become   fully   apparent   by   comparing   several  GOSR2-­PME   fibroblast   lines  
with  healthy  controls.  To  circumvent  these  intrinsic  difficulties,  future  studies  
into   the   cell   biology   of   GOSR2-­PME   would   greatly   benefit   from   the  
generation   of   G144W/K164del   mutant   Membrin   knock-­in   cell   lines   utilizing  
the  CRISPR/Cas9  genome  editing  technology  (Cong  et  al.,  2013;;  Mali  et  al.,  
2013).  The  unedited  cell   line  would   then  be   the  perfect  control,  as   it  would  
contain  the  same  genetic  background.  
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3.5.6          The  importance  of  a  neuronal  model  
The   experiments   at   the   protein   and   basic   cellular   levels   outlined   in   this  
Chapter  have  provided  solid  foundations  for  our  quest  to  shed  light  upon  the  
pathophysiology  of  GOSR2-­PME.  They  have  not  yet,  however,  touched  upon  
the  cardinal  point  related  to  our  investigation,  i.e.  how  neurons  are  exquisitely  
sensitive   to   Membrin   mutations.   In   fact,   the   apparent   lack   of   ER-­to-­Golgi  
trafficking   impairment   in   a   non-­neuronal   mutant   Membrin   model   cell   has  
consolidated   the   spotlight   that   was   already   directed   toward   the   nervous  
system   because   of   the   almost   exclusive   neurological   symptomatology   of  
GOSR2-­PME  patients.  This   is  why  we  developed  Drosophila  models  of   this  
disorder,   which   not   only   allows   for   the   study   of   Membrin   mutant   neurons  
grown  in  their  natural  environment,  but  also  provides  an  organismal  read-­out  
of  the  disease  mutations.  The  summary  of  our  Drosophila  investigations  into  
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Chapter  4.            Investigating   the   pathophysiology   of   GOSR2  
mediated   progressive   myoclonus   epilepsy   in   novel  
Drosophila  models  of  the  disorder  
4.1          Introduction  
The   previous   Chapter   has   established   the   impact   of   the   GOSR2-­PME  
mutations   upon   SNARE-­mediated   membrane   fusion   and   ER-­to-­Golgi  
trafficking  in  a  non-­neuronal  cell.  While  the  G176W/R196del  Bos1  mutations  
(orthologous  to  human  G144W/K164del  Membrin  mutations)  both  decreased  
lipid   fusion   in   a   cell   free   reconstitution   assay   and   G144W/K164del   mutant  
Membrin   correctly   localized   to   their   ERGIC/cis-­Golgi,   G144W   mutant  
Membrin   fibroblasts   appeared   to   traffic   cargo   to   the   Golgi   in   rates  
comparable  to  healthy  controls.  This  finding  might  explain  why  tissues  other  
than   the   nervous   system  are   not   symptomatically   affected   in  GOSR2-­PME  
and   further   reinforced   the   idea   that  neurons  might  be  selectively  vulnerable  
to   these   partial   loss   of   function   Membrin   mutations.   To   investigate   which  
aspects   of   neuronal   cell   biology  might   be   affected   and   how   such   changes  
could   affect   neural   circuits   in   a   way   to   give   rise   to   ataxia   and  
hyperexcitability,  we  introduced  the  disease  mutations  into  Drosophila.  These  
GOSR2-­PME  models  exhibited  severe  motor,  seizure-­like  and  early  lethality  
phenotypes.   Dendritic   growth   was   highly   impaired   in   the   presence   of  
Membrin  mutations,   presumably   due   to   restrictions   in  ER   synthesized,   and  
therefore   ER-­to-­Golgi   trafficking   and   Membrin   dependent,   lipid   supplies,  
which   are   required   for   plasma   membrane   expansion.   Intriguingly,   also  
synaptic   morphological   and   physiological   abnormalities,   such   as   reduced  
trans-­synaptic   stability   and   hyperactive   neurotransmission,   were   detectable  
at   the   experimentally   highly   accessible   neuromuscular   model   synapse.  
These   findings  collectively  show   that  dendritic  growth  and  synaptic   integrity  
depend   upon   tightly   controlled   trafficking   rates.   Our   neuronal   findings   in  
Drosophila   outlined   in   this   Chapter   thereby   provide   the   missing   key   to  
understand   how   the   GOSR2-­PME   mutations   result   in   nervous   system  
dysfunction.  
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4.2          Statement  of  contribution  
Please   refer   to   the   ‘Statement   of   contribution’   section   in   Chapter   3   for   a  
detailed  account  of  my  contribution  to  our  collaborative  investigations  into  the  
pathophysiology   of   GOSR2-­PME.   Experimental   results   from   other  
researchers  than  myself  are  included  also  in  this  section  to  facilitate  a  more  
holistic  view  of  the  project.  The  respective  sources  are  clearly  identified  in  the  
text  and  figure  legends.  
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4.3          Materials  and  Methods  
4.3.1          Plasmids  
Drosophila  melanogaster  membrin  CDS  (of  NCBI  cDNA  NM_139703.4)  with  
and  without  the  G147W  and  K166del  mutations  were  custom  synthesized  by  
GeneArt  (Thermo  Fisher  Scientific)  according  to  the  same  design  as  outlined  
in  ‘Materials  and  Methods’  of  Chapter  3  for  the  GOSR2  constructs,  giving  rise  
to   pMA_FLAG::membrin[WT]/[G147W]/[K166del]   (annotated   sequences   of  
the  custom  synthesized  fragments  can  be  found  in  the  Appendix).    
In  order  to  create  wild-­type  and  mutant  GOSR2/membrin  transgenic  flies  the  
inserts   of   the   pMA   plasmids   were   subsequently   cloned   via   NotI   and   KpnI  
(NEB)   into   pUASTattB   (Bischof   et   al.,   2007),   giving   rise   to  
pUASTattB_FLAG::GOSR2[WT]/[G144W]/[K164del]   and  
pUASTattB_FLAG::membrin[WT]/[G147W]/[K166del]   according   to   the  
subcloning   protocol   as   outlined   in   ‘Materials   and   Methods’   of   Chapter   3.  
Subcloning   of   FLAG::GOSR2[WT]   was   carried   out   by   Kofan   Chen.   The  
presence   of   the   correct   open   reading   frame   was   validated   by   Sanger  
sequencing   with   the   primers   pUASTattB_F2   (5’-­
GCAACCAAGTAAATCAACTGCA-­3’)   and   pUASTattB_R2   (5’-­
TGTCCAATTATGTCACACCACAG-­3’)  by  Source  Biosciences.  
4.3.2          Drosophila  stocks  
4.3.2.1          membrin1524  
A  membrin   null   (membrin1524)   allele   was   previously   generated   in   an   EMS  
screen   investigating   tube   morphogenesis   and   kindly   shared   by   Mark  
Krasnow  (Ghabrial  et  al.,  2011).  These   flies  harbor  a  c.255C>T  mutation   in  
the   membrin   gene,   which   gives   rise   to   a   premature   stop   codon   causing  
termination  of   translation  47  amino  acids  prior   to  membrin’s  critical  SNARE  
domain.  To  control   for   potential   genetic  background  effects,  we  outcrossed  
membrin1524  for  five  generations  into  the  isogenised  white  mutant  (white1118)  
strain   iso31  by   following  an  AccI   (NEB)   restriction  site   that   is   introduced  by  
the   nonsense  mutation.   To   this   end   individual   females   –   either  w[1118];;   +;;  
membrin1524/+  or  w[1118];;  +;;  +/+  –  where  crossed  to  iso31  males.  After  egg  
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laying  and  hatching  of  L1  larvae,  mother  animals  were  removed,  frozen  at  -­
20°C   and   subsequently   ground   in   40   µl   of   ‘dirty   genomic   prep   buffer’  
(Proteinase  K  0.32  U,  10  mM  Tris-­HCl  pH  7.6,  1  mM  EDTA,  25  mM  NaCl).  
Samples   were   subsequently   incubated   for   30   min   at   37°C   followed   by  
Proteinase   K   heat   inactivation   at   95°C   for   10   min.   The   mixture   was   spun  
down  for  30  s  at  14000  g  and  2  µl  of  the  supernatant  used  as  the  template  for  
PCR   with   0.8   µM   of   forward   (mem1524_OUTF1:   5’-­
GTGGTAAAGGACATCGAGCG-­3’)   and   reverse   (mem1524_OUTR1:   5’-­
CCACCACTCCTCCGATGAAT-­3’)   primers   and   12.5   µl   GoTaq   G2   Green  
Master  Mix  (Promega)  in  a  25  µl  final  volume.  Initial  denaturation  at  95°C  for  
2  min  was  followed  by  35  cycles  of  95°C  30  s,  60°C  30  s,  73°C  60  s  and  a  
final  extension  at  73°C  for  5  min.  5  µl  of  this  PCR  product  was  digested  with  
5   U   of   AccI   in   Cutsmart   Buffer   (NEB)   for   2   h   at   37°C,   separated   by   1%  
agarose   gel   electrophoresis   and   visualized   with   UV   light   and   GelRed  
[1/10000]   (Biotium).  A  double  band  around  350/300  basepairs   indicated   the  
desired  genotype,  where  membrin1524  was  present  in  the  heterozygote  state  
(Figure  19).  
  
Figure  19.  Diagnostic  digest  during  outcrossing  of  the  membrin1524  allele  
A   double   band   of   the   expected   size   in   lanes   2,   6,   7,   8   and   10   indicates   that  
these  F2   females,  which  were   previously   individually   crossed   to   iso31  males,  
carried   the   membrin1524   allele   in   the   heterozygous   state.   Therefore,   their  
offspring   virgin   females  were   selected   for   further   backcrossing  and  diagnostic  
AccI  digest.  
  
The  presence  of   the   c.255C>T  membrin1524  was  also   confirmed  by  Sanger  
sequencing.  Therefore,  the  same  fragment  as  above  was  PCR  amplified  with  
Q5  high-­fidelity  DNA  polymerase  (NEB),  cleaned  up  with  the  Wizard  SV  Gel  
and   PCR   clean   up   system   (Promega)   and   sequenced   with  
mem1524_OUTF1  and  mem1524_OUTR1  by  Source  Biosciences.  
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4.3.2.2          Generation   of   wild-­type   and   mutant  GOSR2   and  membrin  
transgenic  flies  
Transgenic   fly   lines   under   the   control   of   the   UAS-­enhancer   (Brand   and  
Perrimon,   1993)   were   generated   by   microinjection   of  
pUASTattB_FLAG::GOSR2[WT]/[G144W]/[K164del]/pUASTattB_FLAG::me
mbrin[WT]/[G147W]/[K166del]   into   y[1]   M{vas-­int.Dm}ZH-­2A   w*;;   M{3xP3-­
RFP.attP'}ZH-­51C  embryos  (Cambridge  fly  facility).  Because  the  pUASTattB  
plasmid  harbors  an  attB  sequence  and  this  fly  line  a  specific  attP  landing  site,  
it   allows   for   site-­specific   integration   into   this   locus   in   germline   cells   via   the  
action   of   phiC31   integrase,   which   is   transgenically   provided   via   the   vasa  
promoter  (Bischof  et  al.,  2007).  This  approach  has  the  advantage  of  ensuring  
that  all  transgenes  are  integrated  precisely  in  the  same  genomic  localization  
and   hence   observed   differences   in   phenotypes   can   be   attributed   to   the  
respective   mutations   rather   than   differences   in   transcription   due   to  
integration   into   transcriptionally   silent   regions   of   the   genome.   The   ZH-­51C  
landing   platform   was   chosen,   as   in   the   current   gene   annotation   (FlyBase  
release  FB2017_03)   it   is  clearly   localized  between  genes  and  not   in  exons,  
introns  or  UTRs,  which  makes  it  less  likely  to  cause  insertional  mutagenesis  
(see  Figure  20).  
  
Figure  20.  Intergenic  localisation  of  the  ZH-­51C  landing  platform  
HSP(1)  indicates  the  position  of  this  transgene  integration  site  on  the  right  arm  
of   chromosome   two.   Screen   shot   is   taken   from   FlyBase   release   FB2017_03  
after  performing  BLAST  with   the   flanking  sequence  of  ZH-­51C  provided  at   the  
flyc31.org  website.  
  
Additionally,  the  light  orange  eye  color  of  pUASTattB  (which  also  contains  a  
mini-­white   gene)   transgene   insertions   in   this   site   facilitates   selection   for  
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additive   mini-­white   effects   when   crossed   to   other   transgenic   flies.  
Furthermore,  ZH-­51C  is  localized  on  the  second  chromosome,  which  allows  
to  readily  combine  these  transgenic  flies  with  the  membrin1524  allele,  which  is  
localized  on  the  third  chromosome.  After  removal  of  the  integrase  from  the  X-­
chromosome,  balanced  transformants  were  provided  to  us  by  the  Cambridge  
Fly  Facility.  Thereafter  UAS-­FLAG::GOSR2[WT]/[G144W]/[K164del]  or  UAS-­
FLAG::membrin[WT]/[G147W]/[K166del]   flies   were   backcrossed   for   five  
generations  into  iso31.  
4.3.2.3          Assembly  of  model  stocks  
In  order  to  express  wild-­type  or  mutant  GOSR2  or  membrin   in  membrin  null  
flies  we  generated  two  stocks  that  then  need  to  be  crossed  to  each  other  –
one  of  them  containing  the  transgenes  plus  the  membrin  null  allele,  the  other  
one  the  membrin  null  allele  plus  a  global  driver.  
To  generate  the  transgene  half  of   the  ‘model  cross’,   I   first  balanced  second  
chromosome  transgenic  flies  for  the  third  chromosome  and  membrin1524  flies  
for   the   second   chromosome.   The   resulting   w[1118];;   UAS-­
FLAG::GOSR2[WT]/[G144W]/[K164del]/+;;   TM2/TM6B-­Tb   or   UAS-­
FLAG::membrin[WT]/[G147W]/[K166del]/CyO;;   MKRS/TM6B-­Tb   were  
crossed  with  w[1118];;  CyO/Sco;;  membrin1524/TM6B-­Tb  and  Curly,  non-­Sco,  
non-­ebony/non-­MKRS   bearing,   mini-­white   males   and   virgin   females   were  
selected  to  establish  the  stocks,  which  were  subsequently  homozygosed  for  
the  second  chromosome  transgene.  This  crossing  gave  rise  to  the  first  half  of  
the  ‘model  cross’  (I.):  w[1118];;  UAS-­FLAG::GOSR2[WT]/[G144W]/[K164del];;  
membrin1524/TM6B-­Tb   or   w[1118];;   UAS-­
FLAG::membrin[WT]/[G147W]/[K166del];;  membrin1524/TM6B-­Tb.  
In   order   to   obtain   the   driver   half   of   the   ‘model   cross’,   membrin1524   was  
combined   with   the   daughterless-­Gal4   (da-­Gal4,   Bloomington   stock   centre  
#55850)   driver,  which  was   outcrossed   for   5   generations   into   iso31   prior   to  
stock  generation  by  members  of  the  Jepson  lab.  w[1118];;  +;;  membrin1524  and  
w[1118];;   +;;  da-­Gal4  were   combined   by   selecting   for  meiotic   recombinants.  
Therefore,  w[1118];;  +;;  membrin1524/da-­Gal4  transheterozygote  virgin  females  
were   crossed   to  w[1118]/Y;;   +;;   TM2/TM6B-­Tb.   In   the   next   generation  mini-­
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white   expressing   males   over   TM6B-­Tb   were   selected   and   individually  
crossed  to  virgins  w[1118];;  +;;  TM2/TM6B-­Tb.  After  egg   laying  and  hatching  
of  L1  larvae  the  presence  of  membrin1524  in  the  father  animals  was  tested  by  
PCR   and   diagnostic   digest   with   AccI   as   described   above.   Where   AccI  
restriction   sites  were  detected,   stocks  were  established   from   their   offspring  
by   crossing  mini-­white   expressing  males  and   virgin   females  over  TM6B-­Tb  
with  each  other.  The  full  genotype  of  the  resulting  second  half  of  the  ‘model  
cross’  is  (II.):  w[1118];;  +;;  membrin1524,  da-­Gal4/TM6B-­Tb.  
In  order  to  express  wild-­type  or  mutant  GOSR2  or  membrin   in  membrin  null  









w[1118];;  +;;  membrin1524,  da-­Gal4/TM6B-­Tb  
Three   of   the   four   possible   genotypes   of   this   cross   are   theoretically   viable  
(homozygosity   for   the   third  chromosome  balancer  TM6B-­Tb   is  known   to  be  
lethal)   and   the   absence   of   the   Tubby   allele   indicates   the   presence   of   the  
desired  genotype  (a)  (X  =  any  of  the  GOSR2  or  membrin  transgenes):  
a)   w[1118];;  UAS-­FLAG::X/+;;  membrin1524,  da-­Gal4/membrin1524  
b)   w[1118];;  UAS-­FLAG::X/+;;  membrin1524/TM6B-­Tb  
c)   w[1118];;  UAS-­FLAG::X/+;;  membrin1524,  da-­Gal4/TM6B-­Tb  
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Because  mutant  human  Membrin  did  not  rescue  membrin  null  animals  to  the  
L3   stage   and   wild-­type   human   Membrin   rescue   yielded   severely   impaired  
adults,  we  based  our  experiments  on  more  physiological  Drosophila  Membrin  
rescue  models.  In  order  to  increase  readability  of  the  full  genotypes  of  these  
flies   I   used   Mem-­WT,   Mem-­G147W   and   Mem-­K166del   as   abbreviations  
throughout  this  thesis  (Table  9).  
Mem-­WT   w[1118];;   UAS-­FLAG::membrin[WT]/+;;   membrin1524,   da-­
Gal4/membrin1524  
Mem-­G147W   w[1118];;   UAS-­FLAG::membrin[G147W]/+;;   membrin1524,   da-­
Gal4/membrin1524  
Mem-­K166del   w[1118];;   UAS-­FLAG::membrin[K166del]/+;;  membrin1524,   da-­
Gal4/membrin1524  
Table  9.  Full  genotypes  of  GOSR2-­PME  model  Drosophila    
  
To  genetically   label   the  highly  elaborate  class   IV  dendritic  arborization   (da)  
neurons  –  which  comprise  of  one  ddaC,  one  v’ada  and  one  vdaB  neuron  per  
hemisegment  (Grueber  et  al.,  2002)  –  for  dendritic  analysis  (see  below),  the  
w[1118];;   ppk-­CD4::tdGFP   (Bloomington   stock   centre   #35842)   stock   was  
used.   This   fly   line   is   an   optimized   expression   system   comprising   of   one  
EGFP  plus  one  GFP  fused  to  the  CD4  transmembrane  domain  downstream  
the  pickpocket  (ppk)  promoter  (Grueber  et  al.,  2003;;  Han  et  al.,  2011).  James  
Jepson  combined  w[1118];;  ppk-­CD4::tdGFP  with  w[1118];;  +;;  membrin1524  da-­
Gal4/TM6B-­Tb   according   to   standard   Drosophila   mating   schemes   (Roote  
and  Prokop,  2013).  The  resulting  stock  is  the  driver  half  of  the  ‘model  cross’  
with  an  additional  ppk-­CD4::tdGFP  transgene  with   the   following  genotype  –
w[1118];;  ppk-­CD4::tdGFP;;  membrin1524,  da-­Gal4/TM6B-­Tb.  These  flies  need  
to  be  crossed  to  (I.)  (see  above)  and  non-­Tubby  animals  selected  for  further  
analysis.  
     102  
4.3.2.4          emp-­GFP  knock-­in  
In   the   course   of   this   PhD   project   I   also   generated   an   endogenously  GFP-­
tagged   emp   allele,   which   is   the   Drosophila   orthologue   of   the   PME-­gene  
SCARB2   (Berkovic   et   al.,   2008).   However,   time   constraints   precluded   me  
from  undertaking  further  investigation  into  SCARB2-­PME  utilizing  these  flies.  
The   emp-­GFP   knock-­in   fly   was   generated   by   recombination-­mediated  
cassette  exchange  of  a  MiMIC  insertion  (Mi12296,  Bloomington  stock  centre  
#57917)  between  exon  1  and  exon  2  of  the  emp  gene.  The  plasmid  pBS-­KS-­
attB1-­2-­PT-­SA-­SD-­1-­EGFP-­FIAsH-­StrepII-­TEV-­3xFlag   was   injected   by   the  
Cambridge   Fly   Facility,   who   provided   us   with   five   independent   flies   with  
successful  cassette  exchange.  Diagnostic  PCR  confirmed  that   in  three  lines  
the  EGFP  coding   sequence  had   inserted   into   the   correct   strand.  Details   of  
this  technique  are  described  in  (Venken  et  al.,  2011).    
4.3.2.5          Additional  Drosophila  stocks  utilized  in  this  study  
To  evaluate  the  lethal  phase  of  membrin1524  at  the  L1  and  L2  larval  stages,  I  
rebalanced   this   allele   over   the   fluorescent   TM3   Kr   >   GFP   balancer  
chromosome  (Casso  et  al.,  2000),  which  was  also  backcrossed  to  iso31  for  5  
generations.   For   nervous   system   overexpression   of   Membrin,   nsyb-­Gal4  
(Bloomington   stock   centre   #51635)   was   used,   which   was   previously  
backcrossed   to   iso31   for   5   generations   by   members   of   the   Jepson   lab.  
w[1118];;   +;;   ppk-­Gal4   (#32079;;   previously   backcrossed   to   iso31   for   5  
generations   by   members   of   the   Jepson   lab),  w[1118];;   +;;   UAS-­RedStinger  
(#8547),   w[*];;   +;;   nsyb::eGFP   (#6922),   w[*];;   nompC-­Gal4   (derived   from  
#36361)  were  from  Bloomington  stock  centre.  Membrin  RNAi  transgene  was  
from  the  Vienna  Drosophila  Research  Center   (GD  44535)  and  backcrossed  
for  5  generations  into  iso31  (Dietzl  et  al.,  2007).    
4.3.3          Fly  husbandry  
Flies  were  reared  on  solid  fly  food  (1  w/v%  agar,  1.5  w/v%  sucrose,  3.3  w/v%  
glucose,   3.5  w/v%   yeast,   1.5  w/v%   corn  meal,   1.5   v/v%   soy   flour,   3  w/v%  
treacle,   1  w/v%  wheat  germ,  0.1  w/v%  nipagin,   0.5   v/v%  propionic  acid)   in  
polystyrene   tubes.   Experimental   flies   were   incubated   at   25°C   with   a   12   h  
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light-­dark  cycle  unless  specified  otherwise.  Stocks  were  maintained  either  at  
room  temperature  or  18  °C.    
4.3.4          Viability  experiments  
To   evaluate   the   lethal   phase   of   the   disease-­causing  membrin   mutations   I  
crossed  20  virgin  females  w[1118];;  +;;  membrin1524,  da-­Gal4/TM6B-­Tb  with  30  
males   w[1118]/Y;;   UAS-­FLAG::membrin[WT]/[G147W]/[K166del];;  
membrin1524/TM6B-­Tb   and   collected   embryos   overnight   with   dedicated  
embryo   collection   cages   (FlyStuff,   Dutscher)   and   apple   juice-­sucrose   agar  
plates   containing   yeast   paste.   These   crosses  were   allowed   to   lay   eggs   for  
several  consecutive  nights  onto  fresh  plates  and  set  up  twice.  During  the  day  
egg/embryos  were  mobilized  with   a   paintbrush,   rinsed  with   water,   counted  
and  transferred  to  standard  food  tubes.  After  10  days  of   incubation  at  25°C  
(11  days  after  initiation  of  egg-­laying)  non-­Tubby  pupae  were  counted.  Given  
that   theoretically  only  one  quarter  of   the  collected  eggs/embryos  are  of   the  
correct  genotype,  we  used   the   following   formula   to  calculate  egg/embryo   to  
pupa   viability:   non-­Tubby   pupae/(total   eggs/4).   The   resulting   fraction   was  
normalized   to   wild-­type   because   we   found   a   considerable   reduction   with  
consecutive  egg-­lays,  presumably  reflecting  decreasing  fertilization.  Eclosion  
rates  were   determined   11   days   (for  GOSR2-­PME   ‘model   crosses’)   and   12  
days   (for   nsyb-­Gal4   and   da-­Gal4   x   UAS-­membrin   crosses   (the   latter  
experiment  was  carried  out  by  Nian  Patel))  after  onset  of  egg  laying,  a  time  
point   where   under   our   conditions   non-­eclosion   was   equal   to   death   or  
imminent   death   in   the   pupal   case.      The   eclosion   data  were   pooled   as   the  
eclosion  rates  did  not  change  over  consecutive  egg-­lays.  
In  mutant  GOSR2   rescue   animals   no   non-­Tubby   pupae   or   L3   larvae  were  
observed.   Therefore   only   eclosion   rates   of   w[1118];;   UAS-­
FLAG::GOSR2[WT]/+;;   membrin1524,   da-­Gal4/membrin1524   animals   were  
determined.   Furthermore,   I   counted   non-­Tubby   and   Tubby   pupae   of   the  
respective   ‘model   cross’,   in   order   to   screen   for   large   deviations   from   the  
expected  Mendelian  ratios.  
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4.3.5          Larval  crawling  assay  
To   test   for   motor   defects   of   GOSR2-­PME   model   larvae,   we   quantified  
locomotion   in   non-­Tubby   third   instar   larvae   from   the   ‘model   cross’   as  
described  above.  Larvae  were  removed  from  their  standard  food  tubes  by  an  
approximately   10   min   incubation   with   20%   sucrose   solution.   This   caused  
larvae   to   emerge   from   the   food   and   to   float   on   the   surface   (Bhatt   and  
Neckameyer,   2013).   Thereafter   L3   larvae   were   selected,   rinsed   with  
deionized  water  and  transferred  to  sucrose-­agar  plates  (2  w/v%  agar,  4  w/v%  
sucrose).   Individual   animals  were   then   picked   up  with   a   paintbrush,   briefly  
dried  with  a  Kimwipe  and  placed   in   the  center  of  a  9  cm  diameter  sucrose-­
agar   dish   residing   above   a   4   mm   grid.   Larvae   were   allowed   to   orient  
themselves   for   30   s   and   filmed   for   the   next   60   s.   A   minimum   total   of   19  
larvae  per  genotype  in  two  independent  experiments  were  recorded  and  grid  
breaks  in  60  s  were  scored  offline.    
4.3.6          Developmental  delay  assay  
Egg-­laying  of   the  membrin   ‘model  crosses’  was  allowed  overnight  on  apple  
juice   agar   plates   as   outlined   above.   The   following   day   yeast   paste   was  
removed  and  fresh  paste  added.  Plates  were  then   incubated  at  25  degrees  
for  24  hours  to  allow  hatching  of  L1   larvae  and  movement   into  the  centrally  
located   yeast   paste.   The   following   day   the   yeast   paste   containing   L1/L2  
larvae   were   transferred   to   fresh   apple   juice   agar   plates,   fresh   yeast   paste  
was   added   and   the   plates   were   again   incubated   overnight.   On   day   three  
yeast  paste  and  apple  juice  agar  plates  were  thoroughly  rinsed  and  animals  
collected   in   70   µm  Falcon  Cell   Strainers.   Late   L2   and   early   L3   non-­Tubby  
larvae  were   then   transferred   into   standard   food   tubes   and   every   day   for   5  
consecutive  days  the  appearance  of  pupae  counted.  Four  batches  of  animals  
derived   from   consecutive   overnight   egg-­lays   of   the   same   parents   were  
pooled.  Counted  pupae  for  each  day  were  expressed  as  percentages  of  the  
overall  counted  pupae  of  the  respective  genotype.  
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4.3.7          Dendritic  analysis  
To  study  dendrites  of  mutant  membrin  animals  the  ‘model  cross’  was  carried  
out  with  the  ppk-­CD4::tdGFP  containing  driver  line  and  non-­Tubby  L3  larvae  
of  the  following  genotypes  were  selected:  
1)   w[1118];;  UAS-­FLAG::membrin[WT]/ppk-­CD4::tdGFP;;  membrin1524,  da-­
Gal4/membrin1524  
2)   w[1118];;  UAS-­FLAG::membrin[G147W]/ppk-­CD4::tdGFP;;  
membrin1524,  da-­Gal4/membrin1524  
3)   w[1118];;  UAS-­FLAG::membrin[K166del]/ppk-­CD4::tdGFP;;  
membrin1524,  da-­Gal4/membrin1524  
Alternatively,  wild-­type  or  mutant  Membrin  was  selectively  overexpressed   in  
class  IV  da  neurons  with  the  ppk  promoter.  Therefore  the  driver  line  w[1118];;  
ppk-­CD4::tdGFP;;  ppk-­Gal4  was  generated  according  to  standard  Drosophila  
mating   schemes   and   crossed   to   w[1118];;   UAS-­
membrin[WT]/[G147W]/[K166del]   as  well   as   to   iso31  and  w[1118];;   +;;  UAS-­
RedStinger.  
Throughout  the  following  experiments  either  the  left  or  right  ddaC  neuron  in  
abdominal  segment  5  of  L3  larvae  was  imaged  (Grueber  et  al.,  2002).  
4.3.7.1          Dendritic  morphology  of  GOSR2-­PME  model  neurons  
In   order   to   avoid  movement   artefacts   L3   larvae   were   heat-­killed   (70°C   for  
approximately   5   s)   and   mounted   under   a   #1.5   glass   coverslip   prior   to  
imaging.   Z-­stacks   of   ddaC   neurons   were   obtained   with   a   Zeiss   confocal  
LSM710  microscope   and   a  N-­Achroplan   10x   0.25  NA  objective.   To   extract  
total  dendrite  length  and  to  serve  as  a  template  for  the  ImageJ  Sholl  Analysis  
plugin,  dendrites  were  semi-­manually  traced  with  the  ImageJ  NeuronJ  plugin  
(Ferreira   et   al.,   2014;;   Meijering   et   al.,   2004).   Terminal   branches   were  
manually  counted  on  dendrite  tracings  with  the  ImageJ  multi-­point  tool.    
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4.3.7.2          Dendritic   baseline   fluorescence   of   GOSR2-­PME   model  
neurons  
The  same  prep  as  outlined  above  for  the  dendritic  morphology  analysis  was  
used  to  obtain  baseline  CD4::tdGFP  fluorescence  in  proximal  dendrites  and  
axons  of  GOSR2-­PME  model  neurons.  Z-­stacks  were  acquired  with  a  Zeiss  
confocal  LSM510  microscope  and  a  Plan-­Neofluar  20x  0.5  NA  objective  and  
a  150  x  150  µm  field  of  view.  After  maximum  intensity  projection  of  z-­stacks  
in  Fiji,  a  region  of  interest  (ROI)  of  axons  and  major  dendrites  contained  in  a  
37.5  µm  radius  ddaC  soma  enclosing  circle  was  manually  drawn  and  mean-­
fluorescence  intensities  extracted  and  background  subtracted  (Figure  21).  
  
Figure  21.  ddaC  baseline  fluorescence  analysis  
Regions  of  interest  around  axon  (*)  and  major  dendrites  contained  within  a  37.5  
µm   circle   around   the   ddaC   abdominal   segment   5   soma   were   drawn.   Mean  
fluorescence   intensities   of   these   regions   were   background   (small   circle)  
corrected.  
  
4.3.7.3          Dendritic  FRAP  of  GOSR2-­PME  model  neurons  
For  FRAP  experiments,   L3   larvae  were   fillet-­prepped   in  HL3  saline  without  
Ca2+   (70   mM   NaCl,   5   mM   KCl,   20   mM   MgCl2,   10   mM   NaHCO3,   5   mM  
trehalose,   115   mM   sucrose,   5   mM   HEPES-­NaOH   pH   7.2).   Animals   were  
opened  along  the  anterior  midline  to  maintain  the  integrity  of  the  dorsal  body  
wall,   where   ddaC   neurons   are   located.   Fillets   were   transferred   to   a   #1.5  
glass  bottom  dished  and  submerged  in  fresh  HL3  saline  with  a  custom-­made  
platinum  wire  anchor  with  the   interior  body  wall   facing  the  solution.   Imaging  
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was  carried  out  on  an  inverted  Zeiss  confocal  LSM510  with  a  Plan-­Neofluar  
20x  0.5  NA  objective.  A  z-­stack  was  taken  every  30  s  –  2  pre-­  and  60  post-­
bleach.  Bleaching  of  a  50  µm2  area  encompassing  major  primary  dendrites  
directly  adjacent  to  the  soma  was  carried  out  by  scanning  for  200  iterations  
with  100%  transmission  of  the  488  nm  Argon  laser  at  a  tube  current  of  6  A.  
Prior  to  extracting  fluorescence  intensities,  z-­stacks  were  maximum  intensity  
projected  for  each  time  point  and  each  resulting  projection  image  aligned  to  
the  first  time  point  with  the  TurboReg  ImageJ  plugin,  in  order  to  compensate  
for   x-­y   optical   drift   during   the   approximately   30   min   acquisition   period  
(Thévenaz   et   al.,   1998).   Mean   fluorescence   intensity   of   a   small   dendritic  
region   contained   in   a   5   µm   diameter   circle   25   µm   from   the   bleach   border  
adjacent   to   the   soma   served   as   a   read-­out   (Figure   22),   which   was  
background  corrected  in  each  frame.  This  is  the  most  distant  dendritic  region  
from  either  bleach  margin  and  thus  the  contribution  to  fluorescence  recovery  
from  lateral  diffusion  of  dendrite  surface  localizing  CD4::tdGFP  is  minimized.  
Bleach  depth  in  this  region  was  consistently  greater  than  87%.    
  
Figure  22.  Dendrite  FRAP  analysis  
Mean  fluorescence   intensity  of  a  small  dendritic   fragment  contained   in  a  5  µm  
circle,  25  µm  (large  circle)  from  the  soma  bleach  margin  was  extracted  over  the  
time  course  and  background  subtracted  for  each  frame  (small  ROI  adjacent  to  
dendrite).   Depicted   is   the   first   maximum   projected   z-­stack,   prior   to  
photobleaching  of  a  50  µm2  area  (square).  
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4.3.7.4          Class  IV  da  neuron  overexpression  studies    
L3   larvae   overexpressing   wild-­type   or   mutant   Membrin   or   control   animals  
were  heat-­killed  and  mounted  as  described  above.  Z-­stacks  were  acquired  
with  an  inverted  Zeiss  confocal  LSM710  with  a  Plan-­Apochromat  20x  0.8  NA  
objective.   To   facilitate   rapid   quantification   of   the   observed   qualitative  
differences,  a  previously  validated  protocol  was  used,  where  Sholl  analysis  is  
performed   directly   on   binary   images   (Ferreira   et   al.,   2014).   Therefore,   all  
image   z-­stack   were   first   maximum   intensity   projected.   Then,   the   same  
thresholds   (10000   –   65535   for   these   16-­bit   images)   were   applied   to   all  
images,  which  yielded  binary   images  with  clearly  visible  dendrites  and  only  
occasional   background   pixels.   The   Sholl   analysis   ImageJ   plugin   was   then  
used  to  compute  total  intersections  with  1  pixel  increasing  radii  starting  at  the  
center   of   the   cell   soma   (Ferreira   et   al.,   2014).   400  µm  was   chosen  as   the  
ending   radius   to   cover   the   majority   of   the   abdominal   segment   5   ddaC  
dendrite   arbor.   Because   these   neurons   are   tightly   surrounded   by   tiling  
neighbouring  class  IV  da  neurons,  some  of  the  more  distal  Sholl  circles  also  
intersect   with   these   dendrites.   Specifically,   these   Sholl   settings   also   yield  
intersections   with   some   distal   branches   of   the   contralateral   abdominal  
segment  5  and  the  ipsilateral  abdominal  segment  3  and  6  ddaC  neurons  as  
well   as   the   ipsilateral   abdominal   segment   5   v’ada   neuron.  However,   these  
additional  intersections  do  not  render  the  experiment  less  powerful,  because  
these  neurons  have  similarly  large  dendritic  arbors,  which  thus  will  be  equally  
vulnerable  to  the  Membrin  mutations.    
4.3.8          Drosophila  brain  immuno-­fluorescence  microscopy  
Dissection   and   immuno-­staining   of   adult   fly   brains   largely   followed   a  
published  protocol  (Wu  and  Luo,  2006).  Flies  were  anaesthetized  with  CO2,  
immersed  in  70%  ethanol,  dissected  with  sharp  forceps  in  phosphate  buffer  
Triton  X-­100   (  PBT;;   100  mM  phosphate   buffer   pH   7.2   plus   0.3%  Triton  X-­
100)  and  fixed  in  4%  PFA  (Alfa  Aesar)  at  room  temperature  for  15  min  under  
constant   agitation.   Remaining   fixative,   as   well   as   primary   and   secondary  
antibodies  were  removed  by  3  short  and  3  x  10  min  washes  with  PBT.  Prior  
to  antibody  labeling,  brains  were  blocked  in  PBT  +  5%  goat  serum.  Primary  
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and   secondary   antibodies   were   diluted   in   PBT   +   5%   goat   serum   and  
incubated  at  4°C  overnight.  The  following  antibodies  and  respective  dilutions  
were   used:   mouse   anti-­FLAG   (clone   M2,   Sigma;;   1:1000),   rat   anti-­FLAG  
(Agilent;;   1:1000),   mouse   anti-­GFP   (clone   3E6,   Thermo   Fisher   Scientific;;  
1:1000),   rabbit   anti-­Drosophila   Membrin   (cusMEM4;;   custom   polyclonal  
production  by  Biomatik  (see  below);;  1:500),  goat  anti-­mouse/rabbit/rat  Alexa  
Fluor  488/647  (Thermo  Fisher  Scientific,  1:500-­1000).  Stained  fly  brains  were  
mounted   in   SlowFade   Gold   antifade   (Thermo   Fisher   Scientific)   with   the  
brain’s   anterior   facing   a   #1.5   glass   coverslip   and   between   #1.5   glass  
coverslip   bridges,   in   order   to   preserve   the   structure   of   the  whole   brain.   Z-­
stacks  were  acquired  with  an   inverted  Zeiss  confocal  LSM710  with  a  Plan-­
Apochromat  20x  0.8  NA  objective.  
4.3.9          Western  blot  
Drosophila  western  blots  were  carried  out  according  to  the  same  protocol  as  
used   for  mammalian  cultured  cells   (described   in   ‘Materials  and  Methods’  of  
Chapter   3).   To   lyse   Drosophila   L3   larvae,   5   animals   were   placed   in   an  
Eppendorf  tube  containing  50  or  100  µl  of  the  above  lysis  buffer  and  ground  
for   10   s   with   Pellet   pestles   (Kimble   Kontes).   For   immuno-­detection  mouse  
anti-­FLAG   (clone   M2,   Sigma;;   1:2000),   rabbit   anti-­Drosophila   Membrin  
(cusMEM4;;   custom   polyclonal   production   by   Biomatik   (see   below);;   1:500),  
mouse  anti-­b-­actin  (clone  AC-­74,  Sigma;;  1:2000)  and  HRP-­conjugated  anti-­
mouse/rabbit  secondaries  (Jackson  Immuno;;  1:1000-­5000)  were  used.  
4.3.10          Antibody  production  
Polyclonal   anti-­Drosophila   Membrin   antibodies   were   custom   produced   by  
Biomatik   for   this   study.   To   this   end   they   synthesized   two   peptides  
corresponding   to   two   independent   regions   of   Drosophila   Membrin.   Both  
peptides   were   injected   into   two   rabbits   (Table   10).   Thereafter,   antibodies  
were  affinity  purified  from  the  rabbit’s  sera,  lyophilized  and  shipped  to  us.    





Peptide  ID   465774   465775  
Animal  ID   RB6725   RB6726   RB6725   RB6726  
Short  name   cusMEM1   cusMEM2   cusMEM3   cusMEM4  
Table  10.  Summary  of  custom  anti-­Drosophila  Membrin  antibodies  
Two   rabbits   were   immunized   with   independent   peptides   corresponding   to  
Drosophila   Membrin   (uniprot   Q9VRL2),   giving   rise   to   four   variants   of   custom  
rabbit  polyclonal  anti-­Drosophila  Membrin  antibodies.  
  
I   reconstituted   these   antibodies   with   deionized   water   to   a   final   1   mg/ml  
concentration  and  screened  each  of   the   four  different   rabbit  polyclonal  anti-­
Drosophila   Membrin   antibodies   for   specificity   in   immuno-­fluorescence  
microscopy  of  Drosophila  brains.  While  cusMEM3  and  4  clearly   recognized  
transgenically   expressed  FLAG::membrin[WT]   in   adult  Mem-­WT  Drosophila  
brains,  cusMEM1  and  2  barely  did  (Figure  23A  and  data  not  shown).    
  
Figure  23.  Custom  anti-­Drosophila  Membrin  antibody  validation  
(A)  Confocal  slices  through  an  adult  Drosophila  Mem-­WT  brain,  co-­stained  with  
an   anti-­FLAG   and   the   custom   anti-­Drosophila   Membrin   antibody   cusMEM4.  
Prominent  colocalization  between   the   two  channels   in  somatic  areas,  such  as  
adjacent  to  the  antennal  lobes  (arrowheads)  indicates  that  the  custom  antibody  
has   the   capability   of   recognizing   Membrin   in   an   immuno-­fluorescence  
preparation.  
(B)  Western  blot  of  L3  larvae  lysates  probed  with  cusMEM4.  The  band  around  
approximately  25  kDa  appears  to  represent  Drosophila  Membrin,  as  it  is  greatly  
reduced   upon   RNAi   mediated   global   Membrin   knock-­down.   15   µg   of   total  
protein  was   loaded   into  each   lane  and  equal   loading  confirmed  with  an  anti-­b-­
actin  antibody.  
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However,   none   of   these   custom   antibodies   yielded   a   robust   perinuclear  
staining   –   as   expected   for   an   antibody   targeting   a   Golgi   protein   –   in  
Drosophila   brains   with   physiological   Membrin   levels   (data   not   shown).  
Because   of   its   superiority   in   immuno-­fluorescence   studies,   cusMEM4   was  
further   validated   in   western   blot.   There   it   recognized   a   band   around   the  
expected   25   kDa   size,   which   disappeared   almost   entirely   upon   Membrin  
RNAi  mediated  knock-­down  (Gasteiger  et  al.,  2003)  (Figure  23B).  This  result  
not  only  suggests  that  the  observed  band  around  25  kDa  indeed  represents  
Drosophila  Membrin,  but  also  that  the  GD  44535  membrin  RNAi  line  induces  
efficient  knock-­down  of  Membrin   levels.  Thus,  cusMEM4  represents  a  good  
tool   for   western   blot   and   might   also   be   useful   for   immuno-­fluorescence  
studies,   should   an   optimization   of   the   immuno-­staining   protocol   provide  
increased  sensitivity  towards  endogenous  Membrin  expression  levels.  
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4.4          Results  
4.4.1          A  novel  Drosophila  model  of  GOSR2-­PME    
In  order  to   investigate  the  pathophysiological  consequences  of  the  GOSR2-­
PME  mutations  in  our  primary  cell  type  of  interest  –  neurons  –  as  well  as  in  
an   entire   organism,   we   developed   the   first   in   vivo   model   of   this   disorder.  
Because  Golgi   SNARE   proteins   are   highly   conserved   throughout   evolution  
(Kienle   et   al.,   2009a;;   2009b;;   Kloepper   et   al.,   2008;;   2007),   we   chose   the  
comparably  simple  yet  genetically  powerful  Drosophila  melanogaster  as  our  
experimental  model.  Drosophila  harbors  a  single  GOSR2  orthologue,  which  
is  termed  membrin.  We  obtained  a  membrin  null  strain  (membrin1524)  for  this  
study,   which   was   previously   generated   in   an   EMS   screen   for   defective  
trachea  morphogenesis  and  kindly  shard  by  Mark  Krasnow  (Ghabrial  et  al.,  
2011).  This  fly  harbors  a  c.253C>T  mutation  in  membrin,  which  gives  rise  to  
a   premature   stop   codon   (Q85X)   upstream   Membrin’s   critical   SNARE   and  
transmembrane  domains  and  is   therefore  a  null  allele.  The  presence  of   this  
mutation  was  confirmed  by  Sanger  sequencing  in  our  lab  (Figure  24A).  
  
Figure  24.  The  membrin  null  allele  membrin1524  
(A)   Chromatogram   depicting   the   heterozygous   c.253C>T  membrin   sequence  
alteration  in  w[1118];;  +;;  membrin1524/TM6B-­Tb.  
(B)   membrin1524   was   balanced   over   the   fluorescently   labeled   TM3   Kr>GFP  
chromosome   to   discern   heterozygote   animals.   Homozygosity   for  membrin1524  
caused   largely   L1   lethality,   as   at   the   L2   stage   hardly   any   non   GFP-­positive  
larvae  could  be  detected.  N  =  50,  53,  56  quantified  larvae  at  the  L1,  2,  3  stages;;  
***  represents  p  <  0.001;;  Fisher’s  exact  test  and  Bonferroni  correction.  
  
Homozygosity   for   membrin1524   caused   pre-­L3   lethality,   as   only   Tubby   L3  
larvae   could   be  observed   in  Drosophila   stock  where   this   allele   is   balanced  
over   TM6B-­Tb.   To   further   investigate   the   lethal   phase   of   this   allele   I  
rebalanced  this  stock  over  the  fluorescent  TM3  Kr>GFP  chromosome,  which  
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allows   to   discern   heterozygous   from   homozygous   animals   from   the   germ  
band   extension   embryonic   stage   onwards   (Casso   et   al.,   2000).   These  
investigations   revealed   that   homozygosity   for  membrin1524   is   largely   lethal  
between  the  L1  and  L2  larval  stages  (Figure  24B).  This  finding  is  surprising  if  
we  consider  Membrin’s  essential  role  in  mediating  ER-­to-­Golgi  trafficking  and  
the  observation  that  BOS1  null  yeast  are  incapable  of  mitotic  growth  (Shim  et  
al.,   1991).   An   explanation   of   this   extended   viability   in  Drosophila  might   be  
maternal  Membrin  mRNA  and/or   protein   deposition   into   the   embryo,  which  
could  rescue  homozygous  membrin1524  to  the  L1  stage.  This  notion  was  not  
experimentally  tested  as  it  goes  beyond  the  central  aim  of  our  investigation,  
which   aimed   to   unravel   how   partial   loss   of   function  Membrin   alleles   cause  
neuronal  disease.  
To  investigate  the  consequences  of  G144W  and  K164del  GOSR2  or  G147W  
and  K166del  membrin  mutations   in  Drosophila  we   first   generated  wild-­type  
and   mutant   UAS-­GOSR2/UAS-­membrin   transgenes,   which   harbor   an   N-­
terminal   FLAG   tag.   Each   of   these   transgenes   was   inserted   into   the   same  
genomic   localization   by  FC31   integrase   mediated   site-­specific   integration,  
thus  enabling  similar  expression  levels  between  the  different  alleles  (Bischof  
et   al.,   2007).   To   activate   the   otherwise   inert   UAS-­transgenes   the   global  
daughterless-­Gal4   (da-­Gal4)   driver   was   used   (Brand   and   Perrimon,   1993).  
Finally,   after   backcrossing   UAS-­GOSR2/UAS-­membrin,   da-­Gal4   and  
membrin1524   into   the   w[1118]   mutant   isogenic   iso31   strain   to   control   for  
genetic  background  effects,  we  combined  all  components  in  a  way  to  enable  
expression   of   wild-­type   or   mutant   GOSR2/membrin   in   a   membrin   null  
background.  
To   assess   functional   conservation,   I   tested   whether   Drosophila   membrin  
could  be  replaced  by  human  GOSR2.  Indeed,  I  found  that  global  expression  
of   wild-­type   GOSR2   was   capable   of   partially   rescuing   homozygous  
membrin1524   animals   –   which   otherwise   would   die   between   the   L1   and   L2  
larval   stages   –   to   the   pupal   and   adult   stages   (Figure   25A,   B).   This  
experiment   provides   evidence   supporting   the   otherwise   bioinformatically  
determined  conservation  between  human  GOSR2  and  Drosophila  membrin.  
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It   therefore   validates   our   approach   of   studying  GOSR2-­PME   in   this  model  
organism.  Furthermore,   this  observation   illustrates   that  our  genetic  setup   is  
functional   and   that   the   N-­terminal   FLAG   tag   does   not   abolish   Membrin’s  
function.   It   has   to   be   noted,   however,   that   these  GOSR2   rescue   animals  
appeared   slow   and   weak   at   the   adult   stage   and   usually   died   within   three  
days   after   eclosion.   Thus,   human   GOSR2   is   only   capable   of   partially  
rescuing  membrin   null   animals.   Furthermore,   G144W   and   K164del   mutant  
GOSR2  were  not   capable  of   rescuing  homozygous  membrin1524   animals   to  
the  pupal  stage,  as  only  Tubby  L3  pupae  were  observed  from  the  respective  
‘model  crosses’  (Figure  25A).  
  
Figure  25.  Wild-­type  human  GOSR2  enables  early  developmental  viability  
of  membrin  null  Drosophila  
(A)   Wild-­type   and   mutant   human   GOSR2   was   globally   expressed   with   the  
daughterless-­Gal4   driver   in   a   membrin   null   genetic   background.   Early  
developmental   viability   was   assessed   at   the   pupal   stage.   Non-­Tubby   pupae  
indicate   the   desired   genotypes   resulting   from   the   necessary   genetic   cross   as  
described   in   the   Methods   section.   No   obvious   shift   from   the   expected  
Mendelian   ratios  was  observed   in  WT,  while  G144W/K164del  mutant  GOSR2  
failed   to   rescue   to   the   pupal   stage.   N   =   139,   87,   115   quantified   total  
WT/G144W/K164del  pupae.  
  (B)  All   scored  WT  GOSR2   non-­Tubby  animals  managed   to   eclose   from   their  
pupal  cases.  N  =  51  quantified  non-­Tubby  pupae.  
  
We  therefore  shifted  our  focus  to  UAS-­membrin  transgenes,  which  are  closer  
to   the   normal   physiology   of   Drosophila.   Expressing   wild-­type   or  
G147W/K166del   mutant   Membrin   in   a  membrin1524   background   yields   two  
GOSR2-­PME  model  mutant  fly  lines  and  one  control.  Their  full  genotypes  are  
abbreviated  Mem-­G147W,  Mem-­K166del  and  Mem-­WT  in  this  thesis  (Figure  
26).  
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Figure  26.  Genetics  of  the  GOSR2-­PME  model  used  in  this  study  
Genotypes   of   the   GOSR2-­PME   Drosophila   model   used   in   this   study.   Four  
components  –  two  membrin  null  alleles  (membrin1524),  the  global  da-­Gal4  driver  
and  UAS-­membrin   transgenes  –  are  combined  by  a  single  genetic  cross   (See  
‘Materials  and  Methods’  for  details).  
  
4.4.2          Early  phenotypes  in  mutant  Membrin  Drosophila  
To  investigate  whether  mutant  Membrin  causes  Drosophila  phenotypes  that  
are   informative   for   the   investigation  of   the  GOSR2-­PME  pathophysiology,   I  
carefully   assessed   the   resulting   organismal   consequences.   Global  
expression  of  wild-­type  as  well  as  G147W  and  K166del  mutant  Membrin  was  
capable   of   rescuing   homozygous  membrin1524   animals   to   the   pupal   stage,  
which  indicates  that  both  mutations  do  not  render  the  protein  completely  un-­
functional   (Figure   27A).  Both  mutants   exhibited   subtle   reductions   in   egg   to  
pupa   viability   rates   when   compared   to   Mem-­WT,   which   reached   statistical  
significance   only   in  Mem-­K166del   (Figure   27A).  While   these   effects   where  
mild,   we   observed   a   striking   clustering   of   lethality   of  GOSR2-­PME  mutant  
Drosophila  at   the  young  adult  stage.  While  Mem-­WT  successfully  managed  
to  eclose   from   their   pupal   cases  and  emerged  as   freely  moving  adults,  we  
observed  that  Mem-­G147W/Mem-­K166del  frequently  died  as  fully  developed  
pharate  adults  within   their  pupal  cases   (Figure  27B).  When  surgically   freed  
from  their  pupal  cases  they  appeared  weak  and  uncoordinated.  While  98%  of  
Mem-­WT  animals  managed  to  eclose,  only  around  10%  of  Mem-­G147W  and  
33%   of   Mem-­K166del   did   (Figure   27B).   Those   mutant   animals   that  
succeeded  in  freeing  themselves  from  the  pupal  cases  often  got  stuck  in  the  
food   and   died   within   a   few   days.   This   aggregation   of   early   lethality   at   the  
pharate   adult   stage   might   be   because   eclosion   represents   a   considerable  
hurdle,  which  might  be  too  big  to  overcome  for  motor  impaired  Mem-­G147W  
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or  Mem-­K166del  animals.  Given   that  G147W  and  K166del  mutant  Membrin  
was   only   partially   able   to   rescue   lethality   arising   from   homozygosity   for   a  
membrin   null   allele,  we   present   organismal   data   that   support   the   liposome  
fusion   assay   derived   notion   that   the  GOSR2-­PME  mutations   confer   partial  
loss  of  Membrin  function.  Further  experimental  evidence  supporting  this  idea  
stems   from   global   Membrin   knock-­down   via   RNA-­interference,   which   also  
resulted  in  pharate  stage  lethality  (Figure  27C,  quantified  by  Nian  Patel).  
  
Figure  27.  Membrin  mutations  cause  early  lethality  
(A)   Global   expression   of  WT,   G147W   and   K166del   mutant   Membrin   rescues  
membrin  null  homozygous  animals  to  the  pupal  stage.  A  subtle  decrease  in  egg  
to  pupa  viability  is  apparent  in  Mem-­K166del  when  compared  to  Mem-­WT.  Data  
expressed   as   relatives   to   Mem-­WT.   N   =   1222,   1308,   1260   counted   total  
eggs/embryos  for  Mem-­WT/-­G147W/-­K166del  crosses.  Statistical  analysis  was  
performed   based   on   the   theoretically   determined   number   of   eggs/embryos   of  
the  desired  genotype,  i.e.  N  =  306,  327,  315  for  Mem-­WT/-­G147W/-­K166del.  
(B)  Mem-­G147W  and  Mem-­K166del   frequently  die  as   fully   developed  pharate  
adults  within  their  pupal  cases  as  shown  by  a  drastic  decrease  in  eclosion  rates  
compared  to  Mem-­WT.  N  =  120,  112,  97  individual  non-­Tubby  pupae  scored  for  
Mem-­WT/-­G147W/-­K166del.  
(C)   Global   RNAi   mediated   Membrin   knock-­down   with   the   da-­Gal4   driver  
resulted   in  pharate  stage   lethality.  N  =  378,  162,  313   individual  pupae  scored  
for   the   da-­Gal4   driver,  membrin   RNAi   only   and   knock-­down   genotypes.   Data  
were  obtained  and  analysed  by  Nian  Patel.  
*,   ***   represent  p  <  0.05,  0.001,  ns  =  not  significant   (p  >  0.05);;  Fisher’s  exact  
test  with  Bonferroni  correction.  
  
Also   global   overexpression   of   mutant   Membrin   in   a   wild-­type   membrin  
background   resulted   in   substantial   pharate   stage   lethality   (Figure   28A   –  
quantified   by   Nian   Patel),   presumably   by   outcompeting   endogenous   wild-­
type   Membrin.   If   the   overexpressed   mutant   Membrin   isoform   is   far   more  
concentrated  in  the  cis-­Golgi,  then  we  can  easily  imagine  a  scenario  where  it  
is  preferentially   integrated   into   the  cis-­Golgi  SNARE  complex   instead  of   the  
endogenous  wild-­type  protein.  Because  endogenous  Membrin  is  still  present  
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and   likely   still   contributes   to   membrane   fusion   in   this   setting,   the   eclosion  
deficits  are  reduced  compared  to  those  observed  in  Mem-­G147W  and  Mem-­
K166del  (compare  Figure  28A  with  Figure  27B).    
  
Figure  28.  Global  and  nervous  system  overexpression  of  mutant  Membrin  
(A)   Global   overexpression   of   mutant   UAS-­membrin   in   wild-­type   membrin  
animals  with  da-­Gal4   resulted   in   reduced   eclosion   rates   due   to   pharate   adult  
lethality.   N   =   284,   514,   403   individual   pupae   scored   for   UAS-­
membrin[WT]/[G147W]/[K166del].   This   experiment   was   performed   and  
analysed  by  Nian  Patel.  
(B)   Nervous   system   specific   overexpression   of   mutant   UAS-­membrin   in   wild-­
type  membrin  animals  with  nsyb-­Gal4  resulted  in  reduced  eclosion  rates  due  to  
pharate   adult   lethality.   N   =   616,   491,   618   individual   pupae   scored   for   UAS-­
membrin[WT]/[G147W]/[K166del].  
***  represent  p  <  0.001;;  Fisher’s  exact  test  with  Bonferroni  correction.  
  
Nevertheless,   this   experiment   suggested   to   us   that   the   genetically   simple  
approach   of   overexpressing   mutant   Membrin   in   an   otherwise   wild-­type  
membrin  animal  could  serve  as  a  tool   to  test  whether  the  observed  lethality  
phenotypes   in   Mem-­G147W/Mem-­K166del   are   derived   from   neuronal  
abnormalities.   Indeed,   when   we   selectively   overexpressed   G147W   or  
K166del  mutant  Membrin  in  the  nervous  system  of  Drosophila  with  the  nsyb-­
Gal4  driver  line  we  observed  pharate  adult  stage  lethality  (Figure  28B),  with  a  
relative   severity   comparable   to   global   overexpression   with   da-­Gal4.   These  
findings  suggest  that  expression  of  mutant  Membrin  in  neurons  is  sufficient  to  
cause  the  lethality  phenotypes  observed  in  Mem-­G147W  and  Mem-­K166del.  
They   therefore   reinforce   the   notion   that   the   GOSR2-­PME   phenotype   can  
arise   from   selective   vulnerability   of   neurons   to   the   respective   Membrin  
mutations.    
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Next   I   tested   whether   GOSR2-­PME   model   Drosophila   also   exhibited  
organismal  phenotypes  prior  to  their  premature  death  as  young  adults,  which  
occurred  either  within   the  pupal   cases  or   soon  after   eclosion.   Interestingly,  
membrin   mutant   animals   appeared   to   be   developmentally   delayed.   I  
quantified  this  effect  by  selecting  late  L2/early  L3  Mem-­WT,  Mem-­G147  and  
Mem-­K166del  larvae,  transferring  them  to  fresh  food  tubes  and  counting  the  
appearance   of   pupae   daily   for   the   next   five   days.   Onset   of   pupation   was  
observed   two  days  after  selection  of   larvae.  While  31%  of  Mem-­WT  rescue  
animals  pupated  by  this  day,  only  around  8%  of  Mem-­K166del  and  none  of  
Mem-­G147W  were  observed  to  reach  this  developmental  stage  (Figure  29A).  
By   day   three   almost   all   Mem-­WT   and   Mem-­K166del   animals   were   pupae  
whereas   only   approximately   21%   of   Mem-­G147W   animals   pupated   and   it  
took  this  group  of  animals  until  day  five  for  all  animals  to  initiate  pupation.    
Given   that   GOSR2-­PME   is   a   severe   epilepsy   syndrome   and   movement  
disorder,  we  wanted   to   find  out  whether  GOSR2-­PME  Drosophila   exhibited  
signs   of   motor   abnormalities.   I   therefore   quantified   larval   locomotion   by  
counting   4  mm  grid   crosses  within   60   s.  Mem-­WT   crossed   on   average   10  
grids   in   60   s   (Figure   29B),   whereas   Mem-­G147W   and   Mem-­K166del   only  
approximately  7.5  grids.  This   finding   illustrates  clear  motor  defects   in   these  
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Figure   29.   Developmental   delay,   locomotor   deficits   and   seizure-­like  
behavior  in  GOSR2-­PME  model  larvae  
(A)  Mem-­WT,  Mem-­G147W  and  Mem-­K166del  larvae  were  transferred  to  fresh  
food  tubes  at  the  late  L2/early  L3  developmental  stages.  Onset  of  pupation  was  
subsequently  scored  for  5  consecutive  days  and  expressed  as  a  fraction  of  total  
pupae.  N  =   36,   58,   59   individual   pupae  were   counted   for  Mem-­WT/-­G147W/-­
K166del.    
(B)  Freely  moving  Mem-­G147W  and  Mem-­K166del  L3   larvae  crossed   fewer  4  
mm   grids   in   60s   than   Mem-­WT.   Replicate   values   derived   from   individual   L3  
larvae,   mean   and   SD   are   shown.   N   =   19,   20,   21   for   Mem-­WT/-­G147W/-­
K166del.  
(C)  Recovery  time  after  a  30  V  electroshock  to  the  central  nervous  system  of  L3  
larvae   was   quantified   as   an   indirect   readout   of   seizure   severity/duration.   A  
significant   increase   in   Mem-­G147W   and   Mem-­K166del   is   apparent   when  
compared   to   Mem-­WT.   Both   mutants   are   comparable   to   the   seizure   mutant  
bang-­senseless   (bss).   Replicate   values   derived   from   30   larvae   per   genotype,  
mean   and   SD   are   shown.   This   experiment   was   carried   out   and   analysed   by  
Carlo  Giachello  in  Richard  Baines’  lab.  
*,   ***   represent  p  <  0.05,  0.001,  ns  =  not  significant   (p  >  0.05);;  Fisher’s  exact  
test  with  Bonferroni  correction  (A),  ANOVA  with  Dunnett’s  multiple  comparison  
test  (B),  Kruskal-­Wallis  test  with  Dunn’s  post-­hoc  test  (C).  
  
Because  GOSR2-­PME   is  a  severe  epilepsy  syndrome,  we  wanted   to  know  
whether   also   Mem-­G147W   and   Mem-­K166del   had   hyperexcitability  
phenotypes.  Indeed,  Carlo  Giachello  in  Richard  Baines’  lab  found  that  Mem-­
G147W  and  Mem-­K166del  L3   larvae  exhibit  seizure-­like  phenotypes,  with  a  
relative  severity  comparable  to  the  bang-­senseless  Drosophila  seizure  model  
(Figure   29C)   (Giachello   and   Baines,   2015;;   Parker   et   al.,   2011).   They  
displayed   significantly   larger   recovery   times   from   electro-­shock   induced  
seizures  when  compared  to  Mem-­WT,  which  is  thought  to  be  a  consequence  
of  increased  seizure  severity  and/or  persistent  epileptiform  activity  in  mutant  
membrin   animals   (Giachello   and   Baines,   2015).   GOSR2-­PME   Drosophila  
therefore   not   only   exhibit   ataxia-­like   locomotor   deficits   but   also   seizure-­like  
phenotypes,  which  are  correlates  of  two  core  neurological  features  observed  
in  the  human  disorder.  
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Collectively,   these   phenotypes   are   thought   to   arise   from   a   decrease   in  
ERGIC/cis-­Golgi  lipid  fusion  rates  due  to  partial  Membrin  SNARE  defects.  In  
order  to  test  whether  also  reductions  in  G147W  mutant  Membrin  levels  could  
contribute   to   the   observed   phenotypes   –   as   is   suggested   by   decreased  
G144W   mutant   Membrin   levels   in   patient   fibroblasts   –   I   performed   semi-­
quantitative  western  blot  with  Mem-­WT,  Mem-­G147W  and  Mem-­K166del  L3  
larvae  lysates  (Figure  30A).  These  studies  revealed  similar  Membrin  levels  in  
Mem-­G147W   and  Mem-­K166del   when   compared   to   Mem-­WT,   with   only   a  
subtle  reduction  in  Mem-­G147W  (Figure  30B).  
  
Figure  30.  Membrin  levels  in  GOSR2-­PME  Drosophila  models  
(A)   Western   blot   of   Mem-­WT,   Mem-­G147W   and   Mem-­K166del   L3   larvae  
lysates.  Animals  were  raised  at  25°C  and  shifted  overnight  to  18°C  prior  to  lysis,  
in   order   to   reduce   Gal4   expression   and   therefore   facilitate   unmasking   of  
potentially   reduced  protein   stability   of  G147W  Membrin   (Duffy,   2002).   5  µg  of  
total  protein  was  loaded  into  each  lane  and  equal  loading  verified  with  Ponceau  
S  staining.  
(B)  Quantification  of  experiment  as  described  in  (A).  Normalized  to  Mem-­WT.  N  
=  6  replicate  values,  derived  from  three  independent  lysates  per  genotype  and  
immunoblotted  twice.  Mean  and  SD  are  shown.  **  represents  p  <  0.01,  ns  =  not  
significant  (p  >  0.05);;  ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
  
This   indicates   that   the   observed  phenotypes   in   our  Drosophila  models   can  
solely   be   attributed   to   the  SNARE  defects   and   not   to   reductions   in  mutant  
Membrin  levels.  One  possible  explanation  for  the  discrepancy  between  high  
G147W  Membrin   levels   in   our  Drosophila  models   and   a   large   reduction   of  
G144W   mutant   Membrin   in   fibroblasts   (Figure   13)   might   be   that   the  
expression  levels  in  our  model  are  artificially  high  and  therefore  largely  mask  
G144W   mutant   Membrin   proteostasis   alterations.   Alternatively,   this   result  
might   further   indicate   that   the   fibroblast   data   are   rather   due   to   individual  
variations   in  Membrin   levels  –  as   is   suggested  by  Membrin   level   variations  
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between  the  healthy  controls  –  and  thus  do  not  represent  changes   incurred  
by   the   G144W   mutation.   To   further   investigate   whether   G144W   causes  
Membrin  protein  instability  it  would  be  revealing  to  overexpress  wild-­type  and  
mutant  Membrin  fused  to  a  Halo  or  SNAP  tag  in  HEK  cells.  These  constructs  
could   then   be   pulse   labelled,   which   would   enable   to   determine   whether  
protein  turnover  rates  are  increased  due  to  the  G144W  mutation.    
In   summary,   I   have   developed   the   first   GOSR2-­PME   in   vivo   models   by  
utilizing   Drosophila.   These   models   exhibit   severe   and   early   phenotypes,  
which   recapitulate  key  aspects  of  human  patients.  By  demonstrating  partial  
functional   inter-­changeability   of   human  GOSR2   and  Drosophila   membrin   I  
have   further   confirmed   the   validity   of   our   choice   of   model   organism.  
Furthermore,   our   phenotypic   data   suggest   partial   loss   of  Membrin   function  
due   to   GOSR2-­PME   mutations,   which   likely   results   in   the   observed  
organismal  phenotypes  due  to  neuronal  abnormalities.  
4.4.3          Profound   dendrite   growth   deficits   in   GOSR2-­PME   model  
neurons  
Important  clues  towards  the  mechanism  underlying  neuronal  dysfunction  due  
to   Membrin   mutations   stemmed   from   studies   investigating   neuronal  
consequences   of   mutations   in   other   ER-­to-­Golgi   trafficking   proteins.  
Overexpression   of   GTP-­locked   Arf1[Q71L]   in   developing   cultured  
hippocampal  neurons  led  to  severely  impaired  dendritic  growth  (Dascher  and  
Balch,  1994;;  Horton  et  al.,  2005).  Similarly,  Ye  et  al.   found   in  a  Drosophila  
forward   genetic   screen   that   mutations   in   Sec23,   Sar1   and   Rab1   cause  
dendritic   growth   deficiencies   (Ye   et   al.,   2007).   The   explanation   for   this  
observation   is   that   an   early   secretory   pathway   block   likely   prevents   ER-­
derived   lipids   and   proteins   from   reaching   the   surface   of   a   growing   neuron,  
which  poses  immense  demands  on  such  supplies  due  to  its  very  large  area  
(Hanus  and  Ehlers,  2008).  
However,   in   contrast   to   Arf1[Q71L]   and   the   truncated   Sar1,   which   was  
studied   due   to   organismal   lethality   in  mosaic   animals   (Dascher   and  Balch,  
1994;;  Horton  et  al.,  2005;;  Ye  et  al.,  2007),  the  G144W  and  K164del  Membrin  
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mutations  will  not  cause  a  complete  block  of  anterograde  trafficking.  After  all,  
yeast  liposome  fusion  studies  and  Drosophila  phenotypes  of  the  orthologous  
mutations   suggested  partial   and   not   complete   loss   of  Membrin   function.   In  
addition,   ER-­to-­Golgi   trafficking   in  G144W  mutant  Membrin   fibroblasts  was  
efficient   (Figure   17   and   Figure   18).   Thus,   we   tested   whether   even   such   a  
partial  decrease  might  be  sufficient  to  impair  dendritic  growth.  To  this  end  we  
utilized  a  set  of  highly  elaborate  sensory  neurons  within  the  larval  body-­wall  
neurons   termed   class   IV   dendritic   arborization   (da)   neurons,   which   we  
genetically   labeled   with   the   ppk   promoter   and   a   membrane   tagged   –   and  
therefore   secretory  pathway  dependent   –  CD4::tdGFP   reporter   (Grueber  et  
al.,   2003;;   Han   et   al.,   2011).   This   is   a   well   established   and   widely   used  
dendritogenesis   model   because   these   neurons   have   highly   sophisticated,  
tiled  dendritic  arbors  that  branch  in  2D  and  they  are  unambiguously  polarized  
into  a   single  axon  and  multiple  dendrites   (Figure  31A;;  arrowhead   indicates  
the   single   axon,   the   remaining   processes   are   dendrites)   (Grueber   et   al.,  
2002).   Amongst   the   three   class   IV   da   neurons,   which   are   labeled   in   each  
hemisegment  by   the  ppk   promoter,  we   imaged  a  particular   subtype   termed  
ddaC   neuron   (the   other   ppk-­positive   larval   body   wall   neurons   are   termed  
v’ada   and   vdaB)   in   abdominal   segment   5   of   Mem-­WT,   Mem-­G147W   and  
Mem-­K166del  L3  larvae  (Figure  31A).  
  
  
     123  
  
Figure  31.  Membrin  mutations  cause  dendritic  growth  deficits  
(A)   Maximum   intensity   projections   of   ddaC   abdominal   segment   5   neurons  
genetically   labeled   with   ppk   >   CD4::tdGFP   in   Mem-­WT/-­G147W/-­K166del.  
Respective   tracings   of   the   dendritic   arbors   are   shown   below.   Arrowheads  
indicate  axons.   9  abdominal   segment  5  ddaC  neurons   from  7/7/8  different   L3  
larvae   for  Mem-­WT/G147W/-­K166del  were   traced  and  analyzed   in   (B,  C)  and  
Figure  32.	 
(B)   Total   dendritic   length   extracted   from   tracings   as   shown   in   (A).   Replicate  
values  derived  from  individual  ddaC  neurons,  mean  and  SD  are  shown.   
(C)   Number   of   terminal   branches   of   ddaC   A5   neurons   as   shown   in   (A).  
Replicate   values   derived   from   individual   ddaC   neurons,   mean   and   SD   are  
shown. 	 
**,   ***   represent   p   <   0.01,   0.001;;   one-­way   ANOVA   with   Dunnett’s   multiple  
comparison  test.    
  
The  unique  advantage  of  this  approach  is  that  we  were  able  to  image  exactly  
the   same   identifiable   neuron   across   different   genotypes   and   thus   reduced  
intrinsic   variation   of   dendritic   size   to   a  minimum.  Strikingly,   both  mutations  
caused   substantial   dendritic   growth   deficiencies.   Mean   reduction   of   total  
dendritic  length  amounted  to  approximately  40%  in  Mem-­G147W  and  67%  in  
Mem-­K166del   when   compared   to   Mem-­WT   (Figure   31B).   Similarly,   the  
average   number   of   terminal   dendritic   branches   was   decreased   in   Mem-­
G147W   and  Mem-­K166del   by   45%   and   64%   respectively   (Figure   31C).   In  
addition,   Sholl   analysis   revealed   a   clearly   reduced   elaboration   of   dendritic  
arborization  in  both  mutants  from  approximately  100  µm  away  from  the  soma  
(Figure   32A)   and   a   significant   decrease   of   overall   dendritic   intersections  
(Figure  32B).  
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Figure  32.  Sholl  analysis  
(A)   Number   of   intersections   of   dendritic   tracings   (Figure   31A)  with   concentric  
circles   with   2   pixel/circle   increasing   radii.   Mean   and   SEM   of   9   abdominal  
segment  5  ddaC  neurons  are  shown  for  each  genotype.	 
(B)   Total   intersection   of   Sholl   analysis   as   described   in   (A).   Replicate   values  
derived   from   individual   ddaC   neurons,   mean   and   SD   are   shown.    **,   ***  
represent  p  <  0.01,  0.001;;  one-­way  ANOVA  with  Dunnett’s  multiple  comparison  
test.    
  
Taken  together  we  found  that  the  partial  loss  of  function  G147W  and  K166del  
Membrin   mutations   exert   a   substantial   effect   upon   neuronal   growth   in  
Drosophila  model  neurons.  This  may  be  the  consequence  of  a  subtle  delay  in  
the   early   secretory   pathway,   thus   limiting   the   availability   of   plasma  
membrane,  which  can  be  added  to  the  growing  dendritic  arbor.  
To   test   whether   a   secretory   pathway   deficit   is   the   cause   of   the   observed  
dendrite  growth  deficits,   I  quantified   the  steady  state   levels  of   the  secretory  
pathway   dependent   CD4::tdGFP   model   cargo   in   proximal   dendrites   of  
GOSR2-­PME   model   Drosophila   (Figure   33A).   Indeed,   mean   fluorescence  
intensity   of   this   cargo   was   significantly   decreased   in   proximal   dendrites   of  
Mem-­K166del   (Figure   33A,   B).   Similarly,   CD4::tdGFP   levels   were  
significantly   reduced   in  proximal  ddaC  axons  of  Mem-­K166del   (Figure  33A,  
C).   It   has   to   be   noted,   however,   that   we   did   not   distinguish   between   cell  
surface   and   intracellular   fluorescence   in   this   experiment.   Thus,   an  
accumulation   of   pre-­Golgi   CD4::tdGFP   –   which   might   be   the   result   of   the  
Membrin  mutations   –  might   be   contributing   to   the   fluorescence   signal   and  
therefore   subtle   effects   could   be   masked.   A   way   to   circumvent   this   issue  
would  be  to  selectively  antibody  stain   the  extracellularly   located  GFP  tag  of  
cell   surface   localizing   CD4::tdGFP   by   omitting   detergent   in   the   staining  
protocol.  Another   potential   pitfall   is   that   I   quantified  neurites   in   proximity   to  
the  somatic  Golgi,  which  might  not  be  sensitive  enough   to  detect  a  smaller  
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effect  size,  such  as  we  would  expect  in  Mem-­G147W.  Indeed,  James  Jepson  
found  that  distal  axonal/synaptic  CD4::tdGFP  was  significantly  reduced  both  
in  Mem-­K166del  and  Mem-­G147W,  which  was   not   significantly   different   to  
Mem-­WT   proximally   in   neither   axons   nor   dendrites   (Figure   33).   James  
Jepson   also   found   that   the   endogenous   synaptic   cargo   cysteine   string  
protein  (CSP)  was  significantly  reduced  at  the  neuromuscular  junction  (NMJ)  
of  Mem-­G147W  and  Mem-­K166del   L3   larvae  when   compared   to  Mem-­WT  
(Figure  33F,  G).  
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Figure  33.  Steady-­state  dendritic,  axonal  and  synaptic  secretory  pathway  
deficits  
(A)   Maximum   intensity   projections   of   abdominal   segment   5   ddaC   neurons   in  
Mem-­WT,  Mem-­G147W  and  Mem-­K166del  L3   larvae  expressing   the  secretory  
pathway  dependent  CD4::tdGFP  model  cargo.  Arrowheads  indicate  axons.	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(B)   Mean   fluorescence   intensity   (MFI)   in   major   dendrites   within   37.5   µm  
distance  from  the  soma  center  of  neurons  as  described  in  (A).  Replicate  values  
were   derived   from   10   ddaC   neurons   per   genotype   (5   L3   larvae   each).  Mean  
and  SD  are  shown.  
(C)  Mean   fluorescence   intensity   (MFI)   in   the   axon  within   37.5  µm  distance   of  
the  soma  center  of  neurons  as  described  in  (A).  Replicate  values  were  derived  
from   10   ddaC   neurons   per   genotype   (5   L3   larvae   each).   Mean   and   SD   are  
shown.  
(D)   Quantification   of   CD4::tdGFP   fluorescence   in   ppk   neuron   axons   and  
synapses  in  the  L3  larval  VNC,  normalized  to  BRP,  as  shown  in  (E).  N  =  5,  6,  6  
for   Mem-­WT/-­G147W/-­K166del.   Replicate   values   derived   from   different   larval  
brains,  mean  and  SD  are  shown.  
(E)  Maximum   intensity  projections  of  distal  ppk  neuron  axons/synapses   reveal  
reduced   levels  of  CD4::tdGFP   in   the  VNC  of  Mem-­G147W  and  Mem-­K166del  
compared  to  Mem-­WT.  Neuropil  is  stained  with  anti-­BRP.  
(F)   NMJs  were   stained  with   anti-­CSP   and   anti-­horseradish   peroxidase   (HRP)  
antibody,  which   labels  neuronal  membranes  due   to  crossreactivity  with  certain  
surface   glycans   (Fabini   et   al.,   2001).   A   significant   reduction   of   CSP   levels   is  
apparent  in  Mem-­WT  as  compared  to  Mem-­G147W  and  Mem-­K166del.  
(G)  Quantification  of  experiment  as  shown   in  (F).  CSP  levels  were  normalized  
to   HRP   and   expressed   relative   to   Mem-­WT.   N   =   77/47/72   synaptic   boutons  
from  9/8/7  L3   larvae   for  Mem-­WT/-­G147W/-­K166del.  Replicate  values  derived  
from  individual  synaptic  boutons,  mean  and  SD  are  shown.  
**,   ***   represent   p   <   0.01,   0.001,   ns   =   not   significant   (p   >   0.05);;   one-­way  
ANOVA  with  Dunnett’s  multiple  comparison  test  (B-­D);;  Kruskal-­Wallis  test  with  
Dunn’s  post-­hoc  test  (G).  
Experiments  and  analysis  shown  in  (D-­G)  were  carried  out  by  James  Jepson.  
  
Importantly,  a  CD4::tdGFP  secretory  pathway   transport  deficit  might  not  be  
apparent  at  steady  state  but  only  when  its  trafficking  is  dynamically  studied.  
In  theory,  we  could  imagine  that  an  ER-­to-­Golgi  trafficking  deficit  would  result  
in  the  availability  of  fewer  post-­Golgi  carriers,  which  are  transported  from  the  
trans-­Golgi   network   to   the   dendritic   surface   and   thereby   enable   its   growth.  
Thus,  to  visualize  the  trafficking  of  CD4::tdGFP  I  photo-­bleached  abdominal  
segment  5  ddaC  soma  adjacent  major  dendrites.  A   large  dendritic   region  –  
contained   within   a   50   µm2   bleach   area   –   was   photo-­bleached   and   the  
recovery  measured  in  a  small  dendritic  region  25  µm  from  the  soma  (Figure  
34A).   This   approach   was   chosen   in   order   to   minimize   the   contribution   of  
lateral   diffusion   of   cell   surface   localized   CD4::tdGFP   into   the   quantified  
region.  After  all,  the  signal  of  interest  is  not  surface  localized  cargo  per  se  but  
CD4::tdGFP  molecules  which  are  trafficked  via  the  secretory  pathway  to  the  
dendritic   surface.   As   a   control   for   my   imaging   settings   I   also   quantified  
fluorescence   in   non-­bleached   dendrites,   which   remained   stable   over   the  
approximately   30   min   time   course   (Figure   34B).   Consistent   with   more  
profound  SNARE  and  secretory  trafficking  defects  in  Mem-­K166del  we  could  
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detect   a   clear   reduction   in   fluorescence   recovery   after   experimental   photo-­
bleaching   in   this   mutant   and   only   a   non-­significant   trend   towards   reduced  
recovery  in  Mem-­G147W  when  compared  to  Mem-­WT  (Figure  34C).    
  
Figure  34.  Dendritic  FRAP  in  Membrin  mutant  ddaC  neurons  
(A)  CD4::tdGFP  in  large  segments  of  major  ddaC  A5  dendrites  adjacent  to  the  
soma  were  photobleached  with  a  50  µm2  region  of  interest  (large  square  in  first  
column)   and   fluorescence   recovery   quantified   25   µm   from   the   soma  proximal  
bleach  margin  for  29.5  min.    
(B)   Non-­bleach   control   measurements   of   unbleached   dendrites.   Mean  
fluorescence   intensities   (MFI)   in   non-­bleached   regions   of   interest   of   5   ddaC  
neurons,   from   5   different   L3   larvae   per   genotype   were   pooled   in   this   graph.  
Mean  and  SD  are  shown.  
(C)   Average   FRAP   traces   of   experiment   as   described   in   (A).  Means   of   9/8/9  
abdominal   segment   5   ddaC   neurons,   from   9/8/9   different   L3   larvae   for  Mem-­
WT/-­G147W/-­K166del  are  shown.  */ns  indicate  endpoint  comparison  after  29.5  
min   recovery.   *   represents   p   <   0.05,   ns   =   not   significant   (p   >   0.05);;   one-­way  
ANOVA  with  Dunnett’s  multiple  comparison  test.  
  
In   summary,   I   found   reduced   dendritic   growth   in   Mem-­G147W   and   Mem-­
K166del,   which   is   likely   caused   by   reduced   cargo   trafficking   into   growing  
dendrites  as  a  result  of  partially  decreased  ER-­to-­Golgi  trafficking  rates.    
4.4.3.1          Overexpression  of  mutant  Membrin   in  class   IV  da  neurons  
causes  dendrite  growth  deficits  
Previous   organismal   data   suggested   that   mutant   Membrin   could   be  
overexpressed   in   otherwise   wild-­type   membrin   Drosophila   to   recapitulate  
aspects  of  GOSR2-­PME  in  a  genetically  more  simple  and  versatile  way  than  
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our   models   permit.   To   validate   the   idea   that   mutant   Membrin   transgenes  
could  serve  as  tools,  I  sought  to  also  study  their  effects  on  the  neuronal  level.  
Therefore,   I   overexpressed   wild-­type   and   mutant   Membrin   in   class   IV   da  
neurons   of   wild-­type   membrin   Drosophila.   To   visualize   ddaC   neurons   in  
abdominal  segment  5,  CD4::tdGFP  was  expressed  with  the  ppk  promoter  (as  
described  above).  This  experiment  revealed  that  also  simple  overexpression  
of  mutant  Membrin  –  when  compared  to  wild-­type  Membrin  overexpression  –  
is  sufficient  to  result  in  less  elaborate  dendrites  (Figure  35A).    
  
Figure  35.  Overexpression  of  mutant  Membrin  in  ddaC  neurons  
(A)   Maximum   intensity   projections   of   ddaC,   abdominal   segment   5   neurons.  
w[1118];;   ppk-­CD4::tdGFP;;   ppk-­Gal4   were   crossed   to   w[1118];;   UAS-­
membrin[WT]/[G147W]/[K166del],  iso31  or  w[1118];;  +;;  UAS-­RedStinger.  
(B)  Sholl   analysis  of   experiment   as  described   in   (A).  N  =  9,   7,   11,   9,   9  ddaC  
neurons   from   9/7/11/9/9   different   L3   larvae   for   iso31,   UAS-­RedStinger,   UAS-­
membrin[WT]/[G147W]/[K166del].   Replicate   values   derived   from   individual  
ddaC  neurons,  mean  and  SD  are  shown.  **,  ***  represent  p  <  0.01,  0.001;;  one-­
way  ANOVA  with  Tukey’s  multiple  comparison  test.  
  
To  rapidly  retrieve  quantitative  results  from  these  neurons,  I  performed  Sholl  
analysis   directly   from   thresholded   images   (Ferreira   et   al.,   2014).   This  
revealed   a   significantly   decreased   number   of   total   intersection   for   G147W  
and   K166del   when   compared   to   wild-­type   (Figure   35B).   Because   the  
mutations  only  affect   the  class  IV  da  neurons  in  this  experiment,   it  provides  
evidence   that   the   dendrite   growth   deficits   as   observed   in   GOSR2-­PME  
Drosophila  is  due  to  a  cell  autonomous  deficiency  and  not  due  to  e.g.  a  lack  
of  trophic  factors  from  other  cell  types  in  the  larval  body  wall.  Given  the  tight  
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connection   between   the   secretory   pathway   and   plasma   membrane  
expansion,  a  primarily  cell  autonomous  deficit  was  a  priori  most  likely,  which  
was   hereby   also   experimentally   confirmed.   The   relative   severity   of   the  
dendritic   growth   deficits   was   lower   in   the   overexpression   setting   when  
compared  to  the  GOSR2-­PME  models.  This  is  expected  and  consistent  with  
less  severe  organismal  phenotypes,  when  endogenous  Membrin   is  present  
(compare  Figure  28A,  Figure  27B).  Of  note,  also  overexpression  of  wild-­type  
Membrin   in   ddaC   neurons   induced   dendrite   growth   deficiencies,   thereby  
suggesting   that   increased   Membrin   levels   can   partially   impair   secretory  
trafficking,  potentially  by   interfering  with   the  trans-­Golgi  SNARE  complex  as  
an   inhibitory   (i-­)  SNARE  (Varlamov  et  al.,  2004).  This   is  apparent  when  we  
compare   wild-­type   Membrin   overexpressing   ddaC   neurons   with   ddaC  
neurons   where   only   CD4::tdGFP   and   Gal4   is   present   and   those,   with  
additional   expression   of   an   unrelated   RFP   and   a   nuclear   localization  
sequence   (Figure   35A,  B).   In   summary,   these   experiments   further   suggest  
that   mutant   Membrin   transgenes   can   readily   be   used   for   the   study   of  
GOSR2-­PME.   Furthermore,   it   highlights   how   increased   Membrin   levels   in  
itself   are   sufficient   to   partially   impair   dendritic   growth   and   confirmed   that  
Membrin   mutation   induced   dendrite   growth   deficits   are   due   to   cell  
autonomous  defects.    
4.4.4          Morphological   and   physiological   abnormalities   at   mutant  
Membrin  synapses  
While  dendritic   length  of  ppk   labelled  ddaC  neurons  was  greatly  reduced   in  
GOSR2-­PME  model  Drosophila,  James  Jepson  found  that  ppk  labelled  class  
IV  da  neuron  axon  bundles  (comprising  of  one  ddaC,  v’ada,  vdaB  axon  per  
hemisegment)   reached   their   target   synaptic   regions   in   the   center   of   the  
ventral   nerve   cord   (Figure   33E)   (Grueber   et   al.,   2007).   This   finding   clearly  
illustrates  that  axonal   length   is  preserved  in  class  IV  da  sensory  neurons  of  
GOSR2-­PME   Drosophila.   These   cells   have   elaborate   dendrites   and   long  
axons,  which  therefore  points  towards  a  preferential  vulnerability  of  dendrites  
due  to  Membrin  mutations.  Thus,  our  finding  underscores  results  from  Ye  et  
al.,  who   suggested   that   axonal   growth   is   less   vulnerable   to   early   secretory  
pathway  defects  than  dendritic  growth  (Ye  et  al.,  2007).  Nevertheless,  James  
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Jepson   found   a   clear   secretory   pathway   deficit   in   distal   axons,   as   steady  
state  levels  of  CD4::tdGFP  levels  were  significantly  reduced  in  Mem-­G147W  
and   Mem-­K166del   when   compared   to   Mem-­WT   (Figure   33D).   Because  
synaptic  development  and  function  are  highly  orchestrated  processes,  where  
many  proteins  must  be  provided  in  the  right  quantity  at  the  right  time  via  the  
secretory  pathway,  we  speculated  that  synaptic  integrity  might  be  altered  as  
a  result  of  the  pathogenic  Membrin  mutations.  In  order  to  evaluate  potential  
synaptic   morphological   abnormalities   in   GOSR2-­PME   Drosophila,   James  
Jepson   studied   the   NMJ   of   L3   larvae.   These   are   glutamatergic   contacts  
between  motoneurons  and  body  wall  muscles,  which  have  been  widely  used  
as   model   synapses   due   to   their   large   size   and   ease   of   experimental  
manipulation   (Harris  and  Littleton,  2015).  Strikingly,   James  Jepson   found  a  
host   of   abnormalities   at   mutant   Membrin   NMJs,   including   elongated  
protrusions   reminiscent   of   collapsed   boutons,   synaptic   retraction,   and  
cytoskeletal  abnormalities  (Figure  36A-­D  and  data  not  shown).  
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Figure  36.  Structural  abnormalities  at  GOSR2-­PME  model  NMJs  
(A)   Muscle   6/7,   abdominal   segment   3   NMJs   were   stained   with   an   anti-­HRP.  
Maximum   intensity   projections   of   confocal   z-­stacks   show   rounded   boutons   in  
Mem-­WT   and   elongated   terminal   protrusions   in   Mem-­G147W   and   K166del.  
Arrowheads   indicate   isolated   boutons,   which   are   indications   of   synaptic  
retraction  and  was  was  further  investigated  in  (C)  and  (D).  
(B)   Quantification   of   experiment   as   described   in   (A).   N   =   32,   31,   31   scored  
NMJs   from  21/19/20  different  L3   larvae   for  Mem-­WT/-­G147W/-­K166del.  Mean  
and  SEM  are  shown.  
(C)   Apposition   between   pre-­   and   postsynaptic   membranes   was   evaluated   by  
co-­staining   the   presynaptic   active   zone   protein   Bruchpilot   (BRP)   and   the  
postsynaptic   glutamate   receptor   (GLURIII).   Arrowheads   indicate   synaptic  
retraction,  where  GLURIII  lacks  its  presynaptic  active  zone.  
(D)  Quantification  of  experiment  as  described  in  (C).  N  =  14,  13,  12  NMJs  from  
9/8/9  L3   larvae   for  Mem-­WT/-­G147W/-­K166del.  Replicate  values  derived   from  
individual  NMJs,  mean  and  SEM  are  shown.  
*,**  represent  p  <  0.05,  0.01;;  Kruskal-­Wallis  test  with  Dunn’s  post-­hoc  test.  
These  experiments  were  carried  out  and  analysed  by  James  Jepson.  
  
These  morphological  changes   in  GOSR2-­PME  Drosophila  and   the   fact   that  
human   patients   suffering   from   this   disorder   are   profoundly   hyperexcitable  
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suggested  to  us   that  also  synaptic  physiology  might  be  altered.  This   is  why  
Simon   Lowe   extended   these   morphological   studies   by   evaluating   synaptic  
transmission  at  this  NMJ  model  synapse.  He  found  a  significant  decrease  in  
spontaneous  neurotransmitter  release  in  mutant  animals  (Figure  37A,  B).   In  
addition,   Mem-­G147W   and   Mem-­K166del   displayed   a   striking   effect   of  
hyperactive   evoked   synaptic   transmission.   Muscular   responses   to   supra-­
threshold   stimulation   of   the   innervating   nerve   frequently   resulted   in  
dysmorphic   and   broadened   excitatory   postsynaptic   potentials   (EPSPs),  
which  was  particularly  striking  under  10  Hz  repetitive  stimulation  (Figure  37C,  
D).  
  
Figure  37.  Hyperactive  GOSR2-­PME  model  NMJs  
(A)   mEPSP   traces   of   Mem-­WT/-­G147W/-­K166del   recorded   from   muscle   6,  
abdominal  segments  2-­4.  
(B)  Cumulative  frequency  of  mEPSP  inter-­event  interval  times  of  recordings  as  
shown  in  (A).  800  mEPSPs  from  8  animals  per  genotype  were  analysed.  
(C)   EPSPs,   evoked   by   5   stimuli   at   10   Hz,   were   recorded   from   muscle   6,  
abdominal   segments   2-­4.   Example   traces   are   shown,   ranging   from   normal   to  
severely  distorted  shapes.  Traces  are  normalized  to  the  peak  amplitude.  
(D)   EPSP   train  morphology  was   classified   by   a   blinded   observer.   10   animals  
per  genotype  were  recorded  and  for  each  of  them  15  EPSP  trains  analyzed.  
***   represents   p   <   0.001;;   Kolmogorov-­Smirnov   test   and   Bonferroni   correction  
(B),  Fisher’s  exact  test  and  Bonferroni  correction  (D).  
These   experiments   were   carried   out   and   analysed   by   Simon   Lowe   in   James  
Hodge’s  and  Maria  Usowicz’s  lab.  
  
Thus,   the   PME   causing  Membrin  mutations   not   only   significantly   disturbed  
dendritic   development   in   our   Drosophila   models,   but   also   caused  
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morphologically  and  physiologically  abnormal  synapses.  This  finding  not  only  
contributes   to   our   understanding   of   how   Membrin   mutations   cause   a  
hyperexcitable   nervous   system   but   also   suggests   a   tight   dependence   of  
synaptic  integrity  upon  efficient  secretory  trafficking.  
Interestingly,   I   have   also   detected   overexpressed   Membrin   in   axons   and  
synapses  of  Drosophila  neurons  (Figure  38A,  B).  
  
Figure  38.  Axonal  and  synaptic  localization  of  overexpressed  Membrin  
(A)  Wild-­type  FLAG::Membrin  was  co-­overexpressed  with   the  synaptic  marker  
nsyb::GFP   utilizing   the   nompC-­Gal4   driver.   Maximum   intensity   projections  
indicating  overlap  between  the  FLAG  and  GFP  signals  in  the  ellipsoid  body  (EB,  
*)  and  antennal  mechanosensory  and  motor  center  (AMMC,  **)  are  shown.  
(B)  Single  confocal  slices  in  the  AMMC  of  a  Drosophila  brain  as  described  in  (A)  
are  depicted.   In  several   instances  colocalization  between  FLAG::Membrin  and  
nsyb::GFP  is  apparent  (arrowheads).  
(C,  D)  Wild-­type  or  mutant  Membrin  was  overexpressed  with   the  nompC-­Gal4  
driver   and   EB   MFI   quantified   from   maximum   intensity   projections.   N   =   8  
Drosophila  brains  per  genotype.  Replicate  values  from  individual  brains,  mean  
and   SD   are   shown.   *,   ***   represent   p   <   0.05,   0.001;;   one-­way   ANOVA   with  
Dunnett’s  multiple  comparison  test.  
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At   present   it   is   unclear  whether   this   represents   spill-­over   from   the   somatic  
Golgi   due   to   artificially   high   expression   levels   or   reflects   the   localization   of  
endogenous  Membrin.   If  Membrin   indeed   localizes   to   this   compartment  we  
could  imagine  a  local  ERGIC  or  Golgi-­like  function,  which  is  suggested  by  the  
observation   that   axons   contain   several   key   components   of   the   secretory  
pathway   (González   et   al.,   2016).   This   could   serve   as   an   additional  
explanation   for   the   observed   synaptic   abnormalities.   Interestingly,   G147W  
mutant   Membrin   localized   to   the   synapse   to   greatly   decreased   amounts,  
while  K166del  mutant  Membrin  was  only  subtly   reduced  when  compared   to  
wild-­type   (Figure   38C,   D).   Thus,   G147W/G144W   might   confer   additional  
pathogenicity   by   this   localization   defect.   In   order   to   unambiguously   study  
such  a  potential  local  axonal/synaptic  role  of  Membrin,  additional  Drosophila  
models   with   lower   expression   levels   would   need   to   be   created.   Therefore  
knock-­in   fly   lines   would   be   the   ideal   tools,   which   should   also   be   epitope  
tagged  to  allow  for  unambiguous  immuno-­staining.  
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4.5          Discussion  
In   this   study,  we  developed   the   first  multicellular   in   vivo  model   of  GOSR2-­
PME,  which  was  an  important  step  towards  uncovering  disease  mechanisms  
that   are   less   intuitively   inferable   from   the   sequence   alterations   and   more  
informative   as   to   what   the   neuronal   bottleneck   might   be.   Previous  
investigations   into   the   molecular   consequences   of   the   GOSR2-­PME  
mutations  carried  out  by  Nancy  Malintan  revealed  that  these  mutations  cause  
a   partial   SNARE   domain   deficit   in   the   yeast   orthologue   Bos1   and   by  
inference  the  Drosophila  and  mammalian  Membrin  SNARE  motifs.  
4.5.1          The  choice  of  in  vivo  model  system  
After  careful  consideration  we  chose  Drosophila  as  our  prime  model.  ER-­to-­
Golgi   trafficking   is   a   highly   conserved   fundamental   mechanism   in   all  
eukaryotic   cells,   which   is   illustrated   by   the   fact   that   several   of   its   key  
molecular  players  were   first   identified   in  yeast   (Bonifacino  and  Glick,  2004;;  
Novick   et   al.,   1980).   Importantly,  Drosophila,   as   well   as   yeast,   contains   a  
single  Membrin  orthologue  and  no   redundancy   for   this  protein   is  present   in  
the  human  genome.  Thus,  Drosophila,  with   its   powerful   genetics  and   rapid  
life  cycle,  appeared  as  the  ideal   ‘minimal’  model  to  gain  critical   insights   into  
the   neuronal   consequences   of   the   GOSR2-­PME   mutations.   It   facilitated  
expression  of  transgenic  wild-­type  or  mutant  Membrin  variants  in  flies  where  
no  endogenous  wild-­type  Membrin  was  present,  which  could  have  otherwise  
potentially  masked  effects  of  the  mutations.  In  this  system,  human  Membrin  
was  capable  of  partially   functionally   replacing   its   fruit   fly  orthologue,   further  
supporting   the   validity   of   our   approach.   However,   this   was   only   an  
incomplete   rescue,   as   human   GOSR2   expressing   membrin   null   animals  
usually  died  within  three  days  after  eclosion  from  their  pupal  case.  While  this  
early   lethality   represents   a   profoundly   reduced   adult  Drosophila   life   span,  
human   GOSR2   nevertheless   was   capable   of   extending   the   viability   of  
membrin   null   animals   approximately   10-­fold,   as   they   otherwise   died   as   L1  
larvae.  Thus,   this  genetic  evidence  suggests   that  human  Membrin  might  be  
functionally   incorporated   into   the  Drosophila  cis-­Golgi  SNARE  complex  and  
thereby  mediate  ER-­to-­Golgi  membrane  fusion.  While  12  of  the  16  interacting  
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layer  amino  acids   in   the  SNARE  motifs  of  human  and  Drosophila  Membrin  
are  conserved,  4  are  not   (Figure   5).   It   is   therefore  conceivable   that  human  
Membrin   in   the   Drosophila   cis-­Golgi   SNARE   complex   might   change   the  
functional   properties   of   this   complex   –   such   as   force   generation   during  
SNARE   zippering,   overall   SNARE   complex   stability   and/or   recycling   of   the  
SNARE   complex   after   a   completed   round   of   fusion   –   and   thus   ultimately  
impair   secretory   trafficking.   Therefore,   in   order   to   evaluate   the   human  
GOSR2-­PME  mutations  in  a  more  physiologic  approach,  we  utilized  wild-­type  
or   mutant   Drosophila   Membrin   to   rescue   homozygous   membrin   null  
animals.Lessons  from  organismal  Drosophila  phenotypes  
Remarkably,  the  Membrin  mutations  resulted  in  dramatic  phenotypes  also  in  
Drosophila,  with  premature   lethality,   locomotor  and  seizure-­like  phenotypes,  
thereby   recapitulating   key   aspects   of   the   disorder   in   human   patients.   The  
early   onset   of   symptoms   in   GOSR2-­PME   patients   and   early   organismal  
abnormalities   in   the   Drosophila   models   suggested   developmental  
abnormalities   as   a   source   of   the   phenotypes.   Because  GOSR2-­PME   is   a  
neurological   syndrome,   we   hypothesized   that   aspects   of   neuronal  
development   might   be   impaired.   This   idea   was   further   reinforced   by   the  
finding   that   nervous   system   restricted   over-­expression   of   mutant   Membrin  
was  sufficient  to  recapitulate  early  adult  lethality  as  observed  in  GOSR2-­PME  
Drosophila.  However,   these  experiments  do  not  establish  whether  neuronal  
Membrin  mutations  are  also  necessary  to  cause  the  organismal  phenotypes,  
which  can  readily  be  tested  in  Drosophila  by  overexpressing  mutant  Membrin  
in   the   entire   animal   except   the   nervous   system.   Therefore,   the   global   da-­
Gal4   driver   could   be   used   and   Gal4   selectively   inhibited   in   the   nervous  
system   with   elav-­Gal80   (Suster   et   al.,   2004).   Should   also   these   genetic  
modifications  yield  pharate  adult  stage   lethality  we  know   that  also  Membrin  
mutations   in  non-­neuronal  cell   types  can  give   rise   to   this  phenotype,  which  
could  then  be  further  dissected  with  tissue  specific  Gal4  driver  lines.  
Both   Membrin   mutations   only   partially   rescued  membrin   null   animals   and  
global  Membrin  knockdown  had  similar  phenotypic  consequences.  Therefore  
our  Drosophila   phenotypic   data   also   provide   genetic   support   for   the   notion  
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that   the   disease   mutations   confer   partial   (not   complete)   loss   of   function,  
which  is  consistent  with  Nancy  Malintan’s  yeast  liposome  fusion  studies.    
4.5.2          Considerations  about  the  GOSR2-­PME  Drosophila  model  
In   our   Drosophila   GOSR2-­PME   models   and   their   control   –   in   shorthand  
termed   Mem-­G147W   (orthologous   to   human   G144W),   Mem-­K166del  
(orthologous  to  human  K164del)  and  Mem-­WT  –  the  effects  of  the  mutations  
are   studied   separately.   We   do   not   take   into   account   the   compound  
heterozygous  state  of  G144W-­K164del.  It  has  to  be  noted  however,  that  the  
Mem-­K166del   model   does   not   reflect   any   known   human   patient.   This  
mutation   has   a   greater   impact   upon   the   Bos1/Membrin   SNARE   domain  
function   and,   judging   from   the   profound   reduction   of   steady   state   dendritic  
and  axonal  CD4::tdGFP,  upon  Golgi  trafficking.  Therefore  I  hypothesize  that  
a  K164del  GOSR2  homozygous  patient  might  present  with  a  different  clinical  
syndrome,   which   might   also   include   abnormalities   in   other   highly   Golgi-­
dependent   organ   systems.   Paradoxically,   the   compound   G144W-­K164del  
GOSR2-­PME  patient  did  not  have  a  more  severe  phenotype  when  compared  
to   G144W   homozygous   patients,   but   a   slightly   milder   presentation.   This  
patient   lived   beyond   60   years   of   life   as   opposed   to   several   homozygous  
G144W  GOSR2-­PME  patients  who  died  prematurely  around  30  years  of  age  
(Boissé  Lomax  et  al.,  2013;;  Praschberger  et  al.,  2015).  However,  it  has  to  be  
noted   that   this   observed   difference  might   simply   reflect   an   outlier   within   a  
very  small  patient  cohort  (less  than  20  reported  cases).  Besides,  the  relative  
contribution   of   the   K164del   Membrin   allele   to   the   phenotype   might   be  
marginal,  as  a  less  disrupted  G144W  Membrin  allele  was  also  present  in  this  
patient.  
Our   Drosophila   model   also   does   not   take   into   account   reduced   G144W  
Membrin   levels  as  observed   in  patient   fibroblasts,   as  expression   levels  are  
artificially   high.   Should   decreased   G144W   Membrin   levels   indeed   be  
functionally   relevant   –   which   thus   far   is   unresolved   –   it   would   further  
aggravate  the  effects  as  seen  in  Mem-­G147W.  Therefore,  if  reduced  G144W  
Membrin   levels   contribute   to  GOSR2-­PME,   our  Mem-­G147W  model   would  
underestimate   the   severity   of   G144W   and   does   not   bear   the   danger   of  
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aggravating,   or   providing   false   positive   results.   Nevertheless,   we   detect   a  
clear   difference   between   Mem-­G147W   and   Mem-­WT,   which   is   the   ideal  
internal   control,   given   that   these   flies   are   genetically   identical   except   the  
absence   of   the   pathogenic   single   codon   alteration.   Thus,   all   observed  
differences   are   directly   attributable   to   the   respective  GOSR2-­PME   disease  
mutations  in  our  Drosophila  models.  Because  our  Mem-­G147W  model  shows  
clear  organismal  and  cellular  phenotypes  while  having  high  expression  levels  
of  the  mutant  protein,  we  can  infer  that  the  SNARE  domain  defect  in  itself  is  
highly  deleterious.  Nevertheless,   it  would  be  an  interesting  avenue  of   future  
research   to   further   investigate   the   potential   pathogenicity   of   reduced  
amounts   of   Membrin   due   to   the   G144W  mutation,   as   observed   in   patient-­
derived   fibroblasts.   Therefore,   Drosophila   phenotypes   as   a   function   of  
varying  degrees  of  RNAi  mediated  Membrin  knock-­down  could  be  evaluated.  
For  this  purpose,  different  RNAi  targets  within  the  Membrin  mRNA  could  be  
utilized   as  well   as   varying   ambient   temperatures   of   the   necessary   crosses  
(da-­Gal4   X   UAS-­Membrin   RNAi),   which   changes   the   activity   of   Gal4   and  
therefore  will  impact  the  degree  of  knock-­down  (Duffy,  2002).  
I   also   note   that   Mem-­WT   controls   are   not   entirely   wild-­type   but   suffer  
presumably   from   mild   secretory   pathway   impairment.   This   is   likely   due   to  
artificially  high  Membrin   levels   in   this  control   line,  which  has  been  shown   in  
yeast   liposome   fusion  studies   to  harbor   the  potential  of   inhibiting   the   trans-­
Golgi   SNARE   complex   in   a   concentration-­dependent  manner   (Varlamov   et  
al.,   2004).   Consistently,   we   observed   that   Mem-­WT   animals   sometimes  
exhibited   downward   turned   wings,   low   penetrance   dendrite   growth   and  
synaptic  morphological  abnormalities  and  also  NMJ  physiological  alterations.  
Importantly   however,   phenotypic,   cellular   and   physiological   abnormalities  
were  strikingly  worse  in  either  mutant  and  these  effects  can  thus  directly  be  
attributed  to  the  disease  mutations.  
4.5.3          Dendrite  growth  deficits  
Utilizing   our  GOSR2-­PME   Drosophila   models   we   were   able   to   show   that  
these   mutations   cause   substantial   dendritic   growth   deficits   in   genetically  
labeled  model   neurons.   These   results   build   upon   the   findings   of   Ye   el   al.,  
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who  discovered  in  a  Drosophila  dendritogenesis  screen  that  mutations  in  the  
ER-­to-­Golgi   transport   proteins   Sec23,   Sar1   and   Rab1   severely   interfered  
with  dendritic  outgrowth   (Ye  et  al.,  2007).  Membrin   is   involved   in   the  same  
trafficking   step   and   thought   to  mediate   its   final   task   –  membrane   fusion   of  
transport   carriers   with   ERGIC   and   Golgi   membranes   and   thereby   the  
deposition   of   anterograde   cargo   into   these   compartments.   Consistent   with  
the  previously  established   importance  of  ER-­to-­Golgi   trafficking   for  dendritic  
growth,   we   also   found   significantly   shorter   dendrites   in   Membrin   mutant  
Drosophila.   Importantly,   because   our   results   are   based   on   the   study   of   a  
Mendelian  human  disorder,  we  thereby  provide  proof  of  principle  that  this  key  
cellular   pathway   can   be   directly   relevant   for   understanding   the  
pathophysiology  of  a  neurological  disease.    
Interestingly,  other  Mendelian  human  disorders  due  to  ER-­to-­Golgi  trafficking  
mutations  in  Sec23A,  Sec23B,  Sec24D  and  Sar1b  present  with  largely  non-­
neuronal  clinical  phenotypes  of  cranio-­lenticulo-­sutural  dysplasia,  congenital  
dyserythropoietic  anemias,  a  syndromic  form  of  osteogenesis  imperfecta  and  
lipid  absorption  disorders  (Annesi  et  al.,  2007;;  Bianchi  et  al.,  2009;;  Boyadjiev  
et  al.,  2006;;  Garbes  et  al.,  2015;;  Jones  et  al.,  2003;;  Schwarz  et  al.,  2009).  
This  appears  to  be  a  consequence  of  tissue-­specific  differential  utilization  of  
the  two  available  isoforms  of  Sec23  and  Sar1  and  special  demands  upon  the  
COPII  coat  due  to  the  large  size  of  procollagen  and  chylomicrons  (Canty  and  
Kadler,  2005;;  Fromme  et  al.,  2008;;  2007;;  Jones  et  al.,  2003).    
A   dendritic   growth   bottle-­neck   as   observed   in   our   GOSR2-­PME   model  
Drosophila  directly  links  back  to  the  human  disease  phenotype  and  provides  
a   potential   high-­level   mechanism   for   one   of   its   hallmarks,   i.e.   ataxia.   If  
Membrin   mutations   cause   reduced   dendritic   growth   due   to   limited   lipid  
supplies   during   times   of   fast   surface   expansion,   we   would   expect   that  
neurons  with   the   largest   dendritic   arbors  would   be   affected  most   severely.  
One   such   neuron   subtype   with   a   particularly   large   dendritic   arbor   is   the  
cerebellar   Purkinje   cell   (Ramón   y   Cajal,   1906).   These   neurons   and   their  
cognate  brain  structure  –  the  cerebellum  –  are  critical   for  motor  control  and  
their  dysfunction  are   tightly   linked   to  many  ataxias   (Cerminara  et  al.,  2015;;  
Kasumu   and   Bezprozvanny,   2010).   Interestingly,   cerebellar   defects   have  
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also   been   implicated   in   the   generation   of   cortical   myoclonus,   which   is  
another  clinical  hallmark  of  GOSR2-­PME  (Ganos  et  al.,  2014).  In  Drosophila  
the  idea  that  neurons  with  larger  dendritic  arbors  are  more  severely  affected  
by  Membrin  mutations  could  be  experimentally  addressed.  Therefore,  highly  
elaborate  class   IV  da  neurons  (as  studied  here)  could  be  compared   to   less  
elaborate  sensory  body  wall  neurons,  such  as  class   I-­III  da  neurons,   in   the  
presence  of  Membrin  mutations  (Grueber  et  al.,  2002).  
4.5.4          Partial  ER-­to-­Golgi  delays  are  sufficient   to   impair  dendrite  
growth  
Importantly,   the   impact   of   the   Membrin   PME   mutations   upon   dendritic  
development  also  extends  previous  findings,  because  it  clearly  demonstrates  
that  also  partial  delays  –  and  not  only  a  very  large  or  complete  block  –  in  ER-­
to-­Golgi   transport  can  be  sufficient   to  significantly   impact  neuronal   integrity.  
Such  subtle  defects  in  this  core  cell  biological  process  are  more  likely  to  be  
relevant   for  human  disorders  as  opposed   to  a  complete  block,  which  would  
presumably  cause  zygotic  or  early  developmental  lethality.  Intriguingly,  while  
we   could   clearly   detect   a   secretory   pathway   deficit   in   Membrin   mutant  
neurons,   ER-­to-­Golgi   trafficking   was   almost   indistinguishable   in   G144W  
mutant   Membrin   fibroblasts   when   compared   to   healthy   controls.   Neurons  
have   extremely   large   secretory   pathway   demands,   as   their   lipid   surface   is  
several   orders   of  magnitude   larger   than   in   non-­neuronal   cells   (Horton   and  
Ehlers,   2004).   Therefore,   our   finding   lends   experimental   support   to   the  
postulated   idea   that   because   of   special   neuronal   demands   upon   the  
secretory   pathway,   even   subtle   alterations   could   result   in   a   selective  
neurological   disorder  while   falling  below  a  critical   threshold   in  other  organs  
(Pfenninger,  2009).  This  notion  in  turn  provides  an  attractive  solution  for  the  
seeming   paradox   of   how   mutations   in   this   ubiquitously   important   protein  
could   give   rise   to   a   selective   neurological   condition.   The  G144W  Membrin  
SNARE   motif   mutation   appears   to   only   very   subtly   alter   ER-­to-­Golgi  
trafficking   rates   –   at   the   edge   of   detection   thresholds   of   common   assays  
used   in   this   study   –  which   therefore   likely   only   affects   cell   types  with   high  
rates   of   secretion.   Non-­neuronal   cell   types   with   such   characteristics   might  
also   display   altered   trafficking   kinetics  without   leading   to   clinical   symptoms  
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due  to  smaller  temporal  constraints  than  those  imposed  by  a  growing  neuron.  
For   example,   plasma   or   exocrine   pancreas   cells   have   high   secretory  
demands,   but   GOSR2-­PME   patients   are   not   reported   to   have   immuno-­
deficiency   or   exocrine   pancreas   insufficiency   (Boissé   Lomax   et   al.,   2013;;  
Farquhar   and   Palade,   1981;;   Palade,   1975).   We   can   easily   imagine   a  
scenario  where  antibody  and  digestive  enzyme  secretion  is  subtly  delayed  in  
these   patients,   which   however   might   not   be   physiologically   relevant.   An  
antibody   that   is  available   in   the  plasma  or  a  digestive  enzyme   in   the  small  
intestine   with   a   30   min   delay   as   compared   to   a   healthy   human  might   not  
significantly   change   the   fate   of   combating   a   viral   infection   or   significantly  
impact  the  digestion  of  a  meal.  
4.5.5          Privileged  axonal  growth  
Our   study   also   reinforces   further   findings   of   Ye   et   al.,   who   proposed   that  
axonal  growth  can  be  privileged  in  the  face  of  secretory  pathway  defects  (Ye  
et   al.,   2007).   Consistent   with   this   notion   James   Jepson   found   in   Mem-­
G147W  and  Mem-­K166del  that  class  IV  da  neuron  axon  bundles  (comprising  
of   ddaC,   v’ada,   vdaB   neuron   axons)   still   managed   to   reach   their   distant  
ventral   nerve   cord   targets.   The   mechanism   of   how   axonal   growth   is  
preserved  while  dendritic  growth  is  reduced  during  limitations  in  lipid  supplies  
is   currently   unclear.   It   has   been   proposed   that   higher   endocytosis   rates   in  
dendrites   might   account   for   this   effect   (Zhong,   2011).   Nevertheless,   the  
secretory   pathway   clearly   is   also   required   for   axonal   outgrowth   because  
Brefeldin  A   treatment  as  well   as  early  developmental  Sar1b  knock-­down   in  
mammalian   neuronal   cultures   resulted   in   reduced  axonal   outgrowth   (Aridor  
and  Fish,  2009;;  Jareb  and  Banker,  1997).  The  notion   that  also  axons  have  
high   trafficking  demands   is   illustrated  by  James  Jepson’s   finding   that  while  
class  IV  da  neuron  axons  still  reached  their  distant  targets  in  membrin  mutant  
Drosophila,   they   displayed   significant   steady-­state   reductions   of   secretory  
pathway   dependent   cargo   in   the   larval   ventral   nerve   cord.   Such   secretory  
pathway   deficits   in   distal   axons   and/or   synapses   suggested   that   also  
synapses  might  be  impaired  as  a  consequence  of  delayed  cargo  delivery.  
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4.5.6          Synaptic  abnormalities  
We  not  only  found  that  the  partial  loss  of  function  Membrin  mutations  impair  
dendritic  growth  but   that   they  also  disrupt  synaptic   integrity.   James  Jepson  
performed   a   comprehensive   structural   investigation   of   the   neuromuscular  
junction   (NMJ)   synapse,   which   revealed   several   salient   abnormalities.  
Amongst   them   were   malformed   boutons,   pre-­synaptic   retraction   and  
cytoskeletal  fragmentation.  An  interesting  parallel  of  these  NMJ  abnormalities  
in   our   disease   model   has   been   reported   in   the   human   disorder.   Some  
GOSR2-­PME   patients   displayed   signs   of   ongoing   denervation   in   needle  
electromyography   (EMG)   studies   (van   Egmond   et   al.,   2014).   Importantly,  
Simon  Lowe  found  at  the  NMJ  of  GOSR2-­PME  Drosophila  also  physiological  
defects.   Spontaneous   release   was   reduced   and   evoked   synaptic  
transmission  appeared  hyperactive,  which  was  particularly  pronounced  under  
repetitive  stimulation.  Given  that  Membrin  is  a  ubiquitously  important  protein  
critical   for   the   basic   cell   biology   of   every   neuron   we   can   infer   that   similar  
structural   and   physiological   synaptic   changes   might   also   affect   central  
synapses   of  GOSR2-­PME  model   flies   and   human   patients.   Such   synaptic  
abnormalities   in   turn   would   likely   contribute   to   the   severe   neurological  
phenotype   of   GOSR2-­PME   patients.   Given   that   the   core   neurological  
features   of   GOSR2-­PME   are   of   central   origin,   it   would   be   important   to  
address   whether   the   morphological   and   physiological   synaptic   changes   at  
the  NMJ  model  synapse  indeed  also  affect  excitatory  and  inhibitory  synapses  
of  the  central  nervous  system  in  our  Drosophila  models.    
The   GOSR2-­PME   models   revealed   that   synaptic   integrity   depends   upon  
tightly   controlled   ER-­to-­Golgi   trafficking   rates,   which   is   a   notion   that   has  
received   little   attention   thus   far   and   might   have   broad   physiological  
relevance.  It  is  not  all  too  surprising,  if  we  consider  that  synapses  are  highly  
specialized  neuronal  domains  with  many  resident  proteins  that  are  secretory  
pathway  dependent  (Wilhelm  et  al.,  2014).  Given  that  Membrin  is  a  cis-­Golgi  
gatekeeper  for  all  these  proteins  it  is  unlikely  that  individual  proteins  mediate  
these   cellular   phenotypes   but   rather   the   complex   interaction   of   several   of  
them.   Presumably   synaptic   proteins  with   the   highest   turn-­over   and   tightest  
temporal  constrains  will  contribute  to  the  synaptic  abnormalities  as  observed  
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in  GOSR2-­PME  model  Drosophila.   It   is   conceivable   that   changes   in   trans-­
synaptic   anchoring   proteins,   ion   channels,   trophic   factors   and   cytoskeleton  
regulating   proteins   could   lead   to   synaptic   retraction,   changes   in   excitability  
and  morphology  of  the  GOSR2-­PME  model  NMJ.  Given  the  vast  number  of  
synaptic   proteins   that   are   secretory   pathway   –   and   thus   Membrin   –  
dependent,  unbiased  synaptic  proteomics  in  these  mutants  might  be  able  to  
point   towards   critical   candidates.   In   addition,   an  EM  based   investigation   of  
the   ultrastructural   changes   at   the   NMJs   and   brains   of   our   GOSR2-­PME  
models   might   yield   further   mechanistic   insights   into   the   observed   synaptic  
defects.   To   further   dissect   the   relative   contribution   of   the   pre-­   vs.   the  
postsynapse,  Membrin  mutations  should  selectively  be  introduced  either  into  
glutamatergic   neurons   or   muscle   and   the   resulting   NMJ   abnormalities  
evaluated.   A   very   elegant  way   to   establish   the   genetics   of   this   experiment  
would   be   to   replace   endogenous  membrin   by   a   cassette   containing   FRT  
flanked  wild-­type  membrin  upstream  of  G147W  or  K166del  mutant  membrin  
(Baena-­Lopez   et   al.,   2013).   Motoneuron   or   muscle   specific   expression   of  
flippase  would   then   yield   animals   that   express  mutant  Membrin   only   in   the  
pre-­   or   postsynaptic   cells   of   the   NMJ   in   an   otherwise   wild-­type   Membrin  
animal.  
In  summary,  the  development  of  Drosophila  models  of  GOSR2-­PME  allowed  
us   extend   our   investigations   at   the   protein   and   basic   cellular   levels   and  
unravel   the   disease   mechanisms   which   lie   at   the   heart   of   neuronal  
dysfunction  of   this   severe  ataxia-­epilepsy  syndrome.  We   therefore  are  now  
left  with  a  deeper  understanding  of  this  disorder  at  the  molecular,  cellular  and  
neuronal   levels,   which   will   be   summarized   in   Chapter   5.   In   addition,   I   will  
discuss  lessons  for  neuronal  cell  biology  learned  from  GOSR2-­PME  and  how  
the  disease  mutations  might  serve  as  novel  tools  for  future  research.    
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Chapter  5.            Concluding  remarks  
The   main   aim   of   this   PhD   project   was   to   shed   light   upon   the   unresolved  
disease  mechanism  of  GOSR2-­PME.  Prior  to  our  functional   investigations,  I  
have  expanded   the  genetics   of   this   disorder   by   the  novel  K164del   disease  
allele,  and  thereby  facilitated  our  subsequent  work  by  being  able  to  compare  
the   novel   with   the   previously   reported  G144W  mutation.   The   key   scientific  
challenge  we  faced  was  how  mutations   in   the  ubiquitously   important  ER-­to-­
Golgi  SNARE  protein  Membrin  could  be  reconciled  with  an  almost  exclusive  
neuronal   phenotype.   A   priori,   one   can   speculate   that   such   selective  
vulnerability  could  either  originate   in  particularly  high  demands  of  Membrin-­
mediated   processes   within   the   nervous   system   or   alternatively   in   an  
additional,  nervous  system  specific  function  of  wild-­type  or  mutant  Membrin.  
5.1          The  GOSR2-­PME  disease  mechanisms  
By  utilizing  a  multi-­layered  approach  spanning  from  molecule  to  organism  we  
have   provided   evidence   for   the   prior   notion.   Nancy   Malintan’s   work   has  
revealed  partial  SNARE  defects   in   liposome  fusion  studies  conferred  by  the  
yeast   orthologous   GOSR2-­PME   mutations.   These   mutations   were  
nevertheless   substantial   enough   to   severely   disturb   dendritic   growth   and  
synaptic   integrity   in  Drosophila.   Intriguingly,   the  G144W  Membrin  mutation  
did   not   cause   significantly   delayed   ER-­to-­Golgi   trafficking   rates   in   a   non-­
neuronal   cell   type,   which   therefore   suggests   that   the   selective   nervous  
system   vulnerability   as   observed   in  GOSR2-­PME   might   have   its   origin   in  
uniquely  high  Golgi  trafficking  demands  of  neurons  (Horton  and  Ehlers,  2004;;  
Pfenninger,   2009).   Our   work   has   thereby   not   only   provided   a   possible  
explanation   for   the  central  paradox  of   this  disease  but  also  yielded   insights  
into   the   pathophysiology   GOSR2-­PME   at   multiple   levels,   ranging   from  
protein   dysfunction   to   higher   level   neuronal   circuit   disturbances   (for   a  
summary  illustration  see  Figure  39).    
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Figure  39.  GOSR2-­PME  pathophysiology  summary  
The  missense  (blue)  and  deletion  (red)  mutations  are  shown  in  a  portion  of  the  
Membrin/Bos1  SNARE  domain  of  Homo  sapiens  (Hs),  Drosophila  melanogaster  
(Dm)  and  Saccharomyces  cerevisiae  (Sc).  These  changes  are  thought  to  result  
in   reduced   cis-­Golgi  membrane   fusion.  While   the   effects   of   the  GOSR2-­PME  
mutations   appear   to   fall   below   a   critical   threshold   in   non-­neuronal   cells,   they  
severely   impair   neurons.   The   core   findings   in   GOSR2-­PME   Drosophila   of  
reduced   dendritic   growth,   synaptic   retraction   (by   James   Jepson)   and  
hyperactive   evoked   neurotransmission   (by   Simon   Lowe)   are   depicted.   Such  
changes   ultimately   give   rise   to   severe   ataxia   and   profound   nervous   system  
hyperexcitability.  
  
5.1.1          The  molecular  mechanism  
The   furthest   ‘upstream’   mechanism   of   the   GOSR2-­PME   phenotype   is  
partially   impaired  Membrin   due   to   the   pathogenic   SNARE  motif   mutations.  
This   conclusion   is   most   directly   suggested   by   Nancy   Malintan’s   yeast  
liposome   fusion   data.   Indirectly,   also   the   partial   phenotypic   rescue   of  
membrin   null   Drosophila   by   mutant   Membrin   also   supports   this   notion.  
Similarly,  the  observation  that  a  key  phenotype  of  GOSR2-­PME  Drosophila  –  
pharate   adult   stage   lethality   –   are   recapitulated   by  membrin   RNAi   knock-­
down  are   in  accord  with   reduced   function   conferred  by  mutant  Membrin.  A  
partial   loss   of   function   mechanism   –   as   opposed   to   gain   of   function   –   is  
consistent  with  the  autosomal-­recessive  transmission  of  the  disorder  and  the  
observation   that   both   pathogenic   mutations   disrupt   the   essential   SNARE  
domain.   Membrin   with   a   reduced   capability   of   forming   a   tight   cis-­Golgi  
SNARE  complex  (with  its  SNARE  partners  Bet1,  Syntaxin-­5  and  Sec22b)  will  
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cause   reduced  membrane   fusion   rates   at   the   cis-­Golgi.   Increases   in   body  
temperature  might   further  destabilize  the  mutant  cis-­Golgi  SNARE  complex,  
which   could   be   an   explanation   why   several   GOSR2-­PME   patients   were  
reported  to  have  suffered  from  fever  induced  declines  (Boissé  Lomax  et  al.,  
2013;;  Praschberger  et  al.,  2015).  
5.1.2          Non-­neuronal  mechanism  
Based  on  unimpaired  ER-­to-­Golgi   trafficking   rates   in  a  non-­neuronal  model  
cell  type  we  now  believe  that  these  partial  ERGIC/cis-­Golgi  fusion  deficits  are  
not  sufficient  to  impair  non-­neuronal  cells  to  a  large  enough  degree  to  cause  
symptoms.  This  notion  serves  as  a  plausible  explanation  why   tissues  other  
than  the  nervous  system  do  not  largely  contribute  to  the  disease  phenotype.  
It   has   to   be   noted   however,   that   more   detailed   experimental   and   clinical  
analysis   might   reveal   measurable   abnormalities   also   in   non-­neuronal,  
asymptomatic   organ   systems.   For   instance,   it   is   likely   that   other   cell   types  
with   large   ER-­to-­Golgi   trafficking   demands   –   such   as   plasma   or   exocrine  
pancreas   cells   –   will   display   subtle   delays   when   harboring   a   G144W   or  
K164del  Membrin  mutation.  
A   non-­neuronal   cell   type   that   appears   to   frequently   cause   measurable  
changes   in  GOSR2-­PME   is   muscle,   as   several   patients   were   reported   to  
have   increased   creatine   kinase   levels.   However,   muscle   histology   was  
reported  as  normal   throughout   (Boissé  Lomax  et  al.,  2013;;  van  Egmond  et  
al.,   2015).   Nevertheless,   this   finding   indicates   that   also   muscle   might   be  
highly  vulnerable  to  Membrin  mutations.  
5.1.3          Neuronal  mechanisms  
While  partial  ERGIC/cis-­Golgi  lipid  fusion  deficiencies  due  to  the  pathogenic  
Membrin  mutations  might  fall  below  a  symptomatic  threshold  in  organs  other  
than   the  nervous  system,   they  seem  nevertheless  substantial  enough  to  be  
highly   deleterious   in   the   context   of   the   very   large   trafficking   demands   of  
neurons.  Neurons  appear   like  magnifying  glasses   for  subtle  early  secretory  
pathway  deficits  induced  by  Membrin  mutations.  Our  study  thereby  provides  
experimental   support   for   the   postulated   idea   that   ‘because   of   the   extreme  
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and   specialized   demands   of   neuronal   membrane   growth,   relatively   small  
losses  of   function   in   the  pathway   from  synthesis   to   insertion  might   interfere  
with  neuronal  membrane  expansion  and  nervous  system  function  selectively,  
without   critically   affecting   other   organs’   (Pfenninger,   2009).   Also  
oligondendrocytes  and  Schwann  cells  have  very  large  membrane  demands,  
because   they   wrap   around   axons   multiple   times   with   thin   membrane  
protrusions   in  order   to  provide  efficient   insulation   (Nave  and  Werner,  2014;;  
Sherman  and  Brophy,   2005).   Therefore   it   is   conceivable   that   also  a   partial  
hypomyelination  might  contribute   to   the  neurological  phenotype  of  GOSR2-­
PME.  However,  due  to  their  expected  partial  nature  they  might  frequently  fall  
below   the  detection   threshold  of   common  clinical   tests,  which  might  be   the  
explanation   why   nerve-­conduction   studies   and   MRI   investigations   do   not  
typically  indicate  myelination  defects  in  GOSR2-­PME  patients  (Boissé  Lomax  
et  al.,  2013).  
Similar  to  the  selective  vulnerability  of  neurons  amongst  all   the  different  cell  
types   constituting  a  human  being,  we  postulate   that   also  amongst   neurons  
certain   neuronal   subtypes   are   likely   to   be   more   severely   disturbed   than  
others   by   the   pathogenic   Membrin   mutations.   Such   differential   changes  
amongst   various   neuronal   subpopulations   might   be   the   explanation   of   the  
neurological  GOSR2-­PME  hallmarks,  which  are  high  level,  complex  network  
phenomena   ultimately   triggered   by   an   innumerable   number   of   individual  
neurons.    
GOSR2-­PME   model   Drosophila   exhibited   profoundly   impaired   dendritic  
growth   in   highly   elaborate   sensory   body   wall   neurons   –   which   served   as  
model  neurons  to  study  dendritic  plasma  membrane  expansion.  This  finding  
highlights   the   notion   that   the   pathogenic   Membrin   mutations   act   as  
hindrances  for  dendritic  growth  by  limiting  the  large  amounts  of  required  lipid  
supplies.   Such   a   bottleneck  might   be   particularly   relevant   for   neurons  with  
very   large  dendritic  arbors,  which   require  proportionally   larger   lipid  supplies  
to  enable  their  growth.  One  such  neuron  type  is  the  cerebellar  Purkinje  cell.  
Thus   we   hypothesize   that   this   neuron   type   is   very   likely   to   have  
underdeveloped  dendritic  arbors   in  GOSR2-­PME  patients.   Its  dysfunction   is  
an   attractive   explanation  why  one  of   the   syndrome’s   hallmarks   is   profound  
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ataxia,   given   the   Purkinje   cell’s   established   role   in   motor   coordination  
(Cerminara   et   al.,   2015).   In   order   to   test   our   prediction,   Golgi   staining   of  
GOSR2-­PME   cerebellar   Purkinje   cells   would   be   an   interesting   future  
research  avenue,  should  sufficient  human  brains  of  this  very  small  cohort  of  
patients  become  available.  
Patients  with  GOSR2-­PME  do  not  typically  present  with  mental  retardation  or  
a  profound  reduction  in  cognitive  function,  as  opposed  to  several  other  forms  
of   progressive   myoclonus   epilepsy,   which   are   characterized   by   the  
development   of   dementia   (Michelucci   et   al.,   2012).   While   intelligence   is  
usually   largely   normal   in   the   early   disease   course   of  GOSR2-­PME,   some  
patients   have   been   reported   with   mild   cognitive   impairment   later   in   life  
(Boissé   Lomax   et   al.,   2013).   We   hypothesize   that   this   remarkable  
preservation   of   cognitive   function  might   also   be   explained   by   a   differential  
effect  of   the  Membrin  mutations  upon  different  neuronal  subtypes.  Possibly  
only   neurons   with   very   large   dendritic   arbors   exhibit   growth   defects,   while  
most   neurons   with   smaller   neuronal   dendritic   trees   are   spared   from   such  
defects.   This   hypothesis   could   readily   be   addressed   in   Drosophila   by  
comparing  dendritic  growth  defects  in  Membin  mutant  larval  sensory  neurons  
that  are  highly  elaborate  (class   IV  da  neurons  –  see  above)  with   those  that  
have  fewer  and  shorter  dendrites  (class  I  and  II)  (Grueber  et  al.,  2002).  
Consistent  with  the  previous  literature,  we  found  that  early  secretory  pathway  
defects   conferred   by   Membrin   mutations   did   not   critically   affect   axonal  
outgrowth,  while  significantly  impacting  dendrite  length  (Ye  et  al.,  2007).  This  
privileged   role   of   axons   in   GOSR2-­PME   Drosophila   might   provide   an  
explanation  why  patients  with  this  disorder  suffer  from  ataxia,  but  not  spastic  
paraplegia.  After  all,  corticospinal  neurons  serving   the   lower   limbs  have   the  
longest  axons,  which  thus  would  be  highly  vulnerable  targets  should  dendritic  
and  axonal  development  be  affected  in  equal  measure  (Synofzik  and  Schüle,  
2017).    
Also   synaptic   abnormalities   found   in   GOSR2-­PME   Drosophila   reveal  
valuable  insights  into  the  pathophysiology  underlying  the  clinical  presentation  
of   this   disorder.   As   a   model   synapse,   James   Jepson   and   Simon   Lowe  
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studied  the  morphology  and  physiology  of  the  larval  neuromuscular   junction  
(NMJ),   because   it   is   highly   amenable   for   experiments   (Harris   and  Littleton,  
2015).   There   the   most   salient   findings   were   a   decrease   in   trans-­synaptic  
stability  and  hyperactive  evoked  neurotransmission.  Because  the  underlying  
partial  secretory  pathway  disruption  due  to  Membrin  mutations  are  ubiquitous  
to  all  neurons  we  hypothesize  that  similar  alterations  are  likely  to  also  affect  
central   synapses.   Given   that   EPSP  malformations   were   more   pronounced  
under  high-­frequency  stimulation  we  would  expect  central  neurons  with  rapid  
firing   patterns   to   be  more   severely   affected,   such   as   fast-­firing  GABAergic  
neurons   (McCormick   et   al.,   1985).   It   is   conceivable   that   a   systematic  
impairment   of   distinct   neuronal   subclasses   based   on   their   intrinsic  
electrophysiological   properties   would   eventually   tilt   the   balance   between  
excitation  and  inhibition  towards  hyper-­excitation.  This  thought  thus  provides  
–   a   necessarily   oversimplified   –   explanatory   framework   of   how   cortical  
myoclonus  and  generalized  epilepsy  might  arise  from  the  GOSR2  mutations.    
Our   NMJ   findings   of   synaptic   retraction   and   altered   neurotransmission   in  
GOSR2-­PME   Drosophila   have   interesting   parallels   in   human   patients.  
Several   of   them   were   found   in   electromyography   studies   to   suffer   from  
neuromuscular   denervation   (van   Egmond   et   al.,   2014).   The  GOSR2-­PME  
clinical   hallmark   of   absence   of   deep   tendon   reflexes   might   also   be   an  
indication  of  such  changes,  but  could  also  point  towards  other  deficiencies  in  
the   reflex   arc,   such   as   in   afferent   sensory   neurons   (Boissé   Lomax   et   al.,  
2013).    
Skeletal   abnormalities   have   been   reported   in  GOSR2-­PME   patients,   most  
commonly   scoliosis.   As   of   now   it   is   unclear   whether   this   is   a   secondary  
consequence   due   to   the   severe   neurological   deficits   in   this   disorder   or   a  
spine   intrinsic   developmental   abnormality   (Grauers   et   al.,   2016;;   Trontelj   et  
al.,   1979).   Possibly   delayed   cell   surface/extracellular   localisation   of   Notch,  
Wnt  and/or  fibroblast  growth  factor,  which  are  critical  for  segmentation,  could  
contribute  to  the  development  of  scoliosis  in  GOSR2-­PME  (Boissé  Lomax  et  
al.,  2013;;  Pourquié,  2011).    
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Why   GOSR2-­PME   is   a   progressive   disorder,   characterized   by   rapid  
deterioration   of   movement   disorder   features   and   subsequent   loss   of  
ambulation,   is  presently  unclear.  Nevertheless,  our  Drosophila   findings  offer  
starting   points   to   formulate   hypotheses   regarding   the   underlying  
pathophysiology.  Several  processes  might  act  collectively  at  the  heart  of  the  
disease   progression   observed   in   GOSR2-­PME.   The   pathogenic   Membrin  
mutations   might   continue   to   negatively   impact   neurodevelopment   as   the  
brains   of   children   suffering   from  GOSR2-­PME   mature   and   grow   into   their  
fully   connected  adult   versions   (Giedd  et   al.,   1999;;  Passemard  et   al.,   2017;;  
Supekar   et   al.,   2009).   In   addition,   our   finding   of   trans-­synaptic   instability  
implies   that   functional   active   zones   might   gradually   be   removed   with  
increasing   age.   It   is   also   conceivable   that   changes   in   synaptic   or   dendritic  
proteomes  as   a   result   of   secretory   pathway  deficits   could   contribute   to   the  
progressive   nature   of   the   disease.  For   instance,   reduced   levels   of   proteins  
critical   for   maintaining   proteostasis   could   have   age   dependent  
synaptic/dendritic   degeneration   as   a   consequence.   Interestingly,   James  
Jepson  found  significantly  reduced  levels  of  the  synaptic  chaperone  CSP  at  
the  NMJ  of  Membrin  mutant  Drosophila.  The  mammalian  CSPa  orthologue  is  
a   synaptic   vesicle-­associated   chaperone   that   is   critical   for   preventing  
neurodegeneration  (Chandra  et  al.,  2005;;  Fernández-­Chacón  et  al.,  2004).  In  
turn,   mutations   in   CSPa   have   been   demonstrated   to   cause   adult-­onset  
neuronal   ceroid-­lipofuscinosis,   which   is   a   neurodegenerative   form   of   PME  
(Benitez   et   al.,   2011;;   Nosková   et   al.,   2011).   Thus,   Membrin   and   more  
generally,   efficient   ER-­to-­Golgi   trafficking,   might   not   only   be   critical   for  
dendritic   and   synaptic   development,   but   also   its   maintenance.   This   is   a  
readily   testable   hypothesis,   with   scientific   relevance   beyond   the   immediate  
problem   of   disentangling   the   causes   of   the   progressive   nature   of  GOSR2-­
PME.  To  this  end,  we  could  express  the  Membrin  mutations  –  or  induce  even  
more  severe  secretory  pathway  disruption  by  expressing  Rab1,  Sar1  or  Arf1  
mutants   –   selectively   at   the   adult   stage   and   thereby   bypass  
neurodevelopmental   defects.   Starting  with   a   healthy   neuron  we   could   then  
assess   the   impact   of   the   acutely   induced   disturbances   upon   dendritic  
elaboration  and  synaptic  integrity  as  a  function  of  time.  
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5.2          Lessons  for  neuronal  cell  biology  
The   mechanisms   presented   in   this   thesis   are   relevant   for   the  
pathophysiology  of   a   very   small   patient   cohort   of   thus   far  only  18  GOSR2-­
PME  cases.  However,  this  does  not  limit  the  relevance  of  our  investigations,  
as   we   also   yielded   insights   into   the   cell   biology   of   neurons.  We   therefore  
provide   results   with   wider   applicability.   While   previous   studies   have  
established   that   a   very   large   or   complete   block   of   ER-­to-­Golgi   trafficking  
prevents   efficient   dendritic   outgrowth,   we   have   added   experimental   data,  
which  support  the  postulated  idea  that  even  minor  alterations  along  this  route  
are   sufficient   to   negatively   impact   neuronal   plasma   membrane   expansion  
(Horton  et  al.,  2005;;  Ye  et  al.,  2011;;  Pfenninger,  2009).  Partial  alterations  in  
this  pathway  are  likely  to  be  more  relevant  for  human  disorders  as  compared  
to   a   complete   block,   which   is   not   compatible   with   cellular,   let   alone  
multicellular,  life.  Our  study  has  also  taught  us  that  synaptic  morphology  and  
physiology  depends  upon  tightly  regulated  ER-­to-­Golgi  trafficking  rates.  One  
might   think   that  such  a  result  does  not  come  as  a  complete  surprise,  given  
that  functional  synapses  require  timely  delivery  of  a  whole  host  of  secretory  
pathway  dependent  proteins.  Yet   to  our  knowledge   this  connection  of  early  
secretory   pathway   trafficking   rates   and   synaptic   abnormalities   has   thus   far  
not  been  a  focus   in   the   literature  (Passemard  et  al.,  2017).  Taken  together,  
because  our  findings  are  based  on  a  very  severe  Mendelian  human  disorder  
we   provide   an   instance   that   directly   illustrates   that   partial   ER-­to-­Golgi  
trafficking  reductions  can  be  highly  relevant  for  human  disease.  
5.3          Future  perspectives  
Our  study  has  provided  a  possible  solution  for  the  apparent  paradox  of  how  
mutations   in   the  ubiquitous  Golgi  SNARE  protein  Membrin  can   result   in  an  
almost   exclusive   neuronal   phenotype.   Yet   some   questions   remain   to   be  
answered  and  several  new  questions  have  arisen  from  our  results.   It  would  
be   interesting   to   test  whether   neurons  with   very   large   dendritic   arbors   and  
neurons   with   high   firing   frequencies   indeed   are   most   vulnerable   to   the  
pathogenic   Membrin   mutations.   The   contribution   of   impaired   dendritic   and  
synaptic   maintenance   –   as   opposed   to   impaired   development   of   these  
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compartments   –   to   the   pathogenesis   of  GOSR2-­PME   is   another   intriguing  
issue.   Also,   the   mechanisms   underlying   the   multifaceted   synaptic  
abnormalities   caused   by   Membrin   mutations   require   further   investigation.  
More   generally,   the   relationship   of   tightly   controlled   trafficking   rates   and  
synaptic   integrity   could   reveal   insights   that   might   also   be   valuable   for   the  
research   of   unrelated   brain   disorders.   Which   are   the   cargoes   that   are  
particularly   relevant   for   the   observed   morphological   and   physiological  
abnormalities?  Is  it  trans-­synaptic  adhesion  molecules,  ion  channels,  trophic  
factors,  etc.?  Many  synaptic  proteins  will  presumably  be  dysregulated  due  to  
a   delay   in   transport   vesicle   fusion  with   the   ERGIC/cis-­Golgi.   Therefore  we  
are  likely  facing  a  complex  phenomenon,  which  bears  the  danger  of  residing  
beyond  the  explicitly  graspable.  Unbiased  synaptic  proteomics  in  Drosophila,  
where   key   ER-­to-­Golgi   trafficking   proteins   are   either   knocked-­down   or  
mutated,  might  nevertheless  provide   interesting  candidates,   that  could   then  
be   validated   in   genetic   interaction   studies.   However,   given   the   very   large  
amounts   of   Drosophila   heads   required   for   the   preparation   of   synaptic  
fractions,   mouse   models   might   be   experimentally   more   suitable   for   this  
question  (Depner  et  al.,  2014).  Another  interesting  avenue  of  future  research  
would   be   the   investigation   of   potential   shared   molecular   and/or   cellular  
pathways  of  GOSR2-­PME  with  other  phenotypically  similar  forms  of  PMEs.    
5.3.1          Knock-­in  strategy  
Future   studies   into   the   mechanisms   of   GOSR2-­PME   would   greatly   be  
facilitated   by   the   generation   of   additional   Drosophila   models.   Our   current  
models  harbor   two  membrin  null  alleles,   the  global  da-­Gal4  driver  and  wild-­
type   or  mutant   UAS-­membrin   transgenes.   These   components   occupy   both  
major  autosomal  Drosophila  chromosomes,  which  makes  genetic  interaction  
studies  more  difficult.  In  addition,  because  the  UAS-­Gal4  system  is  already  in  
use  to  globally  express  the  transgenes,  we  cannot  rely  upon  this  most  widely  
used  binary  system  to  access  distinct  neuronal  circuits  (Brand  and  Perrimon,  
1993).  Orthogonal  binary  systems,  such  as  LexAop-­LexA,  would  be  required,  
where   less   tools   are   currently   available   as   compared   to   the   UAS-­Gal4  
system   (Lai   and   Lee,   2006;;   Pfeiffer   et   al.,   2010).   The   availability   of   fewer  
driver   lines   as  well   as   high   complexity   of   genetic   crossing   schemes  would  
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make  it  rather  cumbersome  to  express  optogenetic  actuators,  neural  activity  
sensors   or   knock-­down   genes   of   interest   in   our  GOSR2-­PME   models.   To  
circumvent   these  problems,  membrin  manipulations  within   its   own  genomic  
locus   are   required.   Therefore,   I   have   carefully   designed   and   initiated   two  
independent   approaches,   one   based   on   ends-­out   homologous  
recombination,   the   other   one   based   on   CRISPR/Cas9   with   subsequent  
homology   directed   repair   from   a   single   stranded   oligonucleotide   donor  
(Baena-­Lopez  et  al.,  2013;;  Gratz  et  al.,  2013;;  2014;;  Rong  and  Golic,  2000).  
Their  common  goal   is   the  replacement  of   the  membrin  5’  UTR  and  most  of  
the  subsequent  coding  sequence  with  an  attP   landing  site  plus  an  adjacent  
loxP   site.   This   make-­up   allows   for   efficient,   site-­specific   retargeting   of   this  
membrin  null  locus  with  any  sequence  of  choice  and  for  the  subsequent  Cre-­
mediated   removal   of   the   plasmid   backbone   (Baena-­Lopez   et   al.,   2013;;  
Bischof  et  al.,  2007).  In  a  first  step,  I  would  retarget  wild-­type  and  mutant  N-­
terminal  FLAG  tagged  membrin  cDNA.  These  animals  would  represent  single  
component  GOSR2-­PME  Drosophila  models,  with  expression  levels  close  to  
physiological.   Such   models   would   also   allow   to   test   whether   endogenous  
wild-­type   and   mutant   Membrin   indeed   localize   to   axons/synapses,   as  
observed  in  overexpression  studies.  In  a  second  step,  I  would  retarget  a  FRT  
flanked   wild-­type  membrin   sequence,   that   is   followed   by   mutant  membrin.  
Such   FRT-­membrin[WT]-­FRT-­membrin[G147W]/[K166del]   flies   would   allow  
for  temporally  and/or  spatially  controlled  switching  of  the  wild-­type  isoform  for  
either   of   the  mutants   by   restricted   expression   of   the   recombinase   flippase  
(Baena-­Lopez   et   al.,   2013).   This   approach   would   facilitate   the   study   of  
potential   synaptic/dendritic   maintenance   defects   in   membrin   mutant  
Drosophila  as  well  as  the  investigation  of  the  relative  contributions  of  different  
neuronal  subclasses  to  the  pathophysiology  of  GOSR2-­PME.  
5.3.2          Shared  mechanisms  with  other  PMEs?  
The  progressive  myoclonus  epilepsies  are  phenotypically  heterogeneous  and  
several  different  causative  genes  are  known  to  date  (Michelucci  et  al.,  2012).  
Therefore  it  is  unlikely  to  find  a  common  pathophysiological  denominator  for  
this   whole   diverse   group.   Nevertheless,   some   of   the   phenotypically   more  
similar   PMEs   might   share   cellular   pathways   and/or   neural   circuits   with  
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GOSR2-­PME,  which  would   be   interesting   avenues   for   future   research.   For  
instance,  the  PME  gene  PRICKLE1  has  been  linked  to  neurite  growth,  which  
we   found   to   also   be   abnormal   in   Drosophila   harboring   the   pathogenic  
Membrin  mutations  (Liu  et  al.,  2013).  PME-­linked  mutations  in  the  potassium  
channel   gene   KCNC1   are   thought   to   mainly   impair   fast-­spiking   neurons  
(Muona  et  al.,  2015;;  Oliver  et  al.,  2017).  Such  a  preferential  defect   in  high-­
frequency   firing  neurons   is   also   conceivable   in  GOSR2-­PME,  where  EPSP  
dysmorphologies  are  more  pronounced  under  repetitive  stimulation.    
5.3.3          Membrin   mutations   as   tools   for   cell   biology   and  
neuroscience  
Finally,  our  study  also  suggests  that  the  pathogenic  GOSR2-­PME  mutations  
could   serve   as   tools   for   cell   biology   and   neuroscience.   Because   these  
mutations  are  not   cell   lethal   they   can  be   integrated   into   cell   lines  or  whole  
organisms.   Even   more   simple   than   that,   they   can   be   overexpressed   in  
otherwise   wild-­type   cells   or   animals,   as   we   found   that   overexpression   of  
mutant  Membrin   resulted   in   similar   phenotypes  as   in  our  models  where  no  
endogenous  wild-­type  Membrin  was  present.  Similarly,  dendritic  growth  was  
also   inhibited   when   mutant   Membrin   was   overexpressed   in   a   wild-­type  
membrin   Drosophila,   which   therefore   provides   an   indirect   readout   for  
impaired  secretory  trafficking.  These  findings  imply  that  the  more  abundantly  
present   mutant   Membrin   might   outcompete   the   endogenous   protein.   If  
several-­fold  more  mutant  than  wild-­type  Membrin  proteins  are  present  at  the  
ERGIC/cis-­Golgi,   then   it   is   conceivable   that   the   majority   of   these   SNARE  
complexes   might   contain   mutant   instead   of   wild-­type   Membrin.   Thus  
overexpression   of   the   reduction   of   function   mutant   Membrin   alleles   could  
mimic  a  gain  of  function  mechanism  and  serve  as  valuable  tools  for  basic  cell  
biology   studies.   Other   commonly   overexpressed   mutants   in   the   ER-­Golgi  
pathway  are  Sar1[H79G],  Sar1[T39N],  Arf1[Q71L],  Arf1[T31N],  Rab1[Q70L]  
and  Rab1[S25N],  which  all  disrupt  different  steps  in  this  process  (Allan  et  al.,  
2000;;   Dascher   and   Balch,   1994;;   Tisdale   et   al.,   1992;;   Ward   et   al.,   2001;;  
Zhang   et   al.,   2007).   Overexpression   of   G144W/G147W,   K164del/K166del  
mutant  Membrin  would  inhibit  another  distinct  step  in  this  pathway.  
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Even  overexpression  of  wild-­type  Membrin  could  be  utilized  as  a  milder  allele  
to   impair  secretory   trafficking.  After  all,  we  observed   that  overexpression  of  
wild-­type  Membrin  in  flies  where  endogenous  Membrin  was  present,  resulted  
in   organismal   and   dendritic   phenotypes.   However,   these   phenotypes   were  
significantly   weaker   than   those   observed   in   either   of   the   mutants.   The  
seeming   paradox   of   how   similar   phenotypes   can   arise   from   reduction   of  
function  Membrin  alleles  and  increased  wild-­type  Membrin  levels  might  have  
an   explanation   in   shared   cellular,   but   distinct  molecular  mechanisms.   Both  
interventions   might   partially   block   secretory   trafficking,   albeit   at   different  
steps.   While   the   Membrin   mutations   are   thought   to   impair   the   cis-­Golgi  
SNARE   complex,   we   hypothesize   that   increased   wild-­type   Membrin   levels  
partially   inhibit   the   trans-­Golgi   SNARE   complex   by   acting   as   an   i-­SNARE.  
Varlamov   et   al.   demonstrated   that   increasing   the   concentrations   of   the  
Membrin   ortholog   Bos1   (or   Bet1/Sec22)   causes   reduced   fusion   rates   of  
liposomes  reconstituted  with  the  yeast  trans-­Golgi  SNAREs  (Varlamov  et  al.,  
2004).  However,  endogenous  Membrin  concentrations  in  the  trans-­Golgi  are  
very  low  and  therefore  might  only  exert  a  comparably  subtle  inhibitory  effect,  
that   is   thought   to   be   relevant   only   for   fine-­tuning   of   fusion   specificity  
(Varlamov  et  al.,  2004;;  Volchuk  et  al.,  2004;;  Hay  et  al.,  1998).  In  contrast,  if  
we  artificially   increase  Membrin   in   this  compartment  by  overexpression,   the  
trans-­Golgi   SNARE   complex   might   be   significantly   inhibited   and   thus  
secretory  trafficking  rates  markedly  reduced.  
In   neuroscience   studies   the   mutant   (and   wild-­type)   Membrin   transgenes  
could   serve   as   tools   to   further   investigate   the   consequences   of   partial  
secretory  pathway  defects  in  different  neuron  subclasses  or  simply  to  restrict  
dendritic  outgrowth.  Overexpressing  the  Membrin  mutants  in  fully  developed  
wild-­type   neurons   would   also   allow   to   bypass   neurodevelopmental   defects  
conferred  by  the  Membrin  mutations  and  thus  disentangle  their  impact  upon  
neuronal  maintenance.    
5.4          Final  conclusions  
Taken  together,  our  study  investigating  the  pathophysiology  of  GOSR2-­PME  
provided   a   potential   multi-­level   explanation   of   this   previously   poorly  
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understood   disorder.   Partial   SNARE   defects   are   thought   to   subtly   delay  
anterograde   cargo   trafficking   via   the   Golgi   apparatus.   This   kinetic   change  
presumably  falls  below  a  critical  threshold  in  non-­neuronal  cells  but  results  in  
multifaceted  effects  upon  neuronal  development  and   function,  because   this  
cell   type   poses   unique   demands   upon   this   basic   cellular   pathway.   The  
pathogenic  Membrin  mutations   significantly   reduce   dendritic   outgrowth   and  
cause   morphologically   abnormal,   hyperactive   synapses   –   neuronal  
abnormalities,  which   in   turn  are   thought   to  give   rise   to   the  core   features  of  
ataxia  and  hyperexcitability  as  observed  in  GOSR2-­PME  patients.  In  addition  
to   these   pathophysiological   insights,   our   study   also   highlights   lessons   for  
general  neuronal  cell  biology.  Our  findings  stress  a  very  intimate  connection  
of  tightly  controlled  anterograde  cargo  trafficking  rates  and  neuronal  integrity.  
Finally,   our   approach   of   overexpressing   mutant   Membrin   in   an   otherwise  
wild-­type   genetic   background   might   facilitate   future   cell   biological   and  
neuroscience  studies  by  readily  enabling  cis-­Golgi  SNARE  complex  inhibition  
in  a  temporally  controlled  and  cell  type  specific  manner.    
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codons mutated in below transgenes 
 
G147W 
 
gcggccgccgacATGGACTACAAAGACGATGACGACAAGGAGAGCTTGTACCACCAAACCAACAATGT
GGTAAAGGACATCGAGCGCGATTTCCAGCGACTGAGTCAGCTCAGTGCCCAGGAATCGCTTGACGTGG
AAAACGGCATTCAATTGAAGATTACCCAGGCGAACGCAAACTGCGATCGGTTGGATGTGCTGTTGTAT
AAGGTGCCACCTTCGCAGCGACAAAGCTCCAAACTTCGTGTGGATCAGCTGAAATATGACCTGAGACA
CCTGCAGACATCACTGCAGACGGCGCGGGAACGAAGACAGCGACGGATGCAGGAGATCTCCGAGAGGG
AACAGCTGCTGAATCACAGATTCACGGCAAACAGCGCGCAGCCGGAGGAAACGCGCCTGCAATTGGAC
TACGAACTGCAGCATCATACGCAGCTGGGTAACGCCCATCGGGGTGTGGACGACATGATTGCCTCGTG
GAGCGGCATTCTCGAGAGCCTGATCTCGCAGAGAATGACGCTGGGCGGAGCGCACAAGAGAATCCAGG
CGATAGGCAGCACACTGGGTCTGTCCAATCACACGATGAAACTTATTGAACGCCGGCTGGTCGAGGAT
CGTCGGATATTCATCGGAGGAGTGGTGGTCACCTTGCTTATCATCGCCCTGATCATCTATTTCCTAGT
GCTCTAAggtacc 
 
K166del 
 
gcggccgccgacATGGACTACAAAGACGATGACGACAAGGAGAGCTTGTACCACCAAACCAACAATGT
GGTAAAGGACATCGAGCGCGATTTCCAGCGACTGAGTCAGCTCAGTGCCCAGGAATCGCTTGACGTGG
AAAACGGCATTCAATTGAAGATTACCCAGGCGAACGCAAACTGCGATCGGTTGGATGTGCTGTTGTAT
AAGGTGCCACCTTCGCAGCGACAAAGCTCCAAACTTCGTGTGGATCAGCTGAAATATGACCTGAGACA
CCTGCAGACATCACTGCAGACGGCGCGGGAACGAAGACAGCGACGGATGCAGGAGATCTCCGAGAGGG
AACAGCTGCTGAATCACAGATTCACGGCAAACAGCGCGCAGCCGGAGGAAACGCGCCTGCAATTGGAC
TACGAACTGCAGCATCATACGCAGCTGGGTAACGCCCATCGGGGTGTGGACGACATGATTGCCTCGGG
CAGCGGCATTCTCGAGAGCCTGATCTCGCAGAGAATGACGCTGGGCGGAGCGCACA[]GAATCCAGGC
GATAGGCAGCACACTGGGTCTGTCCAATCACACGATGAAACTTATTGAACGCCGGCTGGTCGAGGATC
GTCGGATATTCATCGGAGGAGTGGTGGTCACCTTGCTTATCATCGCCCTGATCATCTATTTCCTAGTG
CTCTAAggtacc 
 
GOSR2 CDS 
FLAG 
Kozac sequence 
NotI 
KpnI 
 
